// Auto-generated by scripts/generate-verified-claims.js on 2025-10-28T06:23:04.355Z
// Do not edit by hand. Re-run the script with updated inputs.

export const MOCK_SIMILAR_PAPERS_LIBRARY = {
  "version": 2,
  "defaultEntryId": "3",
  "entries": [
    {
      "id": "3",
      "sourcePdf": {
        "path": "SCALING LARGE LANGUAGE MODELS FOR NEXT-GENERATION SINGLE-CELL ANALYSIS.pdf",
        "publicPath": "/mock-papers/3.pdf",
        "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
        "originalFileName": "SCALING LARGE LANGUAGE MODELS FOR NEXT-GENERATION SINGLE-CELL ANALYSIS.pdf",
        "doi": "10.1101/2025.04.14.648850doi",
        "pages": 29
      },
      "label": "SCALING LARGE LANGUAGE MODELS FOR NEXT-GENERATION SINGLE-CELL ANALYSIS",
      "generatedAt": "2025-10-25T03:44:22.763Z",
      "claimsAnalysis": {
        "text": "# Executive Summary **Main findings:**   1) The authors present C2S-Scale, an LLM family up to 27B parameters trained on \"cell sentences\" and text, claiming broad state-of-the-art performance across predictive, generative, and natural-language single-cell tasks. 2) Performance scales with model and data size, and reinforcement learning (GRPO) improves perturbation response prediction, including a reported 16% reduction in scFID on interferon genes. 3) A dual-context virtual screen nominates silmitasertib as an interferon-conditional amplifier of antigen presentation, validated in two human cell models with consistent MHC-I increases only in the presence of interferon.  **Headline numbers:** 95.43% cell-type annotation accuracy on an immune dataset (vs scGPT 93.1% and Geneformer 94.0%). GRPO gains: Kendall's τ +9.2% and Pearson's r +6.6% for a 410M model on L1000; τ +4.9% and r +3.6% for a 1B model; scFID on interferon-related genes -16%. Silmitasertib validation: MHC-I MFI increases of 13.6% at 10 nM and 34.9% at 1000 nM with IFN-β; 24.9% at 10 nM and 37.3% at 300 nM with IFN-γ; 17.1% at 10 nM and 28.1% at 100 nM in a second cell model.  **Overall evidence strength:** **Moderate.** The work reports consistent cross-task improvements and gives key numeric gains and wet-lab validation, but many evaluations are summarised without full statistics, several benchmarks rely on text metrics or internal datasets, and some details are confined to figures or Supplements not fully visible in the extract.  ---  # Top 3 Claims and Evidence  ## C1. C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks. **Evidence summary:** Multi-task benchmarking shows higher or comparable performance to scGPT and Geneformer on traditional single-cell tasks, plus superior natural-language interpretation and QA vs general LLMs. Example given: immune tissue dataset cell-type annotation at 95.43% accuracy, slightly better than scGPT and Geneformer. Also reports outperforming GPT-4o in natural-language QA by 3% BERTScore and leading cluster captioning and dataset-level interpretation benchmarks. Evidence type: computational benchmarking on held-out cells, clusters, datasets; language metrics (BERTScore) for text tasks.   **Key numbers:** 95.43% accuracy vs scGPT 93.1% and Geneformer 94.0% on immune data; QA BERTScore +3% vs GPT-4o.   **Source location:** Section 2.2 and Fig. 3; Section 2.4 and Fig. 5C-E; lines detailing 95.43% and the 3% QA margin in Section 2.2.   **Strength:** **Moderate.** Assumes fair, comparable fine-tuning; exact dataset sizes, CIs, and formal statistical tests are not reported in text. Language metrics may not fully capture biological correctness.   **Assumptions/conditions:** Comparisons are as described in the text; figures not directly inspectable here. No external validation set beyond those described.  ## C2. Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions. **Evidence summary:** Scaling from 410M to 27B parameters yields consistent gains across tasks; similar trends hold for LoRA-based fine-tuning and as training data grows. For perturbation response prediction, C2S-Scale beats scGen, scGPT, and CellOT on MMD, Wasserstein, and scFID. GRPO with biologically targeted rewards improves L1000 and cytokine-stimulation tasks, including a 16% scFID reduction on interferon-related genes. Evidence type: computational scaling studies and held-out perturbation benchmarks; embedding-space distributional metrics; RL ablations.   **Key numbers:** Parameter range 410M to 27B; scFID on interferon-related genes -16% with GRPO; L1000 gains: Kendall's τ +9.2% and Pearson's r +6.6% for 410M, τ +4.9% and r +3.6% for 1B; outperforms baselines across MMD, Wasserstein, scFID.   **Source location:** Section 2.3 and Fig. 4C-E; Section 2.7 and Fig. 8E-G.   **Strength:** **Moderate.** Clear directional effects with specific improvements reported, but full numeric baselines, confidence intervals, and dataset sizes per metric are not provided in text.   **Assumptions/conditions:** Benchmarks and metrics are as summarised; scFID uses scGPT embeddings; task mixes are comparable between models.  ## C3. A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models. **Evidence summary:** Dual-context in-silico screen predicted a context split for silmitasertib, with strong MHC-I increases only under low-level interferon signalling. Interferon activity in screen contexts differed strongly (****, P < 0.0001, Wilcoxon). Wet-lab validation showed no effect of silmitasertib alone but marked HLA-A,B,C surface increases with low-dose IFN-β and IFN-γ in Merkel-origin cells, replicated in a pulmonary model. Evidence type: computational prediction followed by experimental validation with flow cytometry.   **Key numbers:** IFN context difference: ****, P < 0.0001. Merkel model with IFN-β: MHC-I MFI +13.6% at 10 nM, +34.9% at 1000 nM. With IFN-γ: +24.9% at 10 nM, +37.3% at 300 nM. Pulmonary model: +17.1% at 10 nM and +28.1% at 100 nM. n = 3 independent experiments; two-sided tests with multiple-comparison correction.   **Source location:** Section 2.8 and Fig. 9B-H; Methods 4.8-4.9.   **Strength:** **Moderate.** Replicated across two models with coherent dose responses, but small n, absence of exact p-values for MFI changes in text, and limited cell-type diversity.   **Assumptions/conditions:** The IFN-conditional effect is defined by increases in MHC-I MFI under stated IFN doses; training did not include these cell models.  ---  # Gaps & Limitations (linked to C1-C3) - **Benchmark transparency and statistics (C1, C2):** Many results are summarised without full sample sizes, confidence intervals, or p-values in text. Several outcomes rely on BERTScore rather than biological ground truth for text tasks. Source: Sections 2.2, 2.4; Fig. 3, Fig. 5.   - **Potential evaluation bias and metric dependence (C2):** scFID depends on embeddings from another model (scGPT), which may bias comparisons. Distributional metrics are reported without detailed uncertainty. Source: Section 2.7 and 4.7; Fig. 8E-G.   - **Small-scale wet-lab validation (C3):** n = 3 experiments per condition, two cell models only, no in vivo validation, and no exact p-values for MFI changes in text. Source: Section 2.8; Fig. 9F-H; Methods 4.9.   - **Model architecture caveats and hallucination risk (C1, C2):** Authors note unidirectional causal attention limitations and LLM hallucinations for open-ended tasks. Source: Supplementary 7.1.1-7.1.2.   - **OCR/visibility constraints:** Figures and tables are referenced but not viewable here; some spacing artefacts in numbers and units are present [UNCLEAR].  ---  # Methods Snapshot - **Design:** Develop LLMs that encode scRNA-seq profiles as ranked \"cell sentences\" and jointly train on multimodal corpus with text and metadata. Two-phase training: large-scale self-supervision plus task-specific fine-tuning, with optional GRPO reinforcement learning. Introduces scFID for generative evaluation.   - **Data:** >50 million human and mouse single cells from CELLxGENE and Human Cell Atlas with associated text; additional datasets for tasks including CosMx liver spatial data, Dong et al. cytokine perturbations, and L1000 bulk landmark genes. Source: Sections 2.1, 4.1-4.3, 4.6-4.8.   - **Models:** Decoder-only Transformer backbones up to 27B parameters; input is tokenised gene names with positional encodings preserving rank order; LoRA used for parameter-efficient tuning. Source: Sections 2.1, 4.3-4.5.   - **Analyses:** Benchmarks across classification, generation, embedding, spatial reasoning, NL interpretation, QA, and perturbation prediction; metrics include BERTScore, overlap, MMD, Wasserstein, scFID. Source: Sections 2.2-2.7; 4.4-4.7.  ---  # Risk-of-Bias and Quality Checklist - **Clear primary outcomes and metrics specified:** Partially. Several metrics named, but full numeric details often in figures or Supplement.   - **Comparators appropriate and described:** Yes, named baselines include scGPT, Geneformer, scGen, CellOT, Llama, GPT-4o, etc., but configuration details are brief.   - **Train-test separation and OOD tests:** Claimed for several tasks, including unseen studies and perturbations. Details are summarised, not fully enumerated.   - **Statistical reporting:** Limited in text; few confidence intervals or exact p-values beyond the **** P < 0.0001 IFN context contrast.   - **External validation:** Wet-lab validation for one discovery across two cell models; broader external validations not reported in text.   - **Risk of leakage or overfitting controls:** Not fully detailed; authors note held-out partitions and OOD sets; some training data used to generate language targets with GPT models.   - **Limitations acknowledged by authors:** Yes, causal attention constraints and hallucination risks.   Overall quality: **Moderate**, chiefly due to summarised reporting and reliance on internal metrics without full statistical detail in the text.  ---  # Open Questions and Next Steps 1) **Generalisation of IFN-conditional amplification:** Test silmitasertib across additional tissues, primary cells, and IFN dose-response curves, including mechanistic assays for CK2-STAT1/IRF1 pathway modulation. Source link: Section 2.8; Fig. 9E-H.   2) **Robustness of scFID and embedding-metric conclusions:** Compare scFID using alternative embedding models and report variance and CIs to assess metric sensitivity. Source: Sections 2.7, 4.7.   3) **Benchmark transparency:** Release full per-task numeric tables with N, effect sizes, and uncertainty; include pre-registered evaluation splits. Source: Sections 2.2-2.7; Fig. 3-6, 8.   4) **Mitigating hallucination in NL tasks:** Add constrained decoding or fact-checking against curated gene and pathway KBs for dataset interpretation and cluster captioning. Source: Supplementary 7.1.2.   5) **Architectural exploration:** Evaluate hybrid attention or order-invariance strategies to address causal attention limitations and quantify gains on biologically causal tasks. Source: Supplementary 7.1.1.  ---  ## QA Check - All required sections present.   - Numbers match the provided text exactly.   - Each of C1-C3 includes a strength rating and specific source locations.   - Missing figure values are acknowledged where precise numbers are not visible.",
        "structured": {
          "executiveSummary": [
            "C2S-Scale (up to 27B parameters) trained on \"cell sentences\" and text shows broad state-of-the-art performance across predictive, generative, and natural-language tasks.",
            "Scaling and GRPO improve performance; reported scFID -16% on interferon genes; L1000 gains in Kendall's τ and Pearson's r.",
            "Virtual screen plus wet-lab validation identifies silmitasertib as an interferon-conditional amplifier of antigen presentation.",
            "Overall evidence strength: Moderate."
          ],
          "claims": [
            {
              "id": "C1",
              "claim": "C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks.",
              "evidenceSummary": "Multi-task benchmarking on held-out single-cell tasks and natural-language interpretation shows higher or comparable performance to scGPT and Geneformer, and improved NL interpretation and QA vs general LLMs; example immune dataset cell-type annotation reaches 95.43% accuracy.",
              "keyNumbers": [
                "95.43% accuracy vs scGPT 93.1% and Geneformer 94.0% (immune dataset)",
                "QA BERTScore +3% vs GPT-4o"
              ],
              "source": "Section 2.2; Fig. 3. Section 2.4; Fig. 5C-E.",
              "strength": "Moderate",
              "assumptions": "Assumes comparable fine-tuning and evaluation across models; figures not directly inspectable; language metrics may not fully reflect biological correctness.",
              "evidenceType": "Computational benchmarking on held-out datasets (classification, generation, NL interpretation, QA)."
            },
            {
              "id": "C2",
              "claim": "Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions.",
              "evidenceSummary": "Performance improves from 410M to 27B parameters and with more data; LoRA shows similar trends. Perturbation prediction benchmarks show superiority over scGen, scGPT, CellOT on MMD, Wasserstein, scFID; GRPO yields a 16% scFID reduction on interferon genes and gains on L1000.",
              "keyNumbers": [
                "Model size: 410M-27B",
                "scFID on interferon-related genes -16% with GRPO",
                "L1000: Kendall's τ +9.2% and Pearson's r +6.6% (410M)",
                "L1000: Kendall's τ +4.9% and Pearson's r +3.6% (1B)"
              ],
              "source": "Section 2.3; Fig. 4C-E. Section 2.7; Fig. 8E-G.",
              "strength": "Moderate",
              "assumptions": "scFID computed in scGPT embedding space; baselines and task mixes as summarised.",
              "evidenceType": "Computational scaling study and perturbation benchmarks with RL ablations."
            },
            {
              "id": "C3",
              "claim": "A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models.",
              "evidenceSummary": "Dual-context screen predicts strong MHC-I increases only under low-level interferon signalling; IFN activity differs significantly across contexts. Flow cytometry shows no effect of silmitasertib alone but marked HLA-A,B,C increases with low-dose IFN-β and IFN-γ in a Merkel-origin model, replicated in a pulmonary model.",
              "keyNumbers": [
                "IFN context difference: ****, P < 0.0001 (Wilcoxon)",
                "Merkel model + IFN-β: MHC-I MFI +13.6% (10 nM), +34.9% (1000 nM)",
                "Merkel model + IFN-γ: +24.9% (10 nM), +37.3% (300 nM)",
                "Pulmonary model: +17.1% (10 nM), +28.1% (100 nM)",
                "n = 3 independent experiments; two-sided tests with multiple-comparison correction"
              ],
              "source": "Section 2.8; Fig. 9B-H. Methods 4.8-4.9.",
              "strength": "Moderate",
              "assumptions": "IFN-conditional effect defined by MHC-I MFI increases under stated IFN doses; cell models were unseen during training.",
              "evidenceType": "Computational virtual screening plus experimental validation (flow cytometry)."
            }
          ],
          "gaps": [
            {
              "category": "Benchmark transparency and statistics",
              "detail": "Results often summarised without full Ns, confidence intervals, or p-values; reliance on BERTScore for some tasks.",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Metric dependence and potential bias",
              "detail": "scFID depends on scGPT embeddings; uncertainty estimates not provided.",
              "relatedClaimIds": [
                "C2"
              ]
            },
            {
              "category": "Wet-lab validation scope",
              "detail": "Small n (3), two cell models, no in vivo validation; exact p-values for MFI changes not reported in text.",
              "relatedClaimIds": [
                "C3"
              ]
            },
            {
              "category": "Model limitations and hallucination risk",
              "detail": "Causal attention unidirectionality and LLM hallucinations noted by authors.",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Figure/text visibility",
              "detail": "Figures referenced but not viewable here; possible OCR artefacts [UNCLEAR].",
              "relatedClaimIds": [
                "C1",
                "C2",
                "C3"
              ]
            }
          ],
          "methodsSnapshot": [
            "Develop decoder-only LLMs that encode scRNA-seq as ranked \"cell sentences\", trained on a multimodal corpus with text and metadata.",
            "Two-phase training: large-scale self-supervision plus task-specific fine-tuning; optional GRPO reinforcement learning.",
            "Data include >50M cells (CELLxGENE, HCA) and task-specific datasets (CosMx liver spatial, Dong et al., L1000).",
            "Analyses span classification, generation, embedding, spatial reasoning, NL interpretation, QA, perturbation prediction; metrics include BERTScore, overlap, MMD, Wasserstein, scFID."
          ],
          "riskChecklist": [
            {
              "item": "Clear primary outcomes and metrics specified",
              "status": "partial",
              "note": "Metrics named, but many numeric details only in figures/Supplement."
            },
            {
              "item": "Comparators appropriate and described",
              "status": "met",
              "note": "Baselines named (scGPT, Geneformer, scGen, CellOT, Llama, GPT-4o)."
            },
            {
              "item": "Train-test separation and OOD tests",
              "status": "partial",
              "note": "Held-out and OOD described, but details summarised."
            },
            {
              "item": "Statistical reporting",
              "status": "missing",
              "note": "Few CIs or exact p-values reported in text beyond IFN context comparison."
            },
            {
              "item": "External validation",
              "status": "partial",
              "note": "Wet-lab validation for one discovery in two cell models."
            },
            {
              "item": "Risk of leakage or overfitting controls",
              "status": "unclear",
              "note": "Not fully detailed; some prompts/targets involve GPT-generated text."
            },
            {
              "item": "Limitations acknowledged by authors",
              "status": "met",
              "note": "Causal attention and hallucination risks noted."
            }
          ],
          "openQuestions": [
            "Generalisation of IFN-conditional amplification: test silmitasertib across more tissues and IFN dose-responses; probe CK2-STAT1/IRF1 mechanisms.",
            "Robustness of scFID: evaluate alternative embedding models and report variance/CIs.",
            "Benchmark transparency: release per-task tables with N, effect sizes, uncertainty and pre-registered splits.",
            "Mitigating hallucination in NL tasks: add constrained decoding or biological fact-checking.",
            "Architectural exploration: test hybrid attention or order-invariance to address causal attention limits."
          ],
          "crossPaperComparison": []
        }
      },
      "createdAt": "2025-10-23T21:49:02.191Z",
      "updatedAt": "2025-10-27T20:42:33.510Z",
      "agent": {
        "maxChars": 10579,
        "promptNotes": ""
      },
      "sourcePaper": {
        "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
        "summary": "C2S-Scale (up to 27B parameters) trained on \"cell sentences\" plus text shows broad SOTA across predictive, generative, and natural-language single-cell tasks; scaling and GRPO improve perturbation prediction; a virtual screen with wet-lab validation identifies silmitasertib as an interferon-conditional MHC-I amplifier.",
        "keyMethodSignals": [
          "Decoder-only Transformers on ranked gene-token \"cell sentences\" with text",
          "Two-phase training with task-specific fine-tuning and optional GRPO",
          "Benchmarks across annotation, generation, embedding, spatial reasoning, NL QA",
          "Metrics include BERTScore, MMD, Wasserstein, and scFID",
          "Virtual screen followed by flow-cytometry validation under IFN context"
        ],
        "methodComparison": {
          "sample": ">50 million cells from CELLxGENE and HCA, plus task-specific sets (CosMx liver spatial, cytokine perturbations, L1000).",
          "materials": "Decoder-only LLMs up to 27B; LoRA variants; multimodal corpus combining \"cell sentences\" and text; GRPO for perturbation tasks; compounds including silmitasertib.",
          "equipment": "GPU clusters for training and fine-tuning; flow cytometer for HLA-A,B,C surface assays with IFN-β or IFN-γ.",
          "procedure": "Self-supervised pretraining on \"cell sentences\" followed by task-specific fine-tuning; optional GRPO; multi-task benchmarking; dual-context virtual screen and targeted flow-cytometry validation.",
          "outcomes": "SOTA or parity vs scGPT/Geneformer; scaling gains 410M→27B; GRPO boosts L1000 τ and r and reduces interferon-gene scFID by 16 percent; silmitasertib increases MHC-I only with low-dose IFN."
        }
      },
      "similarPapers": [
        {
          "identifier": "10.1038/s41592-024-02201-0",
          "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
          "authors": [
            "Cui et al."
          ],
          "year": 2024,
          "venue": "Nature Methods",
          "whyRelevant": "Foundation Transformer trained on tens of millions of single cells across tasks. Directly comparable baselines and datasets overlap the brief.",
          "methodOverlap": [
            "Large-scale pretraining on CELLxGENE Census cells",
            "Perturbation prediction with CRISPR Perturb-seq datasets",
            "Multi-task benchmarks including annotation and integration"
          ],
          "methodComparison": {
            "sample": "33M+ cells for pretraining; multiple public evaluation sets including PBMC multiome and CRISPR Perturb-seq.",
            "materials": "Generative pretrained Transformer; public code and processed datasets.",
            "equipment": "GPU compute; standard single-cell preprocessing pipelines for dataset preparation.",
            "procedure": "Domain pretraining on cells, then task-specific fine-tuning across annotation, perturbation, integration and GRN analysis.",
            "outcomes": "SOTA or competitive results across tasks; public splits and data release."
          },
          "gaps": "Reporting is figure-heavy; several details are in Supplement. Perturbation metrics emphasise correlations and MMD-style distances rather than scFID.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "arXiv:2310.01436",
          "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
          "authors": [
            "Gong et al."
          ],
          "venue": "NeurIPS",
          "whyRelevant": "Pretrained Transformer for scRNA-seq with masking on gene tokens. Reports scaling behaviour and strong perturbation prediction performance.",
          "methodOverlap": [
            "Asymmetric encoder-decoder Transformer for sparse scRNA-seq",
            "Pretrained on large gene-token corpus with masking",
            "Downstream tasks include perturbation and drug prediction"
          ],
          "methodComparison": {
            "sample": "Curated multi-study scRNA-seq spanning ~19,264 genes and a large token corpus.",
            "materials": "Auto-discretised value embeddings with gene-token embeddings; masking regression objective.",
            "equipment": "GPU compute; no wet-lab components.",
            "procedure": "Pretrain with biased masking on non-zeros; fine-tune for annotation, perturb-seq and drug tasks.",
            "outcomes": "Scaling improves accuracy; SOTA or competitive on annotation and perturbation prediction."
          },
          "gaps": "Limited disclosure of per-task Ns and uncertainty. Evaluation emphasises accuracy and correlation without generative distributional scores like scFID.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "arXiv:2210.14330",
          "title": "A single-cell gene expression language model (Exceiver)",
          "authors": [
            "Connell",
            "Khan",
            "Keiser"
          ],
          "year": 2022,
          "venue": "NeurIPS Workshop",
          "whyRelevant": "Language-model framing with masking and set-like tokenisation. Explores order-invariant design relevant to causal-attention ordering caveat.",
          "methodOverlap": [
            "Self-supervised masking over gene tokens and counts",
            "Perceiver-IO to handle unordered, long gene inputs",
            "Transfer learning to downstream classification tasks"
          ],
          "methodComparison": {
            "sample": "Pretrained on Tabula Sapiens (~500k cells, 24 organs) with a 70/30 split.",
            "materials": "Learnable gene embeddings scaled by counts; discrete-noise masking objective.",
            "equipment": "GPU compute; open-source codebase.",
            "procedure": "Self-supervised regression masking with optional tissue label; evaluate on new datasets and prediction tasks.",
            "outcomes": "Latent representations align with tissues; transfer improves downstream accuracy."
          },
          "gaps": "Smaller scale than 27B-class models; limited perturbation evaluation and no RL. Uncertainty quantification is minimal.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1038/s41592-023-01969-x",
          "title": "Learning single-cell perturbation responses using neural optimal transport (CellOT)",
          "authors": [
            "Bunne et al."
          ],
          "year": 2023,
          "venue": "Nature Methods",
          "whyRelevant": "Direct comparator for perturbation prediction with distributional metrics. Uses unpaired mapping of control to treated single-cell states.",
          "methodOverlap": [
            "Predicts perturbation effects from unpaired single-cell data",
            "Benchmarks with MMD and correlation against scGen",
            "Evaluates scRNA-seq and 4i multiplexed proteomics"
          ],
          "methodComparison": {
            "sample": "Melanoma cell-line multiplexed proteomics and scRNA-seq drug panels; patient biopsies and cross-species LPS.",
            "materials": "Input-convex neural networks parameterise optimal transport potentials.",
            "equipment": "scRNA-seq and multiplexed imaging datasets; GPU training.",
            "procedure": "Learn OT maps per perturbation from control to treated distributions; test OOD on new patients and species.",
            "outcomes": "Outperforms scGen and others on MMD and r²; captures higher moments of treated distributions."
          },
          "gaps": "Not an LLM and relies on latent autoencoder features. Distributional improvements reported without comprehensive uncertainty bands.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1038/s41592-019-0494-8",
          "title": "scGen predicts single-cell perturbation responses",
          "authors": [
            "Lotfollahi",
            "Wolf",
            "Theis"
          ],
          "year": 2019,
          "venue": "Nature Methods",
          "whyRelevant": "Canonical perturbation-prediction baseline with VAE latent vector arithmetic. Demonstrates cross-study and cross-species generalisation.",
          "methodOverlap": [
            "VAE latent-space shifts to model perturbations",
            "Cross-study and cross-species OOD tests",
            "Public code and reproducibility repository"
          ],
          "methodComparison": {
            "sample": "Multiple scRNA-seq datasets across tissues and species, including infection and drug responses.",
            "materials": "Variational autoencoder with linear latent manipulations; public code and reproducibility resources.",
            "equipment": "Standard single-cell sequencing datasets; GPU training.",
            "procedure": "Train VAE, infer perturbation via latent vector arithmetic; evaluate across studies and species.",
            "outcomes": "Accurate out-of-sample predictions and batch integration capabilities."
          },
          "gaps": "Linear latent shifts can miss complex distributional changes. Uncertainty reporting is limited in the original work.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        }
      ],
      "authorContacts": {
        "maxChars": 2002,
        "truncated": false,
        "text": "Paper: Scaling Large Language Models for Next-Generation Single-Cell Analysis (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Syed Asad Rizvi | syed.rizvi@yale.edu | PhD Student, Yale University, Computer Science | Not found |\n| David van Dijk | Not found | Faculty, Yale School of Medicine; Corresponding author on this paper | 0000-0003-3911-9925 |\n\nPaper: scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Haotian Cui | Not found | Not found | 0000-0001-8119-9485 |\n| Bo Wang | bo.wang@uhn.ca | Canada Research Chair, Assistant Professor, U of T; Vector Institute Faculty Affiliate | 0000-0002-9620-3413 |\n\nPaper: xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Jing Gong | gongjing@biomap.com | Researcher, BioMap Research (per author affiliations) | Not found |\n| Le Song | songle@biomap.com | Professor, MBZUAI; CTO, GenBio AI | 0000-0003-0345-9899 |\n| Xingyi Cheng | xingyi@biomap.com | Principal Researcher, BioMap (per OpenReview profile) | 0009-0002-6403-048X |\n\nPaper: A single-cell gene expression language model (Exceiver)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| William Connell | Not found | Graduate researcher, Keiser Lab, UCSF (per lab page) | Not found |\n| Michael J. Keiser | Not found | Not found | Not found |\n\nPaper: Learning single-cell perturbation responses using neural optimal transport (CellOT)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Charlotte Bunne | Not found | Not found | Not found |\n| Gunnar Rätsch | gunnar.raetsch@inf.ethz.ch | Not found | Not found |\n\nPaper: scGen predicts single-cell perturbation responses\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Mohammad Lotfollahi | Not found | Not found | 0000-0001-6858-7985 |\n| Fabian J. Theis | Not found | Not found | 0000-0002-2419-1943 |",
        "structured": {
          "papers": [
            {
              "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Syed Asad Rizvi",
                  "email": "syed.rizvi@yale.edu",
                  "role": "PhD Student, Yale University, Computer Science",
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=3nspJ4QAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://syedarizvi.com"
                    }
                  ]
                },
                {
                  "name": "David van Dijk",
                  "email": null,
                  "role": "Faculty, Yale School of Medicine; Corresponding author on this paper",
                  "orcid": "0000-0003-3911-9925",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://vandijklab.org"
                    }
                  ]
                }
              ]
            },
            {
              "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
              "identifier": null,
              "authors": [
                {
                  "name": "Haotian Cui",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0001-8119-9485",
                  "profiles": []
                },
                {
                  "name": "Bo Wang",
                  "email": "bo.wang@uhn.ca",
                  "role": "Canada Research Chair, Assistant Professor, U of T; Vector Institute Faculty Affiliate",
                  "orcid": "0000-0002-9620-3413",
                  "profiles": []
                }
              ]
            },
            {
              "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
              "identifier": null,
              "authors": [
                {
                  "name": "Jing Gong",
                  "email": "gongjing@biomap.com",
                  "role": "Researcher, BioMap Research (per author affiliations)",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Le Song",
                  "email": "songle@biomap.com",
                  "role": "Professor, MBZUAI; CTO, GenBio AI",
                  "orcid": "0000-0003-0345-9899",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=OQqQLbMAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://dasongle.github.io"
                    }
                  ]
                },
                {
                  "name": "Xingyi Cheng",
                  "email": "xingyi@biomap.com",
                  "role": "Principal Researcher, BioMap (per OpenReview profile)",
                  "orcid": "0009-0002-6403-048X",
                  "profiles": []
                }
              ]
            },
            {
              "title": "A single-cell gene expression language model (Exceiver)",
              "identifier": null,
              "authors": [
                {
                  "name": "William Connell",
                  "email": null,
                  "role": "Graduate researcher, Keiser Lab, UCSF (per lab page)",
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://wconnell.github.io/research"
                    }
                  ]
                },
                {
                  "name": "Michael J. Keiser",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://keiserlab.org"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Learning single-cell perturbation responses using neural optimal transport (CellOT)",
              "identifier": null,
              "authors": [
                {
                  "name": "Charlotte Bunne",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Gunnar Rätsch",
                  "email": "gunnar.raetsch@inf.ethz.ch",
                  "role": null,
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "scGen predicts single-cell perturbation responses",
              "identifier": null,
              "authors": [
                {
                  "name": "Mohammad Lotfollahi",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0001-6858-7985",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://m0hammadl.github.io/publication/scgen"
                    }
                  ]
                },
                {
                  "name": "Fabian J. Theis",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0002-2419-1943",
                  "profiles": []
                }
              ]
            }
          ],
          "promptNotes": "Converted strictly from analyst notes. Unknown fields set to null."
        }
      },
      "researcherTheses": {
        "maxChars": 6053,
        "truncated": false,
        "text": "Researcher: Syed Asad Rizvi\nEmail: [syed.rizvi@yale.edu](mailto:syed.rizvi@yale.edu)\nData publicly available: yes\nLatest publication:\n  - Title: BrainLM: A foundation model for brain activity recordings\n  - Year: 2024\n  - Venue: ICLR 2024\n  - URL: https://openreview.net/pdf?id=RwI7ZEfR27\nPhD thesis: Not found\n\nResearcher: David van Dijk\nEmail: [david.vandijk@yale.edu](mailto:david.vandijk@yale.edu)\nData publicly available: yes\nLatest publication:\n  - Title: Intelligence at the Edge of Chaos\n  - Year: 2025\n  - Venue: ICLR 2025\n  - URL: https://arxiv.org/abs/2410.02536\nPhD thesis:\n  - Title: The Symphony of Gene Regulation\n  - Year: 2013\n  - Institution: University of Amsterdam\n  - URL: https://pure.uva.nl/ws/files/1692458/126481_02.pdf\n\nResearcher: Haotian Cui\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-024-02201-0.pdf\nPhD thesis:\n  - Title: Foundation Model for Single-Cell Omics\n  - Year: 2024\n  - Institution: University of Toronto\n  - URL: https://utoronto.scholaris.ca/items/6a05cbf8-663b-4c27-b82e-4e799aa4d0dd/full\n\nResearcher: Bo Wang\nEmail: [bo.wang@uhn.ca](mailto:bo.wang@uhn.ca)\nData publicly available: yes\nLatest publication:\n  - Title: scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-024-02201-0.pdf\nPhD thesis:\n  - Title: Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning\n  - Year: 2017\n  - Institution: Stanford University\n  - URL: https://purl.stanford.edu/cc855fh0112\n\nResearcher: Jing Gong\nEmail: [gongjing@biomap.com](mailto:gongjing@biomap.com)\nData publicly available: yes\nLatest publication:\n  - Title: Training Compute-Optimal Protein Language Models\n  - Year: 2024\n  - Venue: NeurIPS 2024\n  - URL: https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf\nPhD thesis:\n  - Title: RNA二级结构及相互作用的计算方法和功能研究\n  - Year: 2020\n  - Institution: Tsinghua University, School of Life Sciences\n  - URL: https://newetds.lib.tsinghua.edu.cn/qh/paper/summary?dbCode=ETDQH&sysId=264093\n\nResearcher: Le Song\nEmail: [songle@biomap.com](mailto:songle@biomap.com)\nData publicly available: yes\nLatest publication:\n  - Title: Training Compute-Optimal Protein Language Models\n  - Year: 2024\n  - Venue: NeurIPS 2024\n  - URL: https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf\nPhD thesis: Not found\n\nResearcher: Xingyi Cheng\nEmail: [xingyi@biomap.com](mailto:xingyi@biomap.com)\nData publicly available: yes\nLatest publication:\n  - Title: Training Compute-Optimal Protein Language Models\n  - Year: 2024\n  - Venue: NeurIPS 2024\n  - URL: https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf\nPhD thesis: Not found\n\nResearcher: William Thomas Connell\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Learning chemical sensitivity reveals mechanisms of cellular response\n  - Year: 2024\n  - Venue: Communications Biology\n  - URL: https://www.nature.com/articles/s42003-024-06865-4.pdf\nPhD thesis:\n  - Title: Learning Chemical Sensitivity to Understand Disease Mechanisms\n  - Year: 2022\n  - Institution: University of California, San Francisco\n  - URL: https://escholarship.org/uc/item/0321d4q3\n\nResearcher: Michael James Keiser\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Retrieval Augmented Docking Using Hierarchical Navigable Small Worlds\n  - Year: 2024\n  - Venue: Journal of Chemical Information and Modeling\n  - URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.4c00683\nPhD thesis:\n  - Title: Relating protein pharmacology by ligand chemistry\n  - Year: 2009\n  - Institution: University of California, San Francisco\n  - URL: https://escholarship.org/uc/item/5vp5h8g4\n\nResearcher: Charlotte Bunne\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Learning single-cell perturbation responses using neural optimal transport\n  - Year: 2023\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-023-01969-x.pdf\nPhD thesis:\n  - Title: Neural Optimal Transport for Dynamical Systems\n  - Year: 2023\n  - Institution: ETH Zürich\n  - URL: https://www.research-collection.ethz.ch/bitstream/handle/20.500.11850/633762/thesis_bunnech.pdf\n\nResearcher: Gunnar Rätsch\nEmail: [gunnar.raetsch@inf.ethz.ch](mailto:gunnar.raetsch@inf.ethz.ch)\nData publicly available: yes\nLatest publication:\n  - Title: Efficient and accurate search in petabase-scale sequence repositories\n  - Year: 2025\n  - Venue: Nature\n  - URL: https://www.nature.com/articles/s41586-025-09603-w.pdf\nPhD thesis:\n  - Title: Robust Boosting via Convex Optimization: Theory and Applications\n  - Year: 2001\n  - Institution: Universität Potsdam\n  - URL: https://publishup.uni-potsdam.de/opus4-ubp/files/40/raetsch.pdf\n\nResearcher: Mohammad Lotfollahi\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Toward learning a foundational representation of cells and genes\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-024-02367-7.pdf\nPhD thesis:\n  - Title: Modeling single-cell perturbations using deep learning\n  - Year: 2022\n  - Institution: Technical University of Munich (TUM), School of Life Sciences\n  - URL: https://mediatum.ub.tum.de/1631269\n\nResearcher: Fabian J. Theis\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Deep generative modeling of transcriptional dynamics for RNA velocity analysis in single cells\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://doi.org/10.1038/s41592-023-01994-w\nPhD thesis:\n  - Title: Geometric Source Separation: Algorithms and Applications\n  - Year: 2003\n  - Institution: Universidad de Granada\n  - URL: https://d-nb.info/1174513586",
        "structured": {
          "researchers": [
            {
              "name": "Syed Asad Rizvi",
              "email": "[syed.rizvi@yale.edu](mailto:syed.rizvi@yale.edu)",
              "latest_publication": {
                "title": "BrainLM: A foundation model for brain activity recordings",
                "year": 2024,
                "venue": "ICLR 2024",
                "url": "https://openreview.net/pdf?id=RwI7ZEfR27"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "David van Dijk",
              "email": "[david.vandijk@yale.edu](mailto:david.vandijk@yale.edu)",
              "latest_publication": {
                "title": "Intelligence at the Edge of Chaos",
                "year": 2025,
                "venue": "ICLR 2025",
                "url": "https://arxiv.org/abs/2410.02536"
              },
              "phd_thesis": {
                "title": "The Symphony of Gene Regulation",
                "year": 2013,
                "institution": "University of Amsterdam",
                "url": "https://pure.uva.nl/ws/files/1692458/126481_02.pdf"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Haotian Cui",
              "email": null,
              "latest_publication": {
                "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-024-02201-0.pdf"
              },
              "phd_thesis": {
                "title": "Foundation Model for Single-Cell Omics",
                "year": 2024,
                "institution": "University of Toronto",
                "url": "https://utoronto.scholaris.ca/items/6a05cbf8-663b-4c27-b82e-4e799aa4d0dd/full"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Bo Wang",
              "email": "[bo.wang@uhn.ca](mailto:bo.wang@uhn.ca)",
              "latest_publication": {
                "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-024-02201-0.pdf"
              },
              "phd_thesis": {
                "title": "Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning",
                "year": 2017,
                "institution": "Stanford University",
                "url": "https://purl.stanford.edu/cc855fh0112"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Jing Gong",
              "email": "[gongjing@biomap.com](mailto:gongjing@biomap.com)",
              "latest_publication": {
                "title": "Training Compute-Optimal Protein Language Models",
                "year": 2024,
                "venue": "NeurIPS 2024",
                "url": "https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf"
              },
              "phd_thesis": {
                "title": "RNA二级结构及相互作用的计算方法和功能研究",
                "year": 2020,
                "institution": "Tsinghua University, School of Life Sciences",
                "url": "https://newetds.lib.tsinghua.edu.cn/qh/paper/summary?dbCode=ETDQH&sysId=264093"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Le Song",
              "email": "[songle@biomap.com](mailto:songle@biomap.com)",
              "latest_publication": {
                "title": "Training Compute-Optimal Protein Language Models",
                "year": 2024,
                "venue": "NeurIPS 2024",
                "url": "https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "Xingyi Cheng",
              "email": "[xingyi@biomap.com](mailto:xingyi@biomap.com)",
              "latest_publication": {
                "title": "Training Compute-Optimal Protein Language Models",
                "year": 2024,
                "venue": "NeurIPS 2024",
                "url": "https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "William Thomas Connell",
              "email": null,
              "latest_publication": {
                "title": "Learning chemical sensitivity reveals mechanisms of cellular response",
                "year": 2024,
                "venue": "Communications Biology",
                "url": "https://www.nature.com/articles/s42003-024-06865-4.pdf"
              },
              "phd_thesis": {
                "title": "Learning Chemical Sensitivity to Understand Disease Mechanisms",
                "year": 2022,
                "institution": "University of California, San Francisco",
                "url": "https://escholarship.org/uc/item/0321d4q3"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Michael James Keiser",
              "email": null,
              "latest_publication": {
                "title": "Retrieval Augmented Docking Using Hierarchical Navigable Small Worlds",
                "year": 2024,
                "venue": "Journal of Chemical Information and Modeling",
                "url": "https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.4c00683"
              },
              "phd_thesis": {
                "title": "Relating protein pharmacology by ligand chemistry",
                "year": 2009,
                "institution": "University of California, San Francisco",
                "url": "https://escholarship.org/uc/item/5vp5h8g4"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Charlotte Bunne",
              "email": null,
              "latest_publication": {
                "title": "Learning single-cell perturbation responses using neural optimal transport",
                "year": 2023,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-023-01969-x.pdf"
              },
              "phd_thesis": {
                "title": "Neural Optimal Transport for Dynamical Systems",
                "year": 2023,
                "institution": "ETH Zürich",
                "url": "https://www.research-collection.ethz.ch/bitstream/handle/20.500.11850/633762/thesis_bunnech.pdf"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Gunnar Rätsch",
              "email": "[gunnar.raetsch@inf.ethz.ch](mailto:gunnar.raetsch@inf.ethz.ch)",
              "latest_publication": {
                "title": "Efficient and accurate search in petabase-scale sequence repositories",
                "year": 2025,
                "venue": "Nature",
                "url": "https://www.nature.com/articles/s41586-025-09603-w.pdf"
              },
              "phd_thesis": {
                "title": "Robust Boosting via Convex Optimization: Theory and Applications",
                "year": 2001,
                "institution": "Universität Potsdam",
                "url": "https://publishup.uni-potsdam.de/opus4-ubp/files/40/raetsch.pdf"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Mohammad Lotfollahi",
              "email": null,
              "latest_publication": {
                "title": "Toward learning a foundational representation of cells and genes",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-024-02367-7.pdf"
              },
              "phd_thesis": {
                "title": "Modeling single-cell perturbations using deep learning",
                "year": 2022,
                "institution": "Technical University of Munich (TUM), School of Life Sciences",
                "url": "https://mediatum.ub.tum.de/1631269"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Fabian J. Theis",
              "email": null,
              "latest_publication": {
                "title": "Deep generative modeling of transcriptional dynamics for RNA velocity analysis in single cells",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://doi.org/10.1038/s41592-023-01994-w"
              },
              "phd_thesis": {
                "title": "Geometric Source Separation: Algorithms and Applications",
                "year": 2003,
                "institution": "Universidad de Granada",
                "url": "https://d-nb.info/1174513586"
              },
              "data_publicly_available": "unknown"
            }
          ],
          "promptNotes": "Compiled from all thesis discovery responses in this thread."
        }
      },
      "patents": {
        "text": "Patent: US20240386990A1\nTitle: Predicting cellular responses to perturbations\nAssignee: Insitro Inc\nFiling Date: 2024-05-17\nGrant Date: Not provided\nAbstract: Discloses generative machine-learning methods that model a cell's basal state and apply sparse latent treatment offsets to predict single- or multi-perturbation responses.\nOverlaps with paper claims: C2\nTechnical overlap: The claims teach disentangled latent representations for cells and perturbations, combining a basal embedding with a treatment mask and vector to predict post-perturbation states as sparse latent offsets. This closely matches the paper's perturbation-prediction framework and benchmarks (e.g., scFID, MMD, Wasserstein) that assess accuracy under chemical and genetic perturbations, validating the paper's approach of scaling model capacity for improved out-of-distribution prediction.\n\nPatent: US20240203531A1\nTitle: Cell type annotation\nAssignee: Illumina Inc (current); Fluent Biosciences Inc (original)\nFiling Date: 2023-12-19\nGrant Date: Not provided\nAbstract: Methods for annotating cell types from single-cell RNA sequencing using non-parametric differential expression scoring and correlation to annotated references, designed for high-throughput workflows.\nOverlaps with paper claims: C1\nTechnical overlap: The patent claims automated, scalable pipelines for cell-type labelling from single-cell data, overlapping the paper's multi-task evaluation where C2S performs or matches specialised models on cell-type annotation. Both address robust classification across diverse datasets; the patent's reference-based scoring complements the paper's LLM-style modelling while validating the same core task domain.\n\nPatent: WO2016050203A1\nTitle: Use of inhibiting activity of casein kinase 2 to enhance expression of type I interferon and interferon-induced genes\nAssignee: Not provided\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: Claims therapeutic use of CK2 inhibitors to enhance expression of type I interferon and interferon-stimulated genes.\nOverlaps with paper claims: C3\nTechnical overlap: By asserting that CK2 inhibition elevates interferon signalling and downstream gene expression, the patent aligns mechanistically with the paper's finding that the CK2 inhibitor silmitasertib acts as an interferon-conditional amplifier of MHC-I antigen presentation. This independent IP on the CK2-IFN axis provides validation for the biological mechanism exploited by the paper's virtual screen and experimental flow-cytometry results.\n\nPatent: WO2017070137A1\nTitle: Combination of CK2 inhibitors and immune checkpoint modulators for treatment of proliferative disorders\nAssignee: Not provided\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: Teaches combining CK2 inhibitors with PD-1/CTLA-4 checkpoint modulators based on immune-modulatory effects of CK2 blockade.\nOverlaps with paper claims: C3\nTechnical overlap: The claimed therapeutic synergy relies on CK2 inhibition increasing tumour immunogenicity, consistent with the paper's observation that CK2 blockade elevates MHC-I antigen presentation under low-level interferon. This supports the translational significance of the paper's interferon-conditional amplification effect within independently claimed immuno-oncology strategies.\n\nPatent: US10227344B2\nTitle: CK2 inhibitors, compositions and methods thereof\nAssignee: Polaris Pharmaceuticals, Inc.\nFiling Date: Not provided\nGrant Date: 2019-03-12\nAbstract: Claims CK2 inhibitor chemotypes, pharmaceutical compositions, and therapeutic methods for proliferative diseases.\nOverlaps with paper claims: C3\nTechnical overlap: The paper's hit compound silmitasertib is a CK2 inhibitor; this granted patent secures composition-of-matter and therapeutic claims for the CK2 inhibitor class used in the paper's validation experiments. The overlap in target class and intended oncology use provides independent IP evidence that CK2 blockade is a viable route to modulate tumour cell biology in ways consistent with enhanced antigen presentation.",
        "structured": {
          "patents": [
            {
              "patentNumber": "US20240386990A1",
              "title": "Predicting cellular responses to perturbations",
              "assignee": "Insitro Inc",
              "filingDate": "2024-05-17",
              "grantDate": null,
              "abstract": "Discloses generative machine-learning methods that model a cell's basal state and apply sparse latent treatment offsets to predict single- or multi-perturbation responses.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "The claims teach disentangled latent representations for cells and perturbations, combining a basal embedding with a treatment mask and vector to predict post-perturbation states as sparse latent offsets. This closely matches the paper's perturbation-prediction framework and benchmarks (e.g., scFID, MMD, Wasserstein) that assess accuracy under chemical and genetic perturbations, validating the paper's approach of scaling model capacity for improved out-of-distribution prediction."
              },
              "url": null
            },
            {
              "patentNumber": "US20240203531A1",
              "title": "Cell type annotation",
              "assignee": "Illumina Inc (current); Fluent Biosciences Inc (original)",
              "filingDate": "2023-12-19",
              "grantDate": null,
              "abstract": "Methods for annotating cell types from single-cell RNA sequencing using non-parametric differential expression scoring and correlation to annotated references, designed for high-throughput workflows.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1"
                ],
                "summary": "The patent claims automated, scalable pipelines for cell-type labelling from single-cell data, overlapping the paper's multi-task evaluation where C2S performs or matches specialised models on cell-type annotation. Both address robust classification across diverse datasets; the patent's reference-based scoring complements the paper's LLM-style modelling while validating the same core task domain."
              },
              "url": null
            },
            {
              "patentNumber": "WO2016050203A1",
              "title": "Use of inhibiting activity of casein kinase 2 to enhance expression of type I interferon and interferon-induced genes",
              "assignee": null,
              "filingDate": null,
              "grantDate": null,
              "abstract": "Claims therapeutic use of CK2 inhibitors to enhance expression of type I interferon and interferon-stimulated genes.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "By asserting that CK2 inhibition elevates interferon signalling and downstream gene expression, the patent aligns mechanistically with the paper's finding that the CK2 inhibitor silmitasertib acts as an interferon-conditional amplifier of MHC-I antigen presentation. This independent IP on the CK2-IFN axis provides validation for the biological mechanism exploited by the paper's virtual screen and experimental flow-cytometry results."
              },
              "url": null
            },
            {
              "patentNumber": "WO2017070137A1",
              "title": "Combination of CK2 inhibitors and immune checkpoint modulators for treatment of proliferative disorders",
              "assignee": null,
              "filingDate": null,
              "grantDate": null,
              "abstract": "Teaches combining CK2 inhibitors with PD-1/CTLA-4 checkpoint modulators based on immune-modulatory effects of CK2 blockade.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "The claimed therapeutic synergy relies on CK2 inhibition increasing tumour immunogenicity, consistent with the paper's observation that CK2 blockade elevates MHC-I antigen presentation under low-level interferon. This supports the translational significance of the paper's interferon-conditional amplification effect within independently claimed immuno-oncology strategies."
              },
              "url": null
            },
            {
              "patentNumber": "US10227344B2",
              "title": "CK2 inhibitors, compositions and methods thereof",
              "assignee": "Polaris Pharmaceuticals, Inc.",
              "filingDate": null,
              "grantDate": "2019-03-12",
              "abstract": "Claims CK2 inhibitor chemotypes, pharmaceutical compositions, and therapeutic methods for proliferative diseases.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "The paper's hit compound silmitasertib is a CK2 inhibitor; this granted patent secures composition-of-matter and therapeutic claims for the CK2 inhibitor class used in the paper's validation experiments. The overlap in target class and intended oncology use provides independent IP evidence that CK2 blockade is a viable route to modulate tumour cell biology in ways consistent with enhanced antigen presentation."
              },
              "url": null
            }
          ],
          "promptNotes": "Converted from analyst notes; unknown fields set to null; URLs standardised to Google Patents."
        }
      },
      "verifiedClaims": {
        "text": "=== OVERALL ASSESSMENT ===\nAcross claims, the strongest support comes from the preprint's internal results and released code, with convergent literature on scalable single-cell Transformers and perturbation modelling. The silmitasertib finding benefits from non-peer-reviewed corroboration and mechanistic patents. Key gaps remain: no third-party replication of multi-task superiority or GRPO gains, limited community validation for the new scFID metric, and sparse public quantitative details for the interferon-conditional experiments; accordingly all three claims are Partially Verified with moderate confidence.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n    Establishes strong foundation-model baselines across annotation, integration, and perturbation tasks; provides comparators overlapping C2S-Scale benchmarks but is not an external replication of C2S-Scale.\n  - [Similar Paper] xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data\n    Demonstrates scalable Transformer pretraining for scRNA-seq with gains across tasks, supporting that single-cell Transformers can be competitive on annotation and perturbation.\n  - [Similar Paper] A single-cell gene expression language model (Exceiver)\n    Earlier language-model framing for single-cell data with set-like tokenisation; conceptually aligns with cell-as-text representation but does not benchmark against C2S-Scale.\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    Internal multi-task benchmarking reports matching or surpassing scGPT and Geneformer on annotation and embeddings, and better natural-language interpretation and QA vs general LLMs, including an immune dataset annotation accuracy of 95.43 percent.\n  - [Research Group] Cell2Sentence GitHub repository\n    Implementation and resources released, enabling some level of reproducibility.\n\nContradicting Evidence:\n  - [Similar Paper] Independent community benchmarks\n    Large, independent benchmarks show method ranking varies by dataset and metric, cautioning against blanket superiority claims; not specific to C2S-Scale.\n\nSummary: The preprint reports that C2S-Scale matches or exceeds scGPT and Geneformer on standard predictive tasks and clearly beats general LLMs on natural-language single-cell tasks, with code released. Independent cross-group replication and exact metrics such as the stated 95.43 percent immune annotation accuracy have not been externally verified, and broad benchmarks caution that winners depend on task and dataset.\n\nClaim: C2\nOriginal: Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    Reported improvements from 410M to 27B parameters and with more data, including LoRA regimes, across predictive and generative tasks.\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    GRPO reinforcement learning described for QA and perturbation prediction, with lower scFID, MMD, and Wasserstein than scGen, scGPT, and CellOT on stated benchmarks; reports a 16 percent scFID reduction on interferon genes and gains on L1000.\n  - [Similar Paper] xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data\n    Independently observes that larger model sizes improve performance on single-cell tasks, supporting the scaling component.\n  - [Similar Paper] scGen predicts single-cell perturbation responses\n    Provides a canonical perturbation-prediction baseline and evaluation framing used by later work.\n  - [Similar Paper] Learning single-cell perturbation responses using neural optimal transport (CellOT)\n    Provides a modern perturbation-prediction comparator using distributional metrics such as MMD and Wasserstein.\n  - [Patent] US20240386990A1: Predicting cellular responses to perturbations\n    Teaches latent-space disentanglement and additive offsets for predicting perturbation responses, aligning with the premise that richer models and learned latent manipulations can improve out-of-distribution prediction.\n\nContradicting Evidence:\n  - [Similar Paper] Independent community benchmarks\n    Studies emphasise inconsistent generalisation and lack of a single dominant method, tempering universal claims.\n\nSummary: Internal evidence shows clear scaling gains and GRPO improvements on perturbation metrics including scFID, MMD, and Wasserstein. External literature supports the scaling portion, but independent confirmation of GRPO's specific boost for perturbation prediction in this domain has not yet appeared.\n\nClaim: C3\nOriginal: A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    Describes a dual-context virtual screen yielding silmitasertib as an interferon-conditional amplifier of antigen presentation with wet-lab validation.\n  - [Research Group] Google Research blog on C2S-Scale interferon-conditional amplifier\n    Reports that silmitasertib alone had no effect but combined with low-dose interferon markedly increased MHC-I in an unseen neuroendocrine model and replicated in a pulmonary model.\n  - [Patent] WO2016050203A1: Use of inhibiting casein kinase 2 to enhance type I interferon and interferon-induced genes\n    Asserts CK2 inhibition elevates interferon signalling and downstream gene expression, providing mechanistic support for an interferon-conditional MHC-I increase.\n  - [Patent] WO2017070137A1: Combination of CK2 inhibitors and immune checkpoint modulators for proliferative disorders\n    Claims therapeutic synergy relying on increased tumour immunogenicity from CK2 inhibition, consistent with interferon-conditioned amplification of antigen presentation.\n  - [Patent] US10227344B2: CK2 inhibitors, compositions and methods thereof\n    Covers composition and therapeutic use of CK2 inhibitors including silmitasertib, supporting the feasibility of modulating tumour cell biology relevant to antigen presentation.\n\nSummary: Independent communications and the preprint align that silmitasertib amplifies MHC-I only with low-level interferon, and patents provide a plausible CK2-interferon mechanism. Peer-reviewed third-party replication and fuller quantitative flow-cytometry details are still pending.\n",
        "structured": {
          "claims": [
            {
              "claimId": "C1",
              "originalClaim": "C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
                  "relevance": "Establishes strong foundation-model baselines across annotation, integration, and perturbation tasks; provides comparators overlapping C2S-Scale benchmarks but is not an external replication of C2S-Scale."
                },
                {
                  "source": "Similar Paper",
                  "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
                  "relevance": "Demonstrates scalable Transformer pretraining for scRNA-seq with gains across tasks, supporting that single-cell Transformers can be competitive on annotation and perturbation."
                },
                {
                  "source": "Similar Paper",
                  "title": "A single-cell gene expression language model (Exceiver)",
                  "relevance": "Earlier language-model framing for single-cell data with set-like tokenisation; conceptually aligns with cell-as-text representation but does not benchmark against C2S-Scale."
                },
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "Internal multi-task benchmarking reports matching or surpassing scGPT and Geneformer on annotation and embeddings, and better natural-language interpretation and QA vs general LLMs, including an immune dataset annotation accuracy of 95.43 percent."
                },
                {
                  "source": "Research Group",
                  "title": "Cell2Sentence GitHub repository",
                  "relevance": "Implementation and resources released, enabling some level of reproducibility."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Independent community benchmarks",
                  "relevance": "Large, independent benchmarks show method ranking varies by dataset and metric, cautioning against blanket superiority claims; not specific to C2S-Scale."
                }
              ],
              "verificationSummary": "The preprint reports that C2S-Scale matches or exceeds scGPT and Geneformer on standard predictive tasks and clearly beats general LLMs on natural-language single-cell tasks, with code released. Independent cross-group replication and exact metrics such as the stated 95.43 percent immune annotation accuracy have not been externally verified, and broad benchmarks caution that winners depend on task and dataset.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C2",
              "originalClaim": "Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "Reported improvements from 410M to 27B parameters and with more data, including LoRA regimes, across predictive and generative tasks."
                },
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "GRPO reinforcement learning described for QA and perturbation prediction, with lower scFID, MMD, and Wasserstein than scGen, scGPT, and CellOT on stated benchmarks; reports a 16 percent scFID reduction on interferon genes and gains on L1000."
                },
                {
                  "source": "Similar Paper",
                  "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
                  "relevance": "Independently observes that larger model sizes improve performance on single-cell tasks, supporting the scaling component."
                },
                {
                  "source": "Similar Paper",
                  "title": "scGen predicts single-cell perturbation responses",
                  "relevance": "Provides a canonical perturbation-prediction baseline and evaluation framing used by later work."
                },
                {
                  "source": "Similar Paper",
                  "title": "Learning single-cell perturbation responses using neural optimal transport (CellOT)",
                  "relevance": "Provides a modern perturbation-prediction comparator using distributional metrics such as MMD and Wasserstein."
                },
                {
                  "source": "Patent",
                  "title": "US20240386990A1: Predicting cellular responses to perturbations",
                  "relevance": "Teaches latent-space disentanglement and additive offsets for predicting perturbation responses, aligning with the premise that richer models and learned latent manipulations can improve out-of-distribution prediction."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Independent community benchmarks",
                  "relevance": "Studies emphasise inconsistent generalisation and lack of a single dominant method, tempering universal claims."
                }
              ],
              "verificationSummary": "Internal evidence shows clear scaling gains and GRPO improvements on perturbation metrics including scFID, MMD, and Wasserstein. External literature supports the scaling portion, but independent confirmation of GRPO's specific boost for perturbation prediction in this domain has not yet appeared.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C3",
              "originalClaim": "A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "Describes a dual-context virtual screen yielding silmitasertib as an interferon-conditional amplifier of antigen presentation with wet-lab validation."
                },
                {
                  "source": "Research Group",
                  "title": "Google Research blog on C2S-Scale interferon-conditional amplifier",
                  "relevance": "Reports that silmitasertib alone had no effect but combined with low-dose interferon markedly increased MHC-I in an unseen neuroendocrine model and replicated in a pulmonary model."
                },
                {
                  "source": "Patent",
                  "title": "WO2016050203A1: Use of inhibiting casein kinase 2 to enhance type I interferon and interferon-induced genes",
                  "relevance": "Asserts CK2 inhibition elevates interferon signalling and downstream gene expression, providing mechanistic support for an interferon-conditional MHC-I increase."
                },
                {
                  "source": "Patent",
                  "title": "WO2017070137A1: Combination of CK2 inhibitors and immune checkpoint modulators for proliferative disorders",
                  "relevance": "Claims therapeutic synergy relying on increased tumour immunogenicity from CK2 inhibition, consistent with interferon-conditioned amplification of antigen presentation."
                },
                {
                  "source": "Patent",
                  "title": "US10227344B2: CK2 inhibitors, compositions and methods thereof",
                  "relevance": "Covers composition and therapeutic use of CK2 inhibitors including silmitasertib, supporting the feasibility of modulating tumour cell biology relevant to antigen presentation."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "Independent communications and the preprint align that silmitasertib amplifies MHC-I only with low-level interferon, and patents provide a plausible CK2-interferon mechanism. Peer-reviewed third-party replication and fuller quantitative flow-cytometry details are still pending.",
              "confidenceLevel": "Moderate"
            }
          ],
          "overallAssessment": "Across claims, the strongest support comes from the preprint's internal results and released code, with convergent literature on scalable single-cell Transformers and perturbation modelling. The silmitasertib finding benefits from non-peer-reviewed corroboration and mechanistic patents. Key gaps remain: no third-party replication of multi-task superiority or GRPO gains, limited community validation for the new scFID metric, and sparse public quantitative details for the interferon-conditional experiments; accordingly all three claims are Partially Verified with moderate confidence.",
          "promptNotes": "Most supporting results originate from the authors' own preprint and communications; independent replications are not yet available. The scFID metric is new and not widely benchmarked. Blog posts and press releases are not peer-reviewed sources and were treated as Research Group communications."
        }
      }
    },
    {
      "id": "hartmann-six-2023",
      "sourcePdf": {
        "path": "Hartmann & Six (2023).pdf",
        "publicPath": "/mock-papers/hartmann-six-2023.pdf",
        "title": "Soil structure and microbiome functions in agroecosystems",
        "originalFileName": "Hartmann & Six (2023).pdf",
        "doi": "10.1038/s43017-022-00366-w",
        "pages": 15
      },
      "label": "Hartmann & Six (2023)",
      "generatedAt": "2025-10-28T03:13:16.766Z",
      "claimsAnalysis": {
        "text": "Executive Summary   This review argues that soil structure governs microbiome function in agroecosystems and that management practices that protect or rebuild structure enhance beneficial microbial processes. Headline numbers include: approximately half of the ~120 Pg C emitted annually on land arises from heterotrophic microbial respiration; methanogens produce about two-thirds of the 500-600 Tg CH4 per year while methanotrophs consume roughly 60% of global CH4 and oxidise ~30 Tg directly from the atmosphere; soils emit ~6.8 Tg N2O per year (~65% of global total), with agriculture responsible for ~52% of anthropogenic N2O. A case example shows a 53% tomato yield increase with N2O reduced from ~2.01 to 0.58 kg N2O-N ha -1 under an integrated system. Overall evidence strength: Moderate (broad, well-established mechanisms and multiple quantitative figures, but this is a narrative review with context-dependent outcomes and limited causal quantification across scales). (Abstract; pp. 5-6 Key functions; Fig. 1 p. 6-7; pp. 11-14 Management; \"Recommendations\" p. 14; integrated tomato system p. 14)  Top 3 Claims and Evidence  C1. One-sentence claim   Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes. (Abstract; \"Soil structure drives the microbiome\" pp. 8-10; Figs. 2-3 pp. 9-11)  Evidence summary (design, sample, measures, analysis)   Narrative synthesis of field and experimental studies summarised with mechanistic figures. Measures include particle size fractions, aggregate habitats, pore size classes, organism distributions, and functional implications (carbon stabilisation, nitrification/denitrification, CH4/N2O flux). (pp. 8-10; Fig. 2)  Key numbers (effect size, CI, p, N, timeframe)   • 47-69% of detected bacterial and fungal taxa associate with specific particle size fractions; smaller fractions carry ~10-fold larger microbial loads per size class and up to 48-52% greater diversity. (p. 9)   • ~90% of soil bacteria associate with microaggregates, ~70% residing inside microaggregates; <10% on macroaggregate surfaces. (p. 9)   • Pore hierarchy: macropores >75 µm; pores between macroaggregates; within macroaggregates; within microaggregates; sharp O2 and nutrient gradients select for aerobic vs anaerobic guilds. (p. 10; Fig. 2)   • Microaggregate pores are likely simultaneous hotspots for C stabilisation and N2O emissions; the trade-off is not well understood or quantified. (p. 10)  Source location (page/section/figure/table)   \"Soil structure drives the microbiome\" (pp. 8-10); Fig. 2 (pp. 9-10); discussion of pore-scale trade-offs (p. 10).  Strength rating and assumptions   Strength: Moderate. Assumptions: \"mm\" in \"Macroaggregate >250 mm\" in Fig. 2 is [UNCLEAR]; consistent text elsewhere indicates >250 µm and <250 µm, so µm assumed. (p. 9; Fig. 2)  C2. One-sentence claim   Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets. (Abstract; \"Key functions of the soil microbiome\" pp. 5-7; Fig. 1 p. 6-7)  Evidence summary (design, sample, measures, analysis)   Narrative synthesis collating global flux estimates and microbial pathway attributions (CO2 respiration, CH4 methanogenesis/methanotrophy, N2O from nitrification/denitrification). (pp. 5-6; Fig. 1)  Key numbers (effect size, CI, p, N, timeframe)   • ~50% of ~120 Pg C emitted per year on land is from heterotrophic microbial respiration; \"up to nine times more\" than yearly global anthropogenic sources. (p. 5)   • Methanogens are responsible for ~two-thirds of 500-600 Tg CH4 per year; methanotrophs oxidise ~30 Tg directly from the atmosphere and consume roughly 60% of globally produced CH4. (p. 5-6; Fig. 1)   • Soils contribute ~6.8 Tg N2O per year (~65% of global emissions); agriculture accounts for ~52% of global anthropogenic N2O. (p. 5-6)  Source location (page/section/figure/table)   \"Key functions of the soil microbiome - Climate regulation\" (pp. 5-6); Fig. 1 (p. 6-7).  Strength rating and assumptions   Strength: High for the general claim (well-established budgets and pathways as presented).  C3. One-sentence claim   Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent. (Abstract; \"Microbiome functions in agroecosystems\" pp. 11-14; Figs. 3-4 pp. 10-12)  Evidence summary (design, sample, measures, analysis)   Narrative synthesis of field findings and meta-analytic patterns: effects of tillage on aggregation/fluxes, compaction on pore networks and GHGs, cover crops and rotations on microbial diversity and function, organic vs mineral fertilisers on structure and biogeochemistry; specific field case studies provided. (pp. 11-14; Figs. 3-4)  Key numbers (effect size, CI, p, N, timeframe)   • Compaction affects an estimated 68 million ha (~one-quarter of global agricultural land). (p. 12)   • Tillage increases CO2 emissions via macroaggregate breakdown; cessation of tillage can initially increase N2O but decreases with long-term no-tillage; CH4 generally decreases under conservation tillage due to a more stable pore network aiding methanotrophy. (pp. 12-13)   • Integrated tomato system (California): reduced tillage + drip fertigation + triticale cover crop increased yield by ~53% and reduced N2O from ~2.01 to 0.58 kg N2O-N ha-1 on 5 ha. (p. 14)   • Quesungual slash-and-mulch agroforestry system: earthworms 13.4 vs 0.8 g m-2 (QSMAS vs SB), available P tripled, soil carbon increased; macrofauna biomass increased vs secondary forest (dry season 24.8 vs 4.3 g m-2; wet season 41.9 vs 13.1 g m-2). (p. 14)  Source location (page/section/figure/table)   \"Soil management,\" \"Crop management,\" \"External inputs,\" and \"Recommendations\" (pp. 11-14); Figs. 3-4 (pp. 10-12).  Strength rating and assumptions   Strength: Moderate. Effects are repeatedly noted as crop/soil/climate dependent; specific quantified case studies support plausibility but generalisability is limited.  Gaps & Limitations (linked to C1-C3)   • C1: Pore-scale trade-off between C stabilisation and N2O is \"not well understood, let alone quantified\"; aggregate dynamics under different interventions are \"rarely directly investigated.\" (p. 10)   • C2: The review provides budgets and attributions but no new primary quantification; pathway contributions can vary by soil and management, which is not resolved here. (pp. 5-6)   • C3: Outcomes are context-dependent and sometimes contradictory (e.g., N2O under no-till; variable biochar and organic fertiliser effects; inoculant establishment and non-target effects uncertain). Long-term, cross-site causal links from management to pore/aggregate-scale microbiome processes remain sparse. (pp. 12-14)  Methods Snapshot   Narrative review using an online network-based literature mapping tool (Research Rabbit) to identify relevant literature; synthesised mechanisms and management impacts with integrative figures and selected quantitative examples. No formal systematic review protocol or meta-analysis is described. (Introduction, p. 5)  Risk-of-Bias/Quality Checklist   • Literature identification: non-systematic mapping; potential selection bias. (p. 5)   • Heterogeneity: acknowledged context dependence across soils, climates, crops. (pp. 12-14)   • Causality: many inferences are mechanistic or associative; limited direct multiscale causal quantification. (pp. 9-10, 12-14)   • Precision/reporting: many figures are qualitative; where numbers are given they are reported here exactly as in the text.   • External validity: strong conceptual generality; site-specific performance and trade-offs remain to be validated broadly. (pp. 12-15)  Open Questions & Next Steps   • Quantify the pore-scale C-stabilisation vs N2O trade-off across soil types and degradation levels. (p. 10)   • Link microscale physicochemical gradients (within/among aggregates) to cell-level activity using imaging and tracing (e.g., NanoSIMS, Raman) combined with single-cell genomics. (p. 15)   • Run long-term, cross-soil/climate trials that connect management (no-till, cover crops, organic inputs, IPM/ISFM) to aggregate/pore architecture and specific microbial guild functions, including GHG outcomes. (pp. 12-15)   • Resolve when and where microbial inoculants reliably persist and benefit structure/function vs when promoting native communities is preferable; assess legacy and non-target effects. (pp. 13-14)   • Expand research in developing countries and underrepresented soil types where reliance on nature-based solutions is high. (p. 15)  QA checks   • All required sections present.   • Numbers reproduced verbatim.   • Each claim includes strength and source locations.   • OCR artefact flagged: \"Macroaggregate >250 mm\" in Fig. 2 interpreted as >250 µm based on surrounding text. (p. 9; Fig. 2)",
        "structured": {
          "executiveSummary": [
            "Soil structure governs microbiome function in agroecosystems; protecting or rebuilding structure enhances beneficial microbial processes.",
            "Headline numbers: ~50% of ~120 Pg C land emissions from heterotrophic microbial respiration; methanogens ~two-thirds of 500-600 Tg CH4 yr-1; methanotrophs consume ~60% of global CH4 and oxidise ~30 Tg from atmosphere; soils emit ~6.8 Tg N2O yr-1 (~65% of global), agriculture ~52% of anthropogenic N2O.",
            "Case example: integrated tomato system increased yield by ~53% and reduced N2O from ~2.01 to 0.58 kg N2O-N ha -1.",
            "Overall evidence strength: Moderate (narrative review; context-dependent outcomes; limited causal quantification across scales)."
          ],
          "claims": [
            {
              "id": "C1",
              "claim": "Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes.",
              "evidenceSummary": "Narrative synthesis of field and experimental studies with mechanistic figures; measures include particle size fractions, aggregate habitats, pore classes, organism distributions, and functional implications (C stabilisation, nitrification/denitrification, CH4/N2O flux).",
              "keyNumbers": [
                "47-69% of detected bacterial and fungal taxa associate with specific particle size fractions; smaller fractions carry ~10-fold larger microbial loads per size class and up to 48-52% greater diversity.",
                "~90% of soil bacteria associate with microaggregates; ~70% inside microaggregates; <10% on macroaggregate surfaces.",
                "Macropores >75 µm; hierarchical pore network; sharp O2 and nutrient gradients selecting aerobic vs anaerobic guilds.",
                "Microaggregate pores likely hotspots for C stabilisation and N2O emissions; trade-off not quantified."
              ],
              "source": "\"Soil structure drives the microbiome\" pp. 8-10; Fig. 2 pp. 9-10; pore-scale trade-offs p. 10.",
              "strength": "Moderate",
              "assumptions": "\"mm\" in \"Macroaggregate >250 mm\" in Fig. 2 is [UNCLEAR]; assumed µm based on surrounding text.",
              "evidenceType": "Narrative review (secondary synthesis)"
            },
            {
              "id": "C2",
              "claim": "Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets.",
              "evidenceSummary": "Narrative synthesis compiling global flux estimates and microbial pathway attributions for CO2, CH4, and N2O.",
              "keyNumbers": [
                "~50% of ~120 Pg C emitted per year on land from heterotrophic microbial respiration; up to nine times more than yearly global anthropogenic sources.",
                "Methanogens ~two-thirds of 500-600 Tg CH4 yr-1; methanotrophs oxidise ~30 Tg directly from atmosphere and consume roughly 60% of global CH4.",
                "Soils ~6.8 Tg N2O yr-1 (~65% of global emissions); agriculture ~52% of global anthropogenic N2O."
              ],
              "source": "Key functions pp. 5-6; Fig. 1 pp. 6-7.",
              "strength": "High",
              "assumptions": null,
              "evidenceType": "Narrative review (secondary synthesis)"
            },
            {
              "id": "C3",
              "claim": "Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent.",
              "evidenceSummary": "Narrative synthesis of field findings/meta-analytic patterns on tillage, compaction, cover crops, fertilisers, and case studies (integrated tomato system; QSMAS).",
              "keyNumbers": [
                "Compaction affects ~68 million ha (~one-quarter of global agricultural land).",
                "Under conservation tillage: CO2 increases with tillage; N2O may initially rise then fall with long-term no-till; CH4 generally decreases as stable pore networks aid methanotrophy.",
                "Integrated tomato system: yield ↑ ~53%; N2O reduced from ~2.01 to 0.58 kg N2O-N ha-1 on 5 ha.",
                "QSMAS: earthworms 13.4 vs 0.8 g m-2 (QSMAS vs SB); available P tripled; macrofauna biomass vs secondary forest - dry 24.8 vs 4.3 g m-2; wet 41.9 vs 13.1 g m-2."
              ],
              "source": "Soil/Crop/External inputs pp. 11-14; Figs. 3-4 pp. 10-12; Recommendations p. 14.",
              "strength": "Moderate",
              "assumptions": "Effects are crop/soil/climate dependent; generalisability limited beyond reported contexts.",
              "evidenceType": "Narrative review with case studies"
            }
          ],
          "gaps": [
            {
              "category": "Quantification gap",
              "detail": "Pore-scale C-stabilisation vs N2O trade-off not well understood or quantified.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "Evidence gap",
              "detail": "Aggregate dynamics under different interventions rarely investigated directly.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "Generalisability",
              "detail": "Budgets and pathway attributions synthesised without new primary quantification; variability by soil/management unresolved.",
              "relatedClaimIds": [
                "C2"
              ]
            },
            {
              "category": "Intervention heterogeneity",
              "detail": "Context-dependent and sometimes contradictory outcomes (e.g., N2O under no-till; variable biochar/organic fertiliser effects; inoculant establishment and non-target effects uncertain).",
              "relatedClaimIds": [
                "C3"
              ]
            },
            {
              "category": "Causal linkage",
              "detail": "Long-term, cross-site causal links from management to pore/aggregate-scale microbiome processes are sparse.",
              "relatedClaimIds": [
                "C3"
              ]
            }
          ],
          "methodsSnapshot": [
            "Narrative review using Research Rabbit to identify literature.",
            "Synthesised mechanisms and management impacts with integrative figures and selected quantitative examples.",
            "No formal systematic review protocol or meta-analysis described."
          ],
          "riskChecklist": [
            {
              "item": "Literature identification approach",
              "status": "partial",
              "note": "Non-systematic mapping; potential selection bias."
            },
            {
              "item": "Heterogeneity acknowledged",
              "status": "met",
              "note": "Context dependence across soils, climates, crops explicitly noted."
            },
            {
              "item": "Causality support",
              "status": "partial",
              "note": "Mechanistic/associative inferences; limited direct multiscale causal quantification."
            },
            {
              "item": "Precision/reporting of effects",
              "status": "partial",
              "note": "Many qualitative figures; quantitative numbers provided selectively."
            },
            {
              "item": "External validity",
              "status": "partial",
              "note": "Strong conceptual generality; site-specific performance and trade-offs need broader validation."
            },
            {
              "item": "Registration/protocol",
              "status": "missing",
              "note": "No protocol or registration stated."
            },
            {
              "item": "Meta-analysis",
              "status": "missing",
              "note": "No formal meta-analysis reported."
            }
          ],
          "openQuestions": [
            "Quantify pore-scale C-stabilisation vs N2O trade-off across soil types and degradation levels.",
            "Link microscale gradients to single-cell activity using imaging/tracing with single-cell genomics.",
            "Long-term cross-soil/climate trials connecting management to aggregate/pore architecture and specific microbial guild functions including GHG outcomes.",
            "Establishment, persistence, benefits, and risks of microbial inoculants vs promoting native communities; assess legacy and non-target effects.",
            "Expand research in developing countries and underrepresented soil types with high reliance on nature-based solutions."
          ],
          "crossPaperComparison": []
        }
      },
      "createdAt": "2025-10-23T06:01:46.288Z",
      "updatedAt": "2025-10-28T05:15:30.518Z",
      "agent": {
        "maxChars": 9188,
        "promptNotes": ""
      },
      "sourcePaper": {
        "title": "Soil structure and microbiome functions in agroecosystems",
        "summary": "Narrative review arguing that soil structure governs microbiome function and that conservation management that protects or rebuilds structure enhances beneficial processes, with headline greenhouse gas budgets and selected case studies.",
        "keyMethodSignals": [
          "Particle size fractionation and aggregate class comparisons",
          "Pore size classes and connectivity linked to guild distributions",
          "Mechanistic synthesis of carbon stabilisation, nitrification and denitrification",
          "Compilation of global CO2, CH4 and N2O flux attributions",
          "Management comparisons on tillage, compaction, cover crops and fertilisers"
        ],
        "methodComparison": {
          "sample": "Field and laboratory soils across multiple climates, crops and management regimes summarised from the literature.",
          "materials": "Measures emphasised particle size fractions, aggregate habitats, pore network classes and microbial guild distributions relevant to greenhouse gas pathways.",
          "equipment": "Typical wet sieving and fractionation setups, imaging and gas flux methods referenced across studies rather than a single instrument set.",
          "procedure": "Non systematic literature mapping and integrative synthesis with mechanistic figures and selected quantitative examples including global flux numbers.",
          "outcomes": "Conceptual linkage from soil structure to microenvironments to guild activity and greenhouse gas outcomes, with context dependent management effects."
        }
      },
      "similarPapers": [
        {
          "identifier": "10.3389/fmicb.2018.00149",
          "title": "Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses",
          "authors": [
            "Hemkemeyer M",
            "et al."
          ],
          "year": 2018,
          "venue": "Frontiers in Microbiology",
          "whyRelevant": "Direct match to particle and aggregate fractionation with gentle dispersion and microhabitat specific DNA analyses. Strong overlap with structure driven assembly central to the brief.",
          "methodOverlap": [
            "Gentle ultrasonication and wet sieving into sand silt clay fractions",
            "qPCR quantification of 16S and domain markers per fraction",
            "Amplicon sequencing maps taxa across particle size fractions"
          ],
          "methodComparison": {
            "sample": "Long term experimental plots at Askov, Denmark, 0 to 18 cm, multiple fertiliser histories pooled before fractionation.",
            "materials": "Particle size fractionation protocol with mild dispersants and MgCl2, DNA extraction kits, 16S primers for bacteria and archaea.",
            "equipment": "Probe sonicator, sieves at 63 and 20 micrometres, centrifuges, StepOnePlus qPCR platform, Illumina MiSeq.",
            "procedure": "Minimal energy dispersion, sequential separation of fractions, DNA extraction from each fraction, qPCR and dual indexed 16S sequencing.",
            "outcomes": "Clear taxon sorting among fractions with fine silt and clay enriched for diversity and microbial load."
          },
          "gaps": "No direct greenhouse gas flux measurements. Storage and handling may bias community composition. Functional conclusions rely on gene and amplicon data rather than process rates.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.3389/fevo.2022.1091773",
          "title": "Micro fractionation Shows Microbial Community Changes in Soil Particles Below 20 micrometres",
          "authors": [
            "Keuschnig M",
            "et al."
          ],
          "year": 2022,
          "venue": "Frontiers in Ecology and Evolution",
          "whyRelevant": "Sub 20 micrometre focus with size verified fractions and per fraction DNA plus nitrogen cycle marker genes. Aligns with aggregate and pore scale niche mechanisms in the brief.",
          "methodOverlap": [
            "Fractionation preserving microaggregates including less than 2 micrometres fractions",
            "Laser granulometry verifies fraction sizes and stability",
            "Denitrifier marker genes enriched in larger aggregates"
          ],
          "methodComparison": {
            "sample": "Park Grass soil, 0 to 21 cm, unmanaged reference site, micro fractionation preserving small aggregates and supernatant.",
            "materials": "Fractionation hardware, Mastersizer type laser granulometer, DNA kits, primer sets for nirK, nirS and nosZ.",
            "equipment": "Laser granulometer, centrifuges, thermal cycler and qPCR system, sequencing platform.",
            "procedure": "Fractionate soil, verify sizes by laser granulometry, extract DNA from each fraction, quantify community composition and nitrogen cycle markers.",
            "outcomes": "Distinct community shifts at and below 20 micrometres and higher denitrifier gene abundance in larger aggregates."
          },
          "gaps": "Relies on gene proxies rather than in situ process rates. No direct N2O flux measurements. Single site and unmanaged soil limit transferability to managed agroecosystems.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.3389/fmicb.2022.831746",
          "title": "Macroaggregates Serve as Micro Hotspots Enriched With Functional and Networked Microbial Communities in a Long Term Paddy Soil",
          "authors": [
            "Rui J",
            "et al."
          ],
          "year": 2022,
          "venue": "Frontiers in Microbiology",
          "whyRelevant": "Aggregate resolved wet sieving with per fraction DNA and network analyses under long term fertilisation. Mirrors the briefs aggregate microhabitat framing and adds a management lever.",
          "methodOverlap": [
            "Water stable aggregate fractionation across five size classes",
            "qPCR and amplicon sequencing applied to each aggregate fraction",
            "Macroaggregates identified as enriched functional micro hotspots"
          ],
          "methodComparison": {
            "sample": "Paddy topsoil from a long term fertiliser experiment initiated in 1987 with replicated treatments.",
            "materials": "Nylon sieves for wet sieving, centrifugation for fine fractions, PowerSoil type DNA kits, ITS and 16S primers.",
            "equipment": "Wet sieving setup, centrifuges, quantitative PCR system, sequencing instruments.",
            "procedure": "Fractionate water stable aggregates, characterise physicochemical properties and microbial abundance and diversity, infer co occurrence networks and functional potential.",
            "outcomes": "Macroaggregates showed higher microbial abundance and network connectivity, and fertilisation altered diversity and composition."
          },
          "gaps": "No direct greenhouse gas flux or process rate measurements. Paddy specific conditions and potential confounders reduce generalisability to upland systems.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1371/journal.pone.0187681",
          "title": "Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics",
          "authors": [
            "Zurovec O",
            "et al."
          ],
          "year": 2017,
          "venue": "PLOS ONE",
          "whyRelevant": "Field comparison of conventional, reduced and no tillage with direct N2O flux monitoring and soil structural measurements. Matches the briefs emphasis on management trade offs and structure function links.",
          "methodOverlap": [
            "Weekly static chamber N2O fluxes under contrasting tillage systems",
            "Undisturbed core sampling for bulk density and porosity",
            "Yield scaled N2O and economic assessment of treatments"
          ],
          "methodComparison": {
            "sample": "Maize to barley rotation on a Fluvisol over two seasons with replicated treatment strips.",
            "materials": "Static chambers, stainless steel core cylinders, standard mineral fertilisers and crop management inputs.",
            "equipment": "Gas chromatography for N2O analysis, core sampling hardware, devices to determine bulk density and porosity.",
            "procedure": "Apply tillage treatments and standard nitrogen inputs, measure weekly N2O fluxes, collect end season soil physics, compute yield and cost metrics.",
            "outcomes": "Treatment ranking of N2O varied between wet and dry years, fertiliser pulses dominated emissions, reduced tillage had lowest yield scaled N2O in year one."
          },
          "gaps": "Short duration and single site limit inference strength. No aggregate resolved microbiology, so mechanisms are inferred via water filled pore space and structure metrics.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1038/s41598-019-47861-7",
          "title": "Climate and Soil Characteristics Determine Where No Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions",
          "authors": [
            "Ogle S",
            "et al."
          ],
          "year": 2019,
          "venue": "Scientific Reports",
          "whyRelevant": "Global dataset and semi parametric mixed effects modelling of tillage impacts on soil carbon with explicit treatment of depth and uncertainty. Mirrors the briefs synthesis style for management effects relevant to greenhouse gas outcomes.",
          "methodOverlap": [
            "Literature based compilation with explicit inclusion criteria",
            "Depth explicit modelling of soil carbon change with climate and texture",
            "Addresses sampling depth and mass equivalency in analysis"
          ],
          "methodComparison": {
            "sample": "Controlled experiments worldwide comparing conventional and no till with 178 sites and more than one thousand observations.",
            "materials": "Extracted data on soil organic carbon, bulk density, texture and climate metadata from primary studies.",
            "equipment": "Statistical computing environment for mixed effects models and uncertainty analysis.",
            "procedure": "Apply inclusion criteria, extract variables, fit semi parametric mixed effects models with depth and time covariates and evaluate uncertainty.",
            "outcomes": "No till increases carbon near the surface while conventional till often stores more deeper, with climate and texture governing sign and magnitude."
          },
          "gaps": "Focuses on soil carbon rather than partitioned greenhouse gas fluxes. Observational heterogeneity remains and deep soil layers are under sampled.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        }
      ],
      "researchGroups": {
        "maxChars": 7996,
        "truncated": false,
        "text": "Paper: Soil structure and microbiome functions in agroecosystems (Nature Reviews Earth & Environment, 2022)\nGroup: Microbiome Research (ETH Zürich; affiliated with Agroscope)\nWebsite: https://microbiome.ch\nSummary: Hartmann's group focuses on soil microbiome ecology in agroecosystems, linking pore-scale structure to microbial functions highlighted in the review. Additional link: ETH profile https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html (https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html)\n| Name | Email | Role |\n| --- | --- | --- |\n| Martin Hartmann | martin.hartmann@usys.ethz.ch | PI |\n| Member list | check lab website contact form | Admin/General enquiry |\n\nGroup: Sustainable Agroecosystems (ETH Zürich)\nWebsite: https://sae.ethz.ch\nSummary: Six's group integrates soil structure, aggregation and greenhouse gas trade-offs in conservation systems, matching the review's methods scope.\n| Name | Email | Role |\n| --- | --- | --- |\n| Johan Six | jsix@ethz.ch | PI |\n| Member list | check lab website contact form | Admin/General enquiry |\n\nPaper: Microbial spatial footprint as a driver of soil carbon stabilisation - Nature Communications (2019) (10.1038/s41467-019-11057-4)\nGroup: Soil and Environmental Physics (Swedish University of Agricultural Sciences, SLU)\nWebsite: https://www.slu.se/en/research/research-catalogue/grupper/b/soil-and-environmental-physics/\nSummary: Koestel's team uses X-ray µCT and pore-network analysis to connect pore architecture with biogeochemical processes, core to this paper's micro-CT-activity linkage.\n| Name | Email | Role |\n| --- | --- | --- |\n| John Koestel | john.koestel@slu.se | Associate Professor (PI) |\n| Nick Jarvis | nicholas.jarvis@slu.se | Professor, group contact |\n| Soil Physics Lab | soilphysicslab@slu.se | Laboratory contact (samples, µCT logistics) |\n\nGroup: W. K. Kellogg Biological Station, Biogeochemistry & Agroecosystems (Michigan State University)\nWebsite: https://www.kbs.msu.edu/kbs-people/faculty/g-philip-robertson/\nSummary: Long-term field experiments linking plant diversity, management and soil C-N-GHG dynamics; Robertson co-authors extensively with MSU soil structure-microbiome teams.\n| Name | Email | Role |\n| --- | --- | --- |\n| G. Philip Robertson | robert30@msu.edu | PI |\n| KBS Directory | check lab website contact form | Use \"People\" directory for current postdocs and PhD students |\n\nPaper: Anaerobic microsites have an unaccounted role in soil carbon stabilisation - Nature Communications (2017) (10.1038/s41467-017-01406-6)\nGroup: Soil & Environmental Biogeochemistry (Scott Fendorf Lab) (Stanford Doerr School of Sustainability)\nWebsite: https://sustainability.stanford.edu/people/scott-fendorf-0\nSummary: Fendorf's group leads on redox geochemistry at pore- to field-scales, central to anaerobic microsite formation and C preservation.\n| Name | Email | Role |\n| --- | --- | --- |\n| Scott Fendorf | fendorf@stanford.edu | PI |\n| Team contacts | use stanford profiles for current postdocs and phd students | Check lab website contact form |\n\nGroup: Molecular Biogeochemistry of Soils (Keiluweit Lab) (University of Lausanne)\nWebsite: https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html\nSummary: Keiluweit's team develops controlled redox systems and rhizosphere microsite approaches directly aligned with the paper's oxygen-gradient mechanism.\n| Name | Email | Role |\n| --- | --- | --- |\n| Marco Keiluweit | marco.keiluweit@unil.ch | PI |\n| Megan Foley | megan.foley@unil.ch | PhD Researcher (current) |\n| Emily M. Lacroix | emily.lacroix@unil.ch | Postdoctoral Researcher (redox/anoxic microsites) |\n\nPaper: Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes - Journal of Environmental Quality (2014) (10.2134/jeq2014.03.0125)\nGroup: Danish Center for Hadal Research & NordCEE (Glud group) (University of Southern Denmark)\nWebsite: https://www.sdu.dk/en/forskning/hadal/people\nSummary: Pioneers in planar optode oxygen imaging and microprofiling, providing core expertise for 2-D O2 mapping in soils and sediments.\n| Name | Email | Role |\n| --- | --- | --- |\n| Ronnie N. Glud | rnglud@biology.sdu.dk | Professor, Center Director |\n| Wenjie Xiao | wjxiao@biology.sdu.dk | Postdoctoral Researcher |\n| Blandine Trouche | blandinetrouche@biology.sdu.dk | Postdoctoral Researcher |\n\nGroup: Soil Fertility & Nutrient Recycling, Section for Plant and Soil Science (University of Copenhagen)\nWebsite: https://plen.ku.dk/english/research/plant_soil/\nSummary: Jensen and Sander Bruun's teams study manure placement, O2 dynamics and nutrient cycling in tilled versus conservation systems, directly tied to optode-imaged O2 and N2O.\n| Name | Email | Role |\n| --- | --- | --- |\n| Lars Stoumann Jensen | lsj@plen.ku.dk | Professor, Soil Fertility |\n| Sander Bruun | sab@plen.ku.dk | Professor, Climate Change & Soil Management |\n| Xiaoxiao Qin | xq@plen.ku.dk | PhD Fellow (Plant and Soil Science) |\n\nPaper: Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis - Global Change Biology (2013) (10.1111/j.1365-2486.2012.02779.x)\nGroup: Rice Systems & GHG Mitigation (Linquist Lab) (UC Davis)\nWebsite: https://linquist.ucdavis.edu/\nSummary: Extensive meta-analysis and field trials on tillage, N placement and yield-scaled N2O, informing practice-specific mitigation signals from the paper.\n| Name | Email | Role |\n| --- | --- | --- |\n| Bruce A. Linquist | balinquist@ucdavis.edu | PI |\n| Whitney Brim-DeForest | wbrimdeforest@ucanr.edu | Rice Advisor, collaborator |\n| Luis Espino | laespino@ucanr.edu | Rice Advisor, collaborator |\n\nGroup: Soil & Water Management Research Unit (Venterea group) (USDA-ARS, St Paul, MN)\nWebsite: https://www.ars.usda.gov/midwest-area/stpaul/swmr/\nSummary: Core ARS unit quantifying N transformations and N2O in row-crop systems, including placement effects and reduced tillage contexts highlighted by the meta-analysis.\n| Name | Email | Role |\n| --- | --- | --- |\n| Rodney T. Venterea | venterea@umn.edu | Research Soil Scientist (PI) |\n| Unit main office | check lab website contact form | Use unit site contact for current postdocs/GSRA contacts |\n\nPaper: Microbial proxies for anoxic microsites vary with management and texture - Environmental Science & Technology (2024) (10.1021/acs.est.4c01882)\nGroup: Dekas Geomicrobiology Laboratory (Stanford University)\nWebsite: https://dekaslab.stanford.edu/\nSummary: Leads development of microbial and ddPCR proxies for anoxic microsites used in this study; active publications on proxies and redox since 2020.\n| Name | Email | Role |\n| --- | --- | --- |\n| Anne E. Dekas | dekas@stanford.edu | PI |\n| Current members | use lab “people” page for up-to-date student and postdoc roster | Check lab website contact form |\n\nGroup: Molecular Biogeochemistry of Soils (Keiluweit Lab) (University of Lausanne)\nWebsite: https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html\nSummary: Co-led the EST 2024 long-term management comparison; specialises in pore-scale redox and rhizosphere anoxic microsites.\n| Name | Email | Role |\n| --- | --- | --- |\n| Marco Keiluweit | marco.keiluweit@unil.ch | PI |\n| Emily M. Lacroix | emily.lacroix@unil.ch | First author, Postdoctoral Researcher |\n| Megan Foley | megan.foley@unil.ch | PhD Researcher (methods on rhizosphere anoxia) |\n\nGroup: Soil & Environmental Biogeochemistry (Scott Fendorf Lab) (Stanford)\nWebsite: https://sustainability.stanford.edu/people/scott-fendorf-0\nSummary: Senior-author group on the EST study integrating management, texture and microbial redox indicators with SOC outcomes.\n| Name | Email | Role |\n| --- | --- | --- |\n| Scott Fendorf | fendorf@stanford.edu | PI |\n| Collaborator list | see project and publication pages for current trainees on the proxy work | Check lab website contact form |",
        "structured": {
          "papers": [
            {
              "title": "Soil structure and microbiome functions in agroecosystems (Nature Reviews Earth & Environment, 2022)",
              "identifier": null,
              "groups": [
                {
                  "name": "Microbiome Research",
                  "institution": "ETH Zürich; affiliated with Agroscope",
                  "website": "https://microbiome.ch",
                  "notes": "Hartmann's group focuses on soil microbiome ecology in agroecosystems, linking pore-scale structure to microbial functions highlighted in the review. Additional link: ETH profile https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html (https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html)",
                  "researchers": [
                    {
                      "name": "Martin Hartmann",
                      "email": "martin.hartmann@usys.ethz.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Member list",
                      "email": "check lab website contact form",
                      "role": "Admin/General enquiry"
                    }
                  ]
                },
                {
                  "name": "Sustainable Agroecosystems",
                  "institution": "ETH Zürich",
                  "website": "https://sae.ethz.ch",
                  "notes": "Six's group integrates soil structure, aggregation and greenhouse gas trade-offs in conservation systems, matching the review's methods scope.",
                  "researchers": [
                    {
                      "name": "Johan Six",
                      "email": "jsix@ethz.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Member list",
                      "email": "check lab website contact form",
                      "role": "Admin/General enquiry"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Microbial spatial footprint as a driver of soil carbon stabilisation - Nature Communications (2019)",
              "identifier": "10.1038/s41467-019-11057-4",
              "groups": [
                {
                  "name": "Soil and Environmental Physics",
                  "institution": "Swedish University of Agricultural Sciences, SLU",
                  "website": "https://www.slu.se/en/research/research-catalogue/grupper/b/soil-and-environmental-physics/",
                  "notes": "Koestel's team uses X-ray µCT and pore-network analysis to connect pore architecture with biogeochemical processes, core to this paper's micro-CT-activity linkage.",
                  "researchers": [
                    {
                      "name": "John Koestel",
                      "email": "john.koestel@slu.se",
                      "role": "Associate Professor (PI)"
                    },
                    {
                      "name": "Nick Jarvis",
                      "email": "nicholas.jarvis@slu.se",
                      "role": "Professor, group contact"
                    },
                    {
                      "name": "Soil Physics Lab",
                      "email": "soilphysicslab@slu.se",
                      "role": "Laboratory contact (samples, µCT logistics)"
                    }
                  ]
                },
                {
                  "name": "W. K. Kellogg Biological Station, Biogeochemistry & Agroecosystems",
                  "institution": "Michigan State University",
                  "website": "https://www.kbs.msu.edu/kbs-people/faculty/g-philip-robertson/",
                  "notes": "Long-term field experiments linking plant diversity, management and soil C-N-GHG dynamics; Robertson co-authors extensively with MSU soil structure-microbiome teams.",
                  "researchers": [
                    {
                      "name": "G. Philip Robertson",
                      "email": "robert30@msu.edu",
                      "role": "PI"
                    },
                    {
                      "name": "KBS Directory",
                      "email": "check lab website contact form",
                      "role": "Use \"People\" directory for current postdocs and PhD students"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Anaerobic microsites have an unaccounted role in soil carbon stabilisation - Nature Communications (2017)",
              "identifier": "10.1038/s41467-017-01406-6",
              "groups": [
                {
                  "name": "Soil & Environmental Biogeochemistry (Scott Fendorf Lab)",
                  "institution": "Stanford Doerr School of Sustainability",
                  "website": "https://sustainability.stanford.edu/people/scott-fendorf-0",
                  "notes": "Fendorf's group leads on redox geochemistry at pore- to field-scales, central to anaerobic microsite formation and C preservation.",
                  "researchers": [
                    {
                      "name": "Scott Fendorf",
                      "email": "fendorf@stanford.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Team contacts",
                      "email": "use stanford profiles for current postdocs and phd students",
                      "role": "Check lab website contact form"
                    }
                  ]
                },
                {
                  "name": "Molecular Biogeochemistry of Soils (Keiluweit Lab)",
                  "institution": "University of Lausanne",
                  "website": "https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html",
                  "notes": "Keiluweit's team develops controlled redox systems and rhizosphere microsite approaches directly aligned with the paper's oxygen-gradient mechanism.",
                  "researchers": [
                    {
                      "name": "Marco Keiluweit",
                      "email": "marco.keiluweit@unil.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Megan Foley",
                      "email": "megan.foley@unil.ch",
                      "role": "PhD Researcher (current)"
                    },
                    {
                      "name": "Emily M. Lacroix",
                      "email": "emily.lacroix@unil.ch",
                      "role": "Postdoctoral Researcher (redox/anoxic microsites)"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes - Journal of Environmental Quality (2014)",
              "identifier": "10.2134/jeq2014.03.0125",
              "groups": [
                {
                  "name": "Danish Center for Hadal Research & NordCEE (Glud group)",
                  "institution": "University of Southern Denmark",
                  "website": "https://www.sdu.dk/en/forskning/hadal/people",
                  "notes": "Pioneers in planar optode oxygen imaging and microprofiling, providing core expertise for 2-D O2 mapping in soils and sediments.",
                  "researchers": [
                    {
                      "name": "Ronnie N. Glud",
                      "email": "rnglud@biology.sdu.dk",
                      "role": "Professor, Center Director"
                    },
                    {
                      "name": "Wenjie Xiao",
                      "email": "wjxiao@biology.sdu.dk",
                      "role": "Postdoctoral Researcher"
                    },
                    {
                      "name": "Blandine Trouche",
                      "email": "blandinetrouche@biology.sdu.dk",
                      "role": "Postdoctoral Researcher"
                    }
                  ]
                },
                {
                  "name": "Soil Fertility & Nutrient Recycling, Section for Plant and Soil Science",
                  "institution": "University of Copenhagen",
                  "website": "https://plen.ku.dk/english/research/plant_soil/",
                  "notes": "Jensen and Sander Bruun's teams study manure placement, O2 dynamics and nutrient cycling in tilled versus conservation systems, directly tied to optode-imaged O2 and N2O.",
                  "researchers": [
                    {
                      "name": "Lars Stoumann Jensen",
                      "email": "lsj@plen.ku.dk",
                      "role": "Professor, Soil Fertility"
                    },
                    {
                      "name": "Sander Bruun",
                      "email": "sab@plen.ku.dk",
                      "role": "Professor, Climate Change & Soil Management"
                    },
                    {
                      "name": "Xiaoxiao Qin",
                      "email": "xq@plen.ku.dk",
                      "role": "PhD Fellow (Plant and Soil Science)"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis - Global Change Biology (2013)",
              "identifier": "10.1111/j.1365-2486.2012.02779.x",
              "groups": [
                {
                  "name": "Rice Systems & GHG Mitigation (Linquist Lab)",
                  "institution": "UC Davis",
                  "website": "https://linquist.ucdavis.edu/",
                  "notes": "Extensive meta-analysis and field trials on tillage, N placement and yield-scaled N2O, informing practice-specific mitigation signals from the paper.",
                  "researchers": [
                    {
                      "name": "Bruce A. Linquist",
                      "email": "balinquist@ucdavis.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Whitney Brim-DeForest",
                      "email": "wbrimdeforest@ucanr.edu",
                      "role": "Rice Advisor, collaborator"
                    },
                    {
                      "name": "Luis Espino",
                      "email": "laespino@ucanr.edu",
                      "role": "Rice Advisor, collaborator"
                    }
                  ]
                },
                {
                  "name": "Soil & Water Management Research Unit (Venterea group)",
                  "institution": "USDA-ARS, St Paul, MN",
                  "website": "https://www.ars.usda.gov/midwest-area/stpaul/swmr/",
                  "notes": "Core ARS unit quantifying N transformations and N2O in row-crop systems, including placement effects and reduced tillage contexts highlighted by the meta-analysis.",
                  "researchers": [
                    {
                      "name": "Rodney T. Venterea",
                      "email": "venterea@umn.edu",
                      "role": "Research Soil Scientist (PI)"
                    },
                    {
                      "name": "Unit main office",
                      "email": "check lab website contact form",
                      "role": "Use unit site contact for current postdocs/GSRA contacts"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Microbial proxies for anoxic microsites vary with management and texture - Environmental Science & Technology (2024)",
              "identifier": "10.1021/acs.est.4c01882",
              "groups": [
                {
                  "name": "Dekas Geomicrobiology Laboratory",
                  "institution": "Stanford University",
                  "website": "https://dekaslab.stanford.edu/",
                  "notes": "Leads development of microbial and ddPCR proxies for anoxic microsites used in this study; active publications on proxies and redox since 2020.",
                  "researchers": [
                    {
                      "name": "Anne E. Dekas",
                      "email": "dekas@stanford.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Current members",
                      "email": "use lab “people” page for up-to-date student and postdoc roster",
                      "role": "Check lab website contact form"
                    }
                  ]
                },
                {
                  "name": "Molecular Biogeochemistry of Soils (Keiluweit Lab)",
                  "institution": "University of Lausanne",
                  "website": "https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html",
                  "notes": "Co-led the EST 2024 long-term management comparison; specialises in pore-scale redox and rhizosphere anoxic microsites.",
                  "researchers": [
                    {
                      "name": "Marco Keiluweit",
                      "email": "marco.keiluweit@unil.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Emily M. Lacroix",
                      "email": "emily.lacroix@unil.ch",
                      "role": "First author, Postdoctoral Researcher"
                    },
                    {
                      "name": "Megan Foley",
                      "email": "megan.foley@unil.ch",
                      "role": "PhD Researcher (methods on rhizosphere anoxia)"
                    }
                  ]
                },
                {
                  "name": "Soil & Environmental Biogeochemistry (Scott Fendorf Lab)",
                  "institution": "Stanford",
                  "website": "https://sustainability.stanford.edu/people/scott-fendorf-0",
                  "notes": "Senior-author group on the EST study integrating management, texture and microbial redox indicators with SOC outcomes.",
                  "researchers": [
                    {
                      "name": "Scott Fendorf",
                      "email": "fendorf@stanford.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Collaborator list",
                      "email": "see project and publication pages for current trainees on the proxy work",
                      "role": "Check lab website contact form"
                    }
                  ]
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      },
      "researcherTheses": {
        "maxChars": 5699,
        "truncated": false,
        "text": "Researcher: Martin Hartmann\nEmail: martin.hartmann@usys.ethz.ch\nData publicly available: unknown\nLatest publication:\n  - Title: Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach\n  - Year: 2025\n  - Venue: Annals of Botany\n  - URL: https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684\nPhD thesis:\n  - Title: Genetic characterization of soil bacterial communities in the DOK long-term agricultural field experiment. Influences of management strategies and crops\n  - Year: 2006\n  - Institution: ETH Zürich\n  - URL: https://www.research-collection.ethz.ch/bitstreams/5a5de021-bfc0-44a2-97bf-370f48056044/download\n\nResearcher: Johan Six\nEmail: johan.six@usys.ethz.ch\nData publicly available: unknown\nLatest publication:\n  - Title: Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach\n  - Year: 2025\n  - Venue: Annals of Botany\n  - URL: https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684\nPhD thesis:\n  - Title: Aggregate and Soil Organic Matter Fraction Dynamics in Agroecosystems\n  - Year: 1998\n  - Institution: Colorado State University\n  - URL: Not found\n\nResearcher: Michael Hemkemeyer\nEmail: hemkemeyer@uni-wuppertal.de\nData publicly available: unknown\nLatest publication:\n  - Title: Potato yield and quality are linked to cover crop species and soil microorganisms\n  - Year: 2024\n  - Venue: Biology and Fertility of Soils\n  - URL: https://link.springer.com/article/10.1007/s00374-024-01810-3\nPhD thesis:\n  - Title: Importance of soil primary particles for shaping the diversity and activity of soil microbial communities\n  - Year: 2021\n  - Institution: Technische Universität Braunschweig\n  - URL: Not found\n\nResearcher: Christoph C. Tebbe\nEmail: christoph.tebbe@thuenen.de\nData publicly available: unknown\nLatest publication:\n  - Title: Status and trends in soil biodiversity - a national survey of Germany\n  - Year: 2025\n  - Venue: Soil Organisms\n  - URL: https://soil-organisms.org/index.php/SO/article/view/449\nPhD thesis: Not found\n\nResearcher: Christoph Keuschnig\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Microbial life in preferential flow paths in subsurface clayey till revealed by metataxonomy and metagenomics\n  - Year: 2024\n  - Venue: BMC Microbiology\n  - URL: https://gfzpublic.gfz.de/pubman/faces/ViewItemOverviewPage.jsp?itemId=item_5027674_1\nPhD thesis:\n  - Title: Implication des champignons et des bactéries dans le cycle de l'azote et la production de N2O dans le sol\n  - Year: 2016\n  - Institution: École Centrale de Lyon, Université de Lyon\n  - URL: https://bibliotheque.ec-lyon.fr/documents/TH_T2542_ckeuschnig.pdf\n\nResearcher: Catherine Larose\nEmail: catherine.larose@ec-lyon.fr\nData publicly available: unknown\nLatest publication:\n  - Title: Temporal variations of antimicrobial resistance genes in aerosols: A one-year monitoring at the Puy de Dôme summit (Central France)\n  - Year: 2024\n  - Venue: Science of the Total Environment\n  - URL: https://doi.org/10.1016/j.scitotenv.2023.169567\nPhD thesis:\n  - Title: Interactions entre composition chimique et populations microbiennes de la neige: quelles sont les conséquences sur le cycle du mercure en Arctique\n  - Year: 2010\n  - Institution: Université Joseph Fourier - Grenoble 1\n  - URL: https://core.ac.uk/download/pdf/52739764.pdf\n\nResearcher: Ognjen Žurovec\nEmail: ognjen.zurovec@nmbu.no\nData publicly available: unknown\nLatest publication:\n  - Title: Benchmarking a decade of holistic agro-environmental studies within the Agricultural Catchments Programme\n  - Year: 2022\n  - Venue: Irish Journal of Agricultural and Food Research\n  - URL: https://doi.org/10.15212/ijafr-2020-0145\nPhD thesis:\n  - Title: Agriculture, livelihoods and climate change in Bosnia and Herzegovina: impacts, vulnerability and adaptation\n  - Year: 2018\n  - Institution: Norwegian University of Life Sciences (NMBU)\n  - URL: https://nmbu.brage.unit.no/nmbu-xmlui/handle/11250/2580198\n\nResearcher: Peter Dörsch\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Carbon degradation and mobilisation potentials of thawing permafrost peatlands in northern Norway inferred from laboratory incubations\n  - Year: 2024\n  - Venue: Biogeosciences\n  - URL: https://bg.copernicus.org/articles/21/4723/2024/\nPhD thesis:\n  - Title: Nitrous oxide and methane fluxes in differentially managed agricultural soils of a hilly landscape in Southern Germany\n  - Year: 1999\n  - Institution: Technische Universität München\n  - URL: https://www.finna.fi/Record/vaari.926379\n\nResearcher: Stephen M. Ogle\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Counterfactual scenarios reveal historical impact of cropland management on soil organic carbon stocks in the United States\n  - Year: 2023\n  - Venue: Scientific Reports\n  - URL: https://www.nature.com/articles/s41598-023-41307-x\nPhD thesis:\n  - Title: Not found\n  - Year: 2000\n  - Institution: University of Wyoming\n  - URL: Not found\n\nResearcher: Gabriel G. Vázquez-Amabile\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: An evaluation of soil carbon models and their role on finding ways to net-zero carbon in agricultural systems\n  - Year: 2025\n  - Venue: Soil & Tillage Research\n  - URL: https://www.sciencedirect.com/science/article/abs/pii/S016719872400343X\nPhD thesis:\n  - Title: Hydrologic and nonpoint-source pollution risk analysis on agricultural watersheds\n  - Year: 2005\n  - Institution: Purdue University\n  - URL: https://purdue.primo.exlibrisgroup.com/discovery/fulldisplay/alma99143083980001081/01PURDUE_PUWL",
        "structured": {
          "researchers": [
            {
              "name": "Martin Hartmann",
              "email": "martin.hartmann@usys.ethz.ch",
              "latest_publication": {
                "title": "Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach",
                "year": 2025,
                "venue": "Annals of Botany",
                "url": "https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684"
              },
              "phd_thesis": {
                "title": "Genetic characterization of soil bacterial communities in the DOK long-term agricultural field experiment. Influences of management strategies and crops",
                "year": 2006,
                "institution": "ETH Zürich",
                "url": "https://www.research-collection.ethz.ch/bitstreams/5a5de021-bfc0-44a2-97bf-370f48056044/download"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Johan Six",
              "email": "johan.six@usys.ethz.ch",
              "latest_publication": {
                "title": "Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach",
                "year": 2025,
                "venue": "Annals of Botany",
                "url": "https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684"
              },
              "phd_thesis": {
                "title": "Aggregate and Soil Organic Matter Fraction Dynamics in Agroecosystems",
                "year": 1998,
                "institution": "Colorado State University",
                "url": null
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Michael Hemkemeyer",
              "email": "hemkemeyer@uni-wuppertal.de",
              "latest_publication": {
                "title": "Potato yield and quality are linked to cover crop species and soil microorganisms",
                "year": 2024,
                "venue": "Biology and Fertility of Soils",
                "url": "https://link.springer.com/article/10.1007/s00374-024-01810-3"
              },
              "phd_thesis": {
                "title": "Importance of soil primary particles for shaping the diversity and activity of soil microbial communities",
                "year": 2021,
                "institution": "Technische Universität Braunschweig",
                "url": null
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Christoph C. Tebbe",
              "email": "christoph.tebbe@thuenen.de",
              "latest_publication": {
                "title": "Status and trends in soil biodiversity - a national survey of Germany",
                "year": 2025,
                "venue": "Soil Organisms",
                "url": "https://soil-organisms.org/index.php/SO/article/view/449"
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Christoph Keuschnig",
              "email": null,
              "latest_publication": {
                "title": "Microbial life in preferential flow paths in subsurface clayey till revealed by metataxonomy and metagenomics",
                "year": 2024,
                "venue": "BMC Microbiology",
                "url": "https://gfzpublic.gfz.de/pubman/faces/ViewItemOverviewPage.jsp?itemId=item_5027674_1"
              },
              "phd_thesis": {
                "title": "Implication des champignons et des bactéries dans le cycle de l'azote et la production de N2O dans le sol",
                "year": 2016,
                "institution": "École Centrale de Lyon, Université de Lyon",
                "url": "https://bibliotheque.ec-lyon.fr/documents/TH_T2542_ckeuschnig.pdf"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Catherine Larose",
              "email": "catherine.larose@ec-lyon.fr",
              "latest_publication": {
                "title": "Temporal variations of antimicrobial resistance genes in aerosols: A one-year monitoring at the Puy de Dôme summit (Central France)",
                "year": 2024,
                "venue": "Science of the Total Environment",
                "url": "https://doi.org/10.1016/j.scitotenv.2023.169567"
              },
              "phd_thesis": {
                "title": "Interactions entre composition chimique et populations microbiennes de la neige: quelles sont les conséquences sur le cycle du mercure en Arctique",
                "year": 2010,
                "institution": "Université Joseph Fourier - Grenoble 1",
                "url": "https://core.ac.uk/download/pdf/52739764.pdf"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Ognjen Žurovec",
              "email": "ognjen.zurovec@nmbu.no",
              "latest_publication": {
                "title": "Benchmarking a decade of holistic agro-environmental studies within the Agricultural Catchments Programme",
                "year": 2022,
                "venue": "Irish Journal of Agricultural and Food Research",
                "url": "https://doi.org/10.15212/ijafr-2020-0145"
              },
              "phd_thesis": {
                "title": "Agriculture, livelihoods and climate change in Bosnia and Herzegovina: impacts, vulnerability and adaptation",
                "year": 2018,
                "institution": "Norwegian University of Life Sciences (NMBU)",
                "url": "https://nmbu.brage.unit.no/nmbu-xmlui/handle/11250/2580198"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Peter Dörsch",
              "email": null,
              "latest_publication": {
                "title": "Carbon degradation and mobilisation potentials of thawing permafrost peatlands in northern Norway inferred from laboratory incubations",
                "year": 2024,
                "venue": "Biogeosciences",
                "url": "https://bg.copernicus.org/articles/21/4723/2024/"
              },
              "phd_thesis": {
                "title": "Nitrous oxide and methane fluxes in differentially managed agricultural soils of a hilly landscape in Southern Germany",
                "year": 1999,
                "institution": "Technische Universität München",
                "url": "https://www.finna.fi/Record/vaari.926379"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Stephen M. Ogle",
              "email": null,
              "latest_publication": {
                "title": "Counterfactual scenarios reveal historical impact of cropland management on soil organic carbon stocks in the United States",
                "year": 2023,
                "venue": "Scientific Reports",
                "url": "https://www.nature.com/articles/s41598-023-41307-x"
              },
              "phd_thesis": {
                "title": null,
                "year": 2000,
                "institution": "University of Wyoming",
                "url": null
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Gabriel G. Vázquez-Amabile",
              "email": null,
              "latest_publication": {
                "title": "An evaluation of soil carbon models and their role on finding ways to net-zero carbon in agricultural systems",
                "year": 2025,
                "venue": "Soil & Tillage Research",
                "url": "https://www.sciencedirect.com/science/article/abs/pii/S016719872400343X"
              },
              "phd_thesis": {
                "title": "Hydrologic and nonpoint-source pollution risk analysis on agricultural watersheds",
                "year": 2005,
                "institution": "Purdue University",
                "url": "https://purdue.primo.exlibrisgroup.com/discovery/fulldisplay/alma99143083980001081/01PURDUE_PUWL"
              },
              "data_publicly_available": "unknown"
            }
          ],
          "promptNotes": ""
        }
      },
      "patents": {
        "text": "Patent: EP3105198B1\nTitle: Soil bacteria for inoculating stress soils\nAssignee: Biofil Mikrobiologiai Gentechnologiai és Biokémiai Kft\nFiling Date: 2015-02-10\nGrant Date: 2022-02-16\nAbstract: Bacterial inoculant mixtures that produce exopolysaccharides and biofilms to cement soil particles into stable aggregates, improve water retention and fertility, and rehabilitate degraded soils.\nOverlaps with paper claims: C1, C3\nTechnical overlap: Independent claims teach inoculating soils with EPS- and biofilm-forming strains that bind particles and increase aggregate stability and porosity, directly mirroring the paper's structure-microbiome mechanism where pore connectivity controls water and oxygen diffusion (C1). The claimed use of microbial inoculants to improve aggregate stability and soil function constitutes a conservation-oriented management intervention, aligning with reduced disturbance and organic amendment strategies in C3.\n\nPatent: WO2021030385A1\nTitle: Microbe-based compositions for restoring soil health and controlling pests\nAssignee: Locus Agriculture IP Co LLC\nFiling Date: 2020-08-12\nGrant Date: Not provided\nAbstract: Microbial consortia and delivery methods that restore soil health by improving structure, porosity and hydrology, while reducing greenhouse-gas emissions and enhancing nutrient cycling.\nOverlaps with paper claims: C1, C2, C3\nTechnical overlap: The claims include improving soil physical structure and porosity through microbe-based amendments, mapping to the paper's emphasis on aggregates and pore networks regulating water and oxygen supply for microbiome assembly and function (C1). Claims also target reductions in CH4 and N2O via microbial pathway modulation, validating the paper's attribution of greenhouse-gas fluxes to microbiomes (C2). As an applied, conservation-style management input, the compositions reflect the paper's management levers such as organic amendments and integrated practices (C3).\n\nPatent: WO2021076458A9\nTitle: Inhibitors of soil nitrification and processes to prevent same\nAssignee: Tessenderlo Group NV\nFiling Date: 2020-10-12\nGrant Date: Not provided\nAbstract: Compositions and field methods for inhibiting soil nitrification to improve nitrogen-use efficiency and reduce nitrogen oxide emissions across crops.\nOverlaps with paper claims: C2, C3\nTechnical overlap: Independent and dependent claims cover administering nitrification inhibitors to slow the microbial oxidation of ammonium to nitrate, directly addressing the microbial pathway responsible for N2O emissions highlighted in the paper's climate regulation analysis (C2). Positioning these inhibitors within fertiliser management validates the paper's integrated nutrient management approach as a conservation-oriented practice with context-dependent trade-offs (C3).\n\nPatent: WO2017117314A1\nTitle: Biochar as a microbial carrier\nAssignee: Cool Planet Energy Systems Inc\nFiling Date: 2016-12-28\nGrant Date: Not provided\nAbstract: Pore-engineered biochar infused with beneficial microbes and nutrients to act as a carrier for controlled release, increasing water holding, nutrient retention and microbial viability in soil.\nOverlaps with paper claims: C1, C3\nTechnical overlap: Claims teach impregnating biochar's hierarchical pore structure with microbial inoculants and nutrients, creating microhabitats and altering pore-size distributions that shape microbial assembly and resource diffusion, matching the paper's pore-class and connectivity framework (C1). The biochar carrier functions as an organic amendment that improves structure and supports beneficial microbial processes, reflecting conservation-oriented soil management in C3.\n\nPatent: WO2024100477A1\nTitle: Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice\nAssignee: Indian Council of Agricultural Research\nFiling Date: 2023-10-17\nGrant Date: Not provided\nAbstract: A granular formulation containing a Methylobacterium methanotroph with specified carriers and binders to reduce methane emissions in flooded rice systems.\nOverlaps with paper claims: C2\nTechnical overlap: The claims specify a methanotroph-based product and field application protocol that enhances methane oxidation in paddy soils, directly validating the paper's assertion that microbiome-mediated pathways control CH4 fluxes at agroecosystem scales (C2). The defined carrier matrix and deployment in flooded conditions link to the paper's emphasis on managing redox and oxygen diffusion regimes that govern microbial greenhouse-gas processes.",
        "structured": {
          "patents": [
            {
              "patentNumber": "EP3105198B1",
              "title": "Soil bacteria for inoculating stress soils",
              "assignee": "Biofil Mikrobiologiai Gentechnologiai és Biokémiai Kft",
              "filingDate": "2015-02-10",
              "grantDate": "2022-02-16",
              "abstract": "Bacterial inoculant mixtures that produce exopolysaccharides and biofilms to cement soil particles into stable aggregates, improve water retention and fertility, and rehabilitate degraded soils.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C3"
                ],
                "summary": "Independent claims teach inoculating soils with EPS- and biofilm-forming strains that bind particles and increase aggregate stability and porosity, directly mirroring the paper's structure-microbiome mechanism where pore connectivity controls water and oxygen diffusion (C1). The claimed use of microbial inoculants to improve aggregate stability and soil function constitutes a conservation-oriented management intervention, aligning with reduced disturbance and organic amendment strategies in C3."
              },
              "url": null
            },
            {
              "patentNumber": "WO2021030385A1",
              "title": "Microbe-based compositions for restoring soil health and controlling pests",
              "assignee": "Locus Agriculture IP Co LLC",
              "filingDate": "2020-08-12",
              "grantDate": null,
              "abstract": "Microbial consortia and delivery methods that restore soil health by improving structure, porosity and hydrology, while reducing greenhouse-gas emissions and enhancing nutrient cycling.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C2",
                  "C3"
                ],
                "summary": "The claims include improving soil physical structure and porosity through microbe-based amendments, mapping to the paper's emphasis on aggregates and pore networks regulating water and oxygen supply for microbiome assembly and function (C1). Claims also target reductions in CH4 and N2O via microbial pathway modulation, validating the paper's attribution of greenhouse-gas fluxes to microbiomes (C2). As an applied, conservation-style management input, the compositions reflect the paper's management levers such as organic amendments and integrated practices (C3)."
              },
              "url": null
            },
            {
              "patentNumber": "WO2021076458A9",
              "title": "Inhibitors of soil nitrification and processes to prevent same",
              "assignee": "Tessenderlo Group NV",
              "filingDate": "2020-10-12",
              "grantDate": null,
              "abstract": "Compositions and field methods for inhibiting soil nitrification to improve nitrogen-use efficiency and reduce nitrogen oxide emissions across crops.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2",
                  "C3"
                ],
                "summary": "Independent and dependent claims cover administering nitrification inhibitors to slow the microbial oxidation of ammonium to nitrate, directly addressing the microbial pathway responsible for N2O emissions highlighted in the paper's climate regulation analysis (C2). Positioning these inhibitors within fertiliser management validates the paper's integrated nutrient management approach as a conservation-oriented practice with context-dependent trade-offs (C3)."
              },
              "url": null
            },
            {
              "patentNumber": "WO2017117314A1",
              "title": "Biochar as a microbial carrier",
              "assignee": "Cool Planet Energy Systems Inc",
              "filingDate": "2016-12-28",
              "grantDate": null,
              "abstract": "Pore-engineered biochar infused with beneficial microbes and nutrients to act as a carrier for controlled release, increasing water holding, nutrient retention and microbial viability in soil.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C3"
                ],
                "summary": "Claims teach impregnating biochar's hierarchical pore structure with microbial inoculants and nutrients, creating microhabitats and altering pore-size distributions that shape microbial assembly and resource diffusion, matching the paper's pore-class and connectivity framework (C1). The biochar carrier functions as an organic amendment that improves structure and supports beneficial microbial processes, reflecting conservation-oriented soil management in C3."
              },
              "url": null
            },
            {
              "patentNumber": "WO2024100477A1",
              "title": "Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice",
              "assignee": "Indian Council of Agricultural Research",
              "filingDate": "2023-10-17",
              "grantDate": null,
              "abstract": "A granular formulation containing a Methylobacterium methanotroph with specified carriers and binders to reduce methane emissions in flooded rice systems.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "The claims specify a methanotroph-based product and field application protocol that enhances methane oxidation in paddy soils, directly validating the paper's assertion that microbiome-mediated pathways control CH4 fluxes at agroecosystem scales (C2). The defined carrier matrix and deployment in flooded conditions link to the paper's emphasis on managing redox and oxygen diffusion regimes that govern microbial greenhouse-gas processes."
              },
              "url": null
            }
          ],
          "promptNotes": "Converted from analyst notes; dates normalised to ISO (YYYY-MM-DD). Grant dates set to null for applications without grant."
        }
      },
      "verifiedClaims": {
        "text": "=== OVERALL ASSESSMENT ===\nThe paper's central framing is consistent with independent evidence: pore and aggregate architecture shape diffusion and redox, which govern microbial processes and agroecosystem outcomes; microbes underpin nutrient cycling and a large share of agricultural greenhouse gases; and conservation practices can improve structure and functions with important context-dependent trade-offs. The strongest support is for the microbial role in greenhouse gas budgets, while structure-as-primary-driver and universal benefits of conservation practices are supported with notable caveats about scale and local conditions.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses\n    Distinct bacterial communities across particle-size and aggregate fractions indicate habitat filtering by structure.\n  - [Similar Paper] Macroaggregates Serve as Micro Hotspots Enriched With Functional and Networked Microbial Communities in a Long Term Paddy Soil\n    Macroaggregates host functional microbial hotspots linking aggregate habitats to community function.\n  - [Research Group] Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)\n    Restricted oxygen diffusion creates anaerobic microsites that shift microbial metabolism and stabilise carbon, a pore-scale structural control.\n  - [Research Group] Microbial spatial footprint as a driver of soil carbon stabilisation (2019)\n    X-ray micro-CT shows pore architecture mediates oxygen access and decomposition, linking structure to microbial function.\n  - [Research Group] Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes (2014)\n    Planar optode imaging mapped oxygen heterogeneity aligned with N2O hotspots, demonstrating structure controls oxygen availability.\n  - [Patent] EP3105198B1: Soil bacteria for inoculating stress soils\n    Inoculants promoting EPS and biofilms increase aggregate stability and porosity, consistent with structure-mediated water and oxygen control.\n  - [Patent] WO2017117314A1: Biochar as a microbial carrier\n    Biochar's hierarchical pores host microbes and alter pore-size distributions, shaping microbial assembly and activity.\n\nSummary: Multiple independent studies support structure-driven assembly and function via diffusion and redox control at micro- to mesoscales. However, across broader gradients soil chemistry such as pH can dominate community composition, so the claim holds with important scale and context caveats.\n\nClaim: C2\nOriginal: Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets.\nStatus: Verified\nConfidence: High\n\nSupporting Evidence:\n  - [Similar Paper] Global Nitrous Oxide Budget (2024)\n    Attributes a large share of anthropogenic N2O to agriculture, linking emissions to microbially mediated nitrification and denitrification.\n  - [Similar Paper] Global Methane Budget (2024-2025)\n    Reports major methane sources from agriculture and waste with microbial origins, including rice system emissions and oxidation dynamics.\n  - [Patent] WO2024100477A1: Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice\n    Field application of methanotrophs reduces CH4 by enhancing microbial oxidation pathways, operationalising microbial control of fluxes.\n  - [Patent] WO2021076458A9: Inhibitors of soil nitrification and processes to prevent same\n    Targets microbial ammonia oxidation to reduce N2O, reinforcing the microbial basis of agricultural greenhouse gas emissions.\n\nSummary: The microbial origin of soil N2O and CH4 and the large agricultural share in global budgets are established by repeated global syntheses and mechanistic studies. Interventions and patents that manipulate microbial pathways further reinforce causality, with uncertainties mainly in magnitude estimates rather than direction.\n\nClaim: C3\nOriginal: Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Climate and Soil Characteristics Determine Where No Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions\n    Shows that mitigation and SOC benefits of no-till depend on climate, soil and depth, highlighting context-dependence.\n  - [Research Group] Microbial spatial footprint as a driver of soil carbon stabilisation (2019)\n    Demonstrates that plant-induced changes to pore architecture under conservation practices influence microbial processes and carbon outcomes.\n  - [Research Group] Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)\n    Indicates that management altering oxygen diffusion can shift microbial functions, linking structure changes to functional outcomes.\n\nContradicting Evidence:\n  - [Similar Paper] Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis (2013)\n    Reports conditions under which reduced tillage increases N2O, emphasising climate and nitrogen placement as critical modifiers.\n  - [Similar Paper] Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics\n    Field comparison highlights that structural benefits may not align with short-term economics and may require adapted nutrient management.\n\nSummary: Conservation practices often improve structure and support beneficial microbial functions, but responses are heterogeneous and can increase N2O or fail to build SOC depending on climate, texture, depth and practice details. The claim is directionally correct, with the context-dependent caveat essential to avoid overgeneralisation.\n",
        "structured": {
          "claims": [
            {
              "claimId": "C1",
              "originalClaim": "Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses",
                  "relevance": "Distinct bacterial communities across particle-size and aggregate fractions indicate habitat filtering by structure."
                },
                {
                  "source": "Similar Paper",
                  "title": "Macroaggregates Serve as Micro Hotspots Enriched With Functional and Networked Microbial Communities in a Long Term Paddy Soil",
                  "relevance": "Macroaggregates host functional microbial hotspots linking aggregate habitats to community function."
                },
                {
                  "source": "Research Group",
                  "title": "Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)",
                  "relevance": "Restricted oxygen diffusion creates anaerobic microsites that shift microbial metabolism and stabilise carbon, a pore-scale structural control."
                },
                {
                  "source": "Research Group",
                  "title": "Microbial spatial footprint as a driver of soil carbon stabilisation (2019)",
                  "relevance": "X-ray micro-CT shows pore architecture mediates oxygen access and decomposition, linking structure to microbial function."
                },
                {
                  "source": "Research Group",
                  "title": "Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes (2014)",
                  "relevance": "Planar optode imaging mapped oxygen heterogeneity aligned with N2O hotspots, demonstrating structure controls oxygen availability."
                },
                {
                  "source": "Patent",
                  "title": "EP3105198B1: Soil bacteria for inoculating stress soils",
                  "relevance": "Inoculants promoting EPS and biofilms increase aggregate stability and porosity, consistent with structure-mediated water and oxygen control."
                },
                {
                  "source": "Patent",
                  "title": "WO2017117314A1: Biochar as a microbial carrier",
                  "relevance": "Biochar's hierarchical pores host microbes and alter pore-size distributions, shaping microbial assembly and activity."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "Multiple independent studies support structure-driven assembly and function via diffusion and redox control at micro- to mesoscales. However, across broader gradients soil chemistry such as pH can dominate community composition, so the claim holds with important scale and context caveats.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C2",
              "originalClaim": "Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets.",
              "verificationStatus": "Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Global Nitrous Oxide Budget (2024)",
                  "relevance": "Attributes a large share of anthropogenic N2O to agriculture, linking emissions to microbially mediated nitrification and denitrification."
                },
                {
                  "source": "Similar Paper",
                  "title": "Global Methane Budget (2024-2025)",
                  "relevance": "Reports major methane sources from agriculture and waste with microbial origins, including rice system emissions and oxidation dynamics."
                },
                {
                  "source": "Patent",
                  "title": "WO2024100477A1: Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice",
                  "relevance": "Field application of methanotrophs reduces CH4 by enhancing microbial oxidation pathways, operationalising microbial control of fluxes."
                },
                {
                  "source": "Patent",
                  "title": "WO2021076458A9: Inhibitors of soil nitrification and processes to prevent same",
                  "relevance": "Targets microbial ammonia oxidation to reduce N2O, reinforcing the microbial basis of agricultural greenhouse gas emissions."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "The microbial origin of soil N2O and CH4 and the large agricultural share in global budgets are established by repeated global syntheses and mechanistic studies. Interventions and patents that manipulate microbial pathways further reinforce causality, with uncertainties mainly in magnitude estimates rather than direction.",
              "confidenceLevel": "High"
            },
            {
              "claimId": "C3",
              "originalClaim": "Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Climate and Soil Characteristics Determine Where No Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions",
                  "relevance": "Shows that mitigation and SOC benefits of no-till depend on climate, soil and depth, highlighting context-dependence."
                },
                {
                  "source": "Research Group",
                  "title": "Microbial spatial footprint as a driver of soil carbon stabilisation (2019)",
                  "relevance": "Demonstrates that plant-induced changes to pore architecture under conservation practices influence microbial processes and carbon outcomes."
                },
                {
                  "source": "Research Group",
                  "title": "Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)",
                  "relevance": "Indicates that management altering oxygen diffusion can shift microbial functions, linking structure changes to functional outcomes."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis (2013)",
                  "relevance": "Reports conditions under which reduced tillage increases N2O, emphasising climate and nitrogen placement as critical modifiers."
                },
                {
                  "source": "Similar Paper",
                  "title": "Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics",
                  "relevance": "Field comparison highlights that structural benefits may not align with short-term economics and may require adapted nutrient management."
                }
              ],
              "verificationSummary": "Conservation practices often improve structure and support beneficial microbial functions, but responses are heterogeneous and can increase N2O or fail to build SOC depending on climate, texture, depth and practice details. The claim is directionally correct, with the context-dependent caveat essential to avoid overgeneralisation.",
              "confidenceLevel": "Moderate"
            }
          ],
          "overallAssessment": "The paper's central framing is consistent with independent evidence: pore and aggregate architecture shape diffusion and redox, which govern microbial processes and agroecosystem outcomes; microbes underpin nutrient cycling and a large share of agricultural greenhouse gases; and conservation practices can improve structure and functions with important context-dependent trade-offs. The strongest support is for the microbial role in greenhouse gas budgets, while structure-as-primary-driver and universal benefits of conservation practices are supported with notable caveats about scale and local conditions.",
          "promptNotes": "Independence: Evidence spans multiple groups and continents, plus unrelated patents.  Data availability: Global budgets are open; several studies have data supplements but analysis code is not always fully public.  Replication and rigour: Greenhouse gas findings are repeatedly synthesised; structure-function mechanisms are reproduced across methods, but effect sizes vary with context and some pipelines remain bespoke."
        }
      },
      "authorContacts": {
        "maxChars": 2349,
        "truncated": false,
        "text": "Paper: Soil structure and microbiome functions in agroecosystems (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Martin Hartmann | martin.hartmann@usys.ethz.ch | Scientist, Sustainable Agroecosystems, ETH Zürich | 0000-0001-8069-5284 |\n| Johan Six | johan.six@usys.ethz.ch | Professor, ETH Zürich (Sustainable Agroecosystems) | 0000-0001-9336-4185 |\n\nPaper: Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Michael Hemkemeyer | hemkemeyer@uni-wuppertal.de | Academic councillor, Department of Soil & Groundwater Management, University of Wuppertal | 0000-0002-2554-2231 |\n| Christoph C. Tebbe | christoph.tebbe@thuenen.de | Scientist, Thünen Institute of Biodiversity | 0000-0003-4861-0214 |\n\nPaper: Micro-fractionation shows microbial community changes in soil particles below 20 μm\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Christoph Keuschnig | Not found | MSCA Postdoctoral Fellow, GFZ German Research Centre for Geosciences (Potsdam) | 0000-0002-5246-2640 |\n| Catherine Larose | catherine.larose@ec-lyon.fr | Environmental Microbial Genomics, École Centrale de Lyon, Université de Lyon | 0000-0001-5641-0701 |\n\nPaper: Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Ognjen Žurovec | ognjen.zurovec@nmbu.no | Department of International Environment and Development Studies, NMBU (Ås, Norway) | Not found |\n| Peter Dörsch | Not found | Faculty of Environmental Sciences and Natural Resource Management, NMBU | Not found |\n\nPaper: Climate and Soil Characteristics Determine Where No-Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Stephen M. Ogle | Not found | Not found | Not found |\n| Gabriel G. Vázquez-Amabile | Not found | Not found | Not found |\n\nPaper: Soil structure and microbiome functions in agroecosystems (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Martin Hartmann | martin.hartmann@usys.ethz.ch | Scientist, Sustainable Agroecosystems, ETH Zürich | 0000-0001-8069-5284 |\n| Johan Six | johan.six@usys.ethz.ch | Professor, ETH Zürich (Sustainable Agroecosystems) | 0000-0001-9336-4185 |",
        "structured": {
          "papers": [
            {
              "title": "Soil structure and microbiome functions in agroecosystems",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Martin Hartmann",
                  "email": "martin.hartmann@usys.ethz.ch",
                  "role": "Scientist, Sustainable Agroecosystems, ETH Zürich",
                  "orcid": "0000-0001-8069-5284",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=G5wlvxYAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/martin-hartmann-microbiome/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://microbiome.ch"
                    }
                  ]
                },
                {
                  "name": "Johan Six",
                  "email": "johan.six@usys.ethz.ch",
                  "role": "Professor, ETH Zürich (Sustainable Agroecosystems)",
                  "orcid": "0000-0001-9336-4185",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=tknRgfkAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/johan-six-eth/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://johansix.ethz.ch/en/johan.html"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses",
              "identifier": null,
              "authors": [
                {
                  "name": "Michael Hemkemeyer",
                  "email": "hemkemeyer@uni-wuppertal.de",
                  "role": "Academic councillor, Department of Soil & Groundwater Management, University of Wuppertal",
                  "orcid": "0000-0002-2554-2231",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=YNHGIpMAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/hemkemeyer/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://www.boden.uni-wuppertal.de/en/home-1/dr-michael-hemkemeyer/"
                    }
                  ]
                },
                {
                  "name": "Christoph C. Tebbe",
                  "email": "christoph.tebbe@thuenen.de",
                  "role": "Scientist, Thünen Institute of Biodiversity",
                  "orcid": "0000-0003-4861-0214",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=a14fbqMAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/christophtebbe/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://www.thuenen.de/en/institutes/biodiversity/staff/christoph-tebbe"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Micro-fractionation shows microbial community changes in soil particles below 20 μm",
              "identifier": null,
              "authors": [
                {
                  "name": "Christoph Keuschnig",
                  "email": null,
                  "role": "MSCA Postdoctoral Fellow, GFZ German Research Centre for Geosciences (Potsdam)",
                  "orcid": "0000-0002-5246-2640",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://www.gfz.de/en/staff/christoph.keuschnig"
                    }
                  ]
                },
                {
                  "name": "Catherine Larose",
                  "email": "catherine.larose@ec-lyon.fr",
                  "role": "Environmental Microbial Genomics, École Centrale de Lyon, Université de Lyon",
                  "orcid": "0000-0001-5641-0701",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=NCuGHZgAAAAJ"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics",
              "identifier": null,
              "authors": [
                {
                  "name": "Ognjen Žurovec",
                  "email": "ognjen.zurovec@nmbu.no",
                  "role": "Department of International Environment and Development Studies, NMBU (Ås, Norway)",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Peter Dörsch",
                  "email": null,
                  "role": "Faculty of Environmental Sciences and Natural Resource Management, NMBU",
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "Climate and Soil Characteristics Determine Where No-Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions",
              "identifier": null,
              "authors": [
                {
                  "name": "Stephen M. Ogle",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Gabriel G. Vázquez-Amabile",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "Soil structure and microbiome functions in agroecosystems",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Martin Hartmann",
                  "email": "martin.hartmann@usys.ethz.ch",
                  "role": "Scientist, Sustainable Agroecosystems, ETH Zürich",
                  "orcid": "0000-0001-8069-5284",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=G5wlvxYAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/martin-hartmann-microbiome/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://microbiome.ch"
                    }
                  ]
                },
                {
                  "name": "Johan Six",
                  "email": "johan.six@usys.ethz.ch",
                  "role": "Professor, ETH Zürich (Sustainable Agroecosystems)",
                  "orcid": "0000-0001-9336-4185",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=tknRgfkAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/johan-six-eth/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://johansix.ethz.ch/en/johan.html"
                    }
                  ]
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      }
    },
    {
      "id": "an-open-science-study-of-ageing-in-companion-dog",
      "sourcePdf": {
        "path": "An open science study of ageing in companion dogs.pdf",
        "publicPath": "/mock-papers/an-open-science-study-of-ageing-in-companion-dog.pdf",
        "title": "An open science study of ageing in companion dogs",
        "originalFileName": "An open science study of ageing in companion dogs.pdf",
        "doi": "10.1038/s41586-021-04282-9",
        "pages": 15
      },
      "label": "An open science study of ageing in companion dogs",
      "generatedAt": "2025-10-28T05:34:08.809Z",
      "claimsAnalysis": {
        "text": "# Executive Summary This paper describes the Dog Aging Project (DAP), an open-data, long-term longitudinal programme studying ageing in tens of thousands of companion dogs. It outlines (1) the study's scale, cohorts, and multi-modal data collection; (2) the rationale for dogs as a translational ageing model; and (3) a planned randomised, double-masked, placebo-controlled rapamycin trial (TRIAD). Headline numbers include over 30,000 canine participants and owners, sequencing targeting 10,000 dogs, and deeply phenotyped Precision (n = 1,000) and TRIAD (n = 350) cohorts. As this is a design/methods article with no outcome analyses, overall evidence strength for substantive biological claims is Low to Moderate; for descriptive claims about the programme's design and operations it is High. Sources: Abstract; Design of the DAP and subsequent sections (pp. 2-7); Figs 1-3 (pp. 12-14); Table 1 (end).  ---  ## Top 3 Claims and Evidence  ### C1. The DAP is a large, open-data, long-term longitudinal study capturing genetic, environmental, clinical and multi-omics data from companion dogs to identify determinants of healthy lifespan and enable community science. - **Evidence summary:** Descriptive report of study design and operations. States open-data policy; annual surveys and biospecimens; electronic veterinary medical records; low-pass whole-genome sequencing; multi-omics (metabolome, epigenome, microbiome); geospatial environmental linkage; biobanking; infrastructure for ancillary studies and public data release.   - **Key numbers:** \"tens of thousands\" of dogs (Abstract); \"over 30,000 canine participants and their owners\" and \"more than 100 staff... from more than 20 academic institutions\" (p. 2); sequencing target \"10,000 dogs\" (p. 6 and Fig. 3a, p. 14); Precision n = 1,000; TRIAD n = 350 (Fig. 3a, p. 14); public release on Terra with first release scheduled for first quarter of 2022 (p. 7); data and biospecimens collected **annually** (p. 2); Biobank at Cornell (p. 5 and Fig. 3a, p. 14).   - **Source location:** Abstract; \"The DAP is an interdisciplinary, open-data, community science project\" (p. 2); \"Data and sample release\" (p. 7); Fig. 3a (p. 14); Table 1 (end).   - **Strength rating:** **High** for existence/operations (authoritative description by study leads); **[Assumption]** This rating applies to the descriptive claim about the platform, not to downstream causal inferences which are not analysed here.  ### C2. Companion dogs are an ideal, socially relevant model for studying biological ageing with translational potential to humans because they share human environments and healthcare, experience similar age-related diseases, and age much faster. - **Evidence summary:** Argumentation with descriptive statistics and comparative rationale. Notes dogs' phenotypic variability, similar functional decline and diseases, parallel healthcare, shared environment, and accelerated ageing enabling feasible longitudinal and interventional work.   - **Key numbers:** Dogs \"age approximately seven to ten times faster than humans\" (p. 2); diseases and functional declines \"nearly every\" as in people (p. 2).   - **Source location:** \"The companion dog is an ideal animal...\" paragraph (p. 2).   - **Strength rating:** **Moderate** (strong rationale but no new comparative outcome data presented in this article).  ### C3. The DAP will test whether a one-year course of weekly low-dose rapamycin increases lifespan and healthspan in middle-aged, large-breed dogs via the randomised, double-masked, placebo-controlled TRIAD trial. - **Evidence summary:** Protocol description of a planned/ongoing clinical trial embedded within DAP, including endpoints and operational details. Cardiovascular phenotyping at seven US veterinary teaching hospitals; biannual visits; biospecimen kits; cardiology assessments listed in Table 1.   - **Key numbers:** Design \"randomized, double-masked, placebo-controlled\" (p. 2); dosing \"one-year course of weekly low-dose rapamycin\" (p. 6); endpoints: lifespan, heart and cognitive function, age-related disease incidence (p. 6); enrolment began June 2021 and continued through 2022 (p. 6); TRIAD cohort size n = 350 (Fig. 3a, p. 14); \"seven US veterinary teaching hospitals\" (p. 4).   - **Source location:** \"The DAP has four primary scientific aims...\" (p. 2); \"Key outcomes-Scientific findings\" (p. 6); \"Data collection\" and TRIAD logistics (pp. 4-5); Table 1 (end); Fig. 3a (p. 14).   - **Strength rating:** **Low/Unclear** for efficacy (no results reported); **High** for the descriptive protocol.  ---  ## Gaps & Limitations (linked to C1-C3) - **Sampling and representativeness (C1, C2):** Participation currently US-based (Fig. 1b, p. 12); one dog per household (p. 2); eligibility for sampled cohorts requires qualifying veterinary records, which \"may create a bias\" toward regularly cared-for dogs (p. 3).   - **Pre-analytical variability (C1):** Biospecimen collection by community veterinarians and owners necessitates tolerance assessments; variation in collection, transport and handling acknowledged (p. 5), albeit with QA/QC measures.   - **Lack of outcome data (C2, C3):** Paper presents no analyses quantifying translational concordance to humans or rapamycin efficacy; all biological endpoints are prospective (pp. 2, 6).   - **Ethical/operational constraints (C3):** Trial in healthy subjects raises ethical considerations; oversight described but potential risk-benefit trade-offs not quantified (pp. 5-6; refs 18-19 cited).   - **OCR/format [UNCLEAR]:** Minor URL spacing (e.g., \"https:// dogagingproject.org\") and hyphenation artefacts do not affect substantive content.  ---  ## Methods Snapshot - **Design:** Multi-cohort longitudinal observational platform plus an embedded RCT (TRIAD). Cohorts: Pack (survey-based), Foundation, Precision, TRIAD, and Centenarian (top 0.1% of size-specific age distribution) (Fig. 1a, p. 12; pp. 2-4).   - **Recruitment & consent:** Owner nomination via website, informed consent through REDCap on Azure; additional consents for sampled cohorts; privacy policy specified (p. 3).   - **Data:** Annual HLES; additional validated instruments (e.g., canine cognitive dysfunction rating scale), morphometrics and mobility tasks, end-of-life survey; veterinary EMR extraction (Table 1, end; pp. 4-5).   - **Biospecimens & assays:** Cheek swab for low-pass WGS; Precision and TRIAD annual or biannual kits for blood, plasma/serum, urine, hair, faeces; clinicopathology, cytokines, lipoproteins, epigenome, metabolome, microbiome; flow cytometry; inflammageing assays; activity monitors; cardiology assessments in TRIAD (pp. 4-5; Table 1, end; Fig. 3a, p. 14).   - **Environment:** Geospatial linkage to sociodemographics, air pollution (O3, CO, SO2, NO2; PM10, PM2.5), temperature/precipitation, and walkability (p. 5; Fig. 3b, p. 14).   - **Data sharing:** De-identified data on Terra; Biobank access with data-return requirement (p. 7).  ---  ## Risk-of-Bias / Quality Checklist - **Sampling frame:** Nationwide US Pack; stratified selection for sampled cohorts by size, sex, age, breed background, and location (p. 3). Risk of selection bias acknowledged due to EMR requirement (p. 3).   - **Measurement:** Standardised annual surveys; validated cognitive instrument cited; EMR confirmation of key demographics; QC/QA pipelines and documentation of pre/post-analytical variables (pp. 4-5; Table 1, end).   - **Confounding:** Observational components will face environmental and lifestyle confounding; multi-omics and rich covariates planned, but no analytic strategies detailed here [DETAIL NEEDED].   - **Blinding:** TRIAD specified as double-masked (p. 2), reducing performance and detection bias for trial endpoints.   - **Outcome data:** None presented; risk of reporting bias not assessable [DETAIL NEEDED].   - **Ethics & oversight:** IACUC approvals listed; advisory boards and DSMB for TRIAD noted (pp. 5-6, 8).  ---  ## Open Questions & Next Steps 1. **Normative ageing baselines (C1/C2):** Quantify age-, size- and breed-specific trajectories for multimorbidity, frailty, and inflammageing; publish reference ranges and variance components (pp. 2, 6; Box 1, p. 11).   2. **Gene-environment mechanisms (C1/C2):** Conduct GWAS with low-pass WGS (target n = 10,000) integrating environmental exposures and multi-omics to identify causal pathways and predictive biomarkers (pp. 2, 6-7; Fig. 3a, p. 14).   3. **TRIAD outcomes (C3):** Report lifespan and healthspan endpoints, cardiology and cognition results, adverse events, and subgroup effects in large-breed middle-aged dogs; assess durability post-treatment (pp. 6; Table 1, end).   4. **Generalisation & diversity (C1/C2):** Expand beyond US and one-dog-per-household constraint; quantify representativeness and participation biases (pp. 2-3; Fig. 1b, p. 12).   5. **Data quality impact (C1):** Model how pre-analytical variation influences omics and clinical measures; publish QC thresholds and batch-effect mitigation performance (p. 5).  ---  ### QA Check - All required sections present.   - Numbers transcribed exactly as written in the text.   - Each claim (C1-C3) includes a strength rating and page/figure/table citation.   - Results, CIs, or p-values are not reported in the paper; flagged as [DETAIL NEEDED] where applicable.",
        "structured": {
          "executiveSummary": [
            "Describes an open-data, long-term longitudinal programme (DAP) studying ageing in tens of thousands of companion dogs, with multi-cohort design and rich data collection.",
            "Provides rationale for dogs as translational models and outlines an embedded randomised, double-masked, placebo-controlled rapamycin trial (TRIAD).",
            "Headline numbers: >30,000 participants, sequencing target 10,000 dogs, Precision n = 1,000, TRIAD n = 350; no outcome analyses presented; design claims are strong."
          ],
          "claims": [
            {
              "id": "C1",
              "claim": "The DAP is a large, open-data, long-term longitudinal study capturing genetic, environmental, clinical and multi-omics data from companion dogs to identify determinants of healthy lifespan and enable community science.",
              "evidenceSummary": "Descriptive report of study design and operations including open-data policy, annual surveys and biospecimens, EMRs, low-pass WGS, multi-omics, environmental linkage, biobanking, and infrastructure for ancillary studies and public data release.",
              "keyNumbers": [
                "\"tens of thousands\" of dogs (Abstract)",
                "over 30,000 canine participants and their owners (p. 2)",
                "more than 100 staff and more than 20 academic institutions (p. 2)",
                "sequencing target 10,000 dogs (p. 6; Fig. 3a, p. 14)",
                "Precision n = 1,000; TRIAD n = 350 (Fig. 3a, p. 14)",
                "annual data and biospecimen collection (p. 2)",
                "first public data release scheduled Q1 2022 on Terra (p. 7)",
                "Biobank at Cornell (p. 5; Fig. 3a, p. 14)"
              ],
              "source": "Abstract; p. 2; p. 7; Fig. 3a (p. 14); Table 1 (end).",
              "strength": "High",
              "assumptions": "Strength applies to descriptive existence/operations, not to downstream causal inferences or outcomes.",
              "evidenceType": "Descriptive programme report"
            },
            {
              "id": "C2",
              "claim": "Companion dogs are an ideal, socially relevant model for studying biological ageing with translational potential to humans because they share human environments and healthcare, experience similar age-related diseases, and age much faster.",
              "evidenceSummary": "Argument-based rationale noting phenotypic variability, shared environment and healthcare, similar functional decline and diseases, and accelerated ageing enabling feasible longitudinal and interventional research.",
              "keyNumbers": [
                "dogs age approximately seven to ten times faster than humans (p. 2)",
                "companion dogs experience nearly every functional decline and disease of ageing that people do (p. 2)"
              ],
              "source": "p. 2 (\"The companion dog is an ideal animal...\" paragraph).",
              "strength": "Moderate",
              "assumptions": "Rationale only; no new comparative outcome data presented in this article.",
              "evidenceType": "Rationale/argument based on comparative context"
            },
            {
              "id": "C3",
              "claim": "The DAP will test whether a one-year course of weekly low-dose rapamycin increases lifespan and healthspan in middle-aged, large-breed dogs via the randomised, double-masked, placebo-controlled TRIAD trial.",
              "evidenceSummary": "Protocol description of a planned/ongoing RCT embedded within DAP with endpoints (lifespan, heart and cognitive function, age-related disease), seven teaching hospitals, biannual visits, and specified biospecimens and cardiology assessments.",
              "keyNumbers": [
                "randomized, double-masked, placebo-controlled design (p. 2)",
                "one-year course of weekly low-dose rapamycin (p. 6)",
                "endpoints: lifespan, heart and cognitive function, age-related disease incidence (p. 6)",
                "enrolment began June 2021 and continued through 2022 (p. 6)",
                "TRIAD n = 350 (Fig. 3a, p. 14)",
                "seven US veterinary teaching hospitals with six-month visit cadence (p. 4)"
              ],
              "source": "pp. 2, 4-6; Table 1 (end); Fig. 3a (p. 14).",
              "strength": "High",
              "assumptions": "Strength pertains to protocol existence and design; no efficacy evidence is presented here, so effectiveness remains [DETAIL NEEDED].",
              "evidenceType": "Protocol description of planned RCT"
            }
          ],
          "gaps": [
            {
              "category": "Sampling and representativeness",
              "detail": "US-only participation, one dog per household, and EMR requirement may bias sampled cohorts toward regularly cared-for dogs.",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Pre-analytical variability",
              "detail": "Variation in biospecimen collection, transport, and handling acknowledged despite QA/QC measures.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "Lack of outcome data",
              "detail": "No analyses presented for translational concordance or rapamycin efficacy; endpoints are prospective.",
              "relatedClaimIds": [
                "C2",
                "C3"
              ]
            },
            {
              "category": "Ethical/operational constraints",
              "detail": "Trial in healthy subjects raises ethical considerations; oversight noted but risk-benefit not quantified.",
              "relatedClaimIds": [
                "C3"
              ]
            },
            {
              "category": "OCR/format",
              "detail": "Minor URL spacing and hyphenation artefacts [UNCLEAR]; no impact on substantive content.",
              "relatedClaimIds": [
                "C1",
                "C2",
                "C3"
              ]
            }
          ],
          "methodsSnapshot": [
            "Multi-cohort longitudinal observational platform plus embedded RCT (TRIAD); cohorts include Pack, Foundation, Precision, TRIAD, Centenarian.",
            "Recruitment via website; informed consent through REDCap on Azure; additional consents for sampled cohorts; privacy policy specified.",
            "Annual HLES; validated instruments; morphometrics and mobility tasks; end-of-life survey; veterinary EMR extraction.",
            "Cheek swab low-pass WGS; Precision/TRIAD annual or biannual kits for blood, plasma/serum, urine, hair, faeces; clinicopathology, cytokines, lipoproteins, epigenome, metabolome, microbiome; flow cytometry; inflammageing assays; activity monitors; TRIAD cardiology assessments.",
            "Environmental linkage: sociodemographics, air pollution (O3, CO, SO2, NO2; PM10, PM2.5), temperature/precipitation, walkability.",
            "Data sharing via Terra; Biobank access with data-return requirement."
          ],
          "riskChecklist": [
            {
              "item": "Sampling frame and selection",
              "status": "partial",
              "note": "Nationwide US Pack with stratified selection; potential selection bias due to EMR requirement."
            },
            {
              "item": "Measurement and data quality controls",
              "status": "met",
              "note": "Standardised surveys, validated instruments, EMR confirmation, QC/QA and pre/post-analytical metadata."
            },
            {
              "item": "Confounding control and analytic strategy",
              "status": "unclear",
              "note": "Observational components will face confounding; no analytic strategies detailed [DETAIL NEEDED]."
            },
            {
              "item": "Blinding (TRIAD)",
              "status": "met",
              "note": "Double-masked randomised design reduces performance/detection bias for trial endpoints."
            },
            {
              "item": "Outcome data availability",
              "status": "missing",
              "note": "No outcome analyses reported in this paper."
            },
            {
              "item": "Ethics and oversight",
              "status": "met",
              "note": "IACUC approvals; advisory boards; DSMB oversight for TRIAD."
            }
          ],
          "openQuestions": [
            "Quantify normative ageing trajectories for multimorbidity, frailty, and inflammageing by size, breed, and sex; publish reference ranges.",
            "Integrate GWAS (low-pass WGS) with environmental exposures and multi-omics to identify causal pathways and predictive biomarkers.",
            "Report TRIAD lifespan/healthspan results, cardiology and cognition outcomes, adverse events, subgroup effects, and durability post-treatment.",
            "Expand beyond US and one-dog-per-household; measure representativeness and participation biases quantitatively.",
            "Quantify effects of pre-analytical variation on omics and clinical measures; publish QC thresholds and batch-effect mitigation performance."
          ],
          "crossPaperComparison": []
        }
      },
      "createdAt": "2025-10-21T10:28:37.732Z",
      "updatedAt": "2025-10-28T06:23:04.339Z",
      "agent": {
        "maxChars": 9317,
        "promptNotes": ""
      },
      "sourcePaper": {
        "title": "An open science study of ageing in companion dogs",
        "summary": "Open data, long term longitudinal program studying ageing in tens of thousands of companion dogs, with multi cohort design and an embedded randomised, double masked, placebo controlled rapamycin trial.",
        "keyMethodSignals": [
          "Annual owner surveys, EMRs, biospecimens with multi omics, geospatial linkage, and biobanking with public release",
          "Rationale for dogs as translational models due to shared environments, healthcare, diseases, and accelerated ageing",
          "Embedded RCT (TRIAD) testing weekly low dose rapamycin with cardiology and cognition endpoints"
        ],
        "methodComparison": {
          "sample": "Tens of thousands of US companion dogs across Pack, Foundation, Precision (about 1,000), TRIAD (about 350), and Centenarian cohorts. One dog per household; EMR required for sampled cohorts.",
          "materials": "Annual surveys including validated instruments, veterinary EMRs, cheek swab low pass WGS, multi omics panels (metabolome, epigenome, microbiome), environmental linkage; biobanking; open data on Terra.",
          "equipment": "Activity monitors, clinicopathology and flow cytometry platforms, cardiology equipment at seven veterinary teaching hospitals, environmental data pipelines.",
          "procedure": "Longitudinal annual biospecimen kits with QC and pre and post analytical metadata; infrastructure for ancillary studies and public data release. TRIAD is randomised, double masked, placebo controlled, weekly low dose rapamycin for one year with biannual visits and specified cardiology assessments.",
          "outcomes": "No outcomes reported; prospective endpoints include lifespan, healthspan, heart and cognitive function, and age related disease."
        }
      },
      "similarPapers": [
        {
          "identifier": "10.1371/journal.pone.0269425",
          "title": "Cohort profile: The Golden Retriever Lifetime Study",
          "authors": [
            "Labadie J",
            "Swafford B",
            "DePena M",
            "Tietje K",
            "Page R",
            "Patterson-Kane J"
          ],
          "year": 2022,
          "venue": "PLOS ONE",
          "whyRelevant": "Large, prospective owner survey plus clinic visit platform with annual biospecimens, central biobanking, and adjudicated outcomes. Closely mirrors DAP platform mechanics and sample handling.",
          "methodOverlap": [
            "Annual questionnaires, veterinary exams, and biospecimen collection with banking",
            "Overnight kit shipping to repository with defined processing steps",
            "Pathology adjudication with blinded secondary and tertiary reads"
          ],
          "methodComparison": {
            "sample": "3,044 US Golden Retrievers enrolled at 6 to 24 months; follow up status and loss tracked over time.",
            "materials": "Annual owner and veterinarian questionnaires; blood, serum, urine, feces, hair, nails; necropsy tissues; EMRs at death; genotyping program underway.",
            "equipment": "Reference laboratory CBC, chemistry, urinalysis; flow cytometry and PARR for lymphoma subtyping; central biobank infrastructure.",
            "procedure": "Annual clinic visits with kit shipment; core samples shipped overnight for freezing and storage; cancer events trigger biopsy kits and multi pathologist adjudication.",
            "outcomes": "Cancer incidence tracking with diagnostic certainty tiers; retention and participation metrics reported."
          },
          "gaps": "Single breed and US only limit representativeness. Samples not flash frozen may introduce pre analytical variability. EMRs abstracted mainly at death rather than continuously.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1186/s12917-020-02730-8",
          "title": "Generation Pup - protocol for a longitudinal study of dog behaviour and health",
          "authors": [
            "Hall J et al."
          ],
          "year": 2021,
          "venue": "BMC Veterinary Research",
          "whyRelevant": "National all breeds owner survey cohort with optional biological sampling kits, consented veterinary clinical notes, central processing, and biobanking. Procedurally similar to DAP survey plus biospecimen model.",
          "methodOverlap": [
            "Scheduled owner questionnaires using validated instruments across life stages",
            "Owner collected samples with mailer kits and return logistics",
            "Consent workflow enabling extraction of veterinary clinical notes"
          ],
          "methodComparison": {
            "sample": "UK puppies at enrolment across mixed and pure breeds; retention and loss to follow up tracked.",
            "materials": "Owner surveys; veterinary health cards; optional samples including hair, urine, feces, skin swab, buccal; veterinary notes via consent; planned omics assays.",
            "equipment": "Processing at Clinical Investigation Centre with transfer to commercial biobank for long term storage.",
            "procedure": "Timetabled survey mailouts; kit instructions and videos; annual sampling cadence; engagement and reminders; operational adjustments documented.",
            "outcomes": "Protocol and feasibility metrics; data completeness and participation rates described without biological endpoints."
          },
          "gaps": "Self selection bias acknowledged; biological sampling not universal. EMR access incomplete across practices.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1126/science.abk0639",
          "title": "Ancestry inclusive dog genomics challenges popular breed stereotypes",
          "authors": [
            "Morrill K",
            "Hekman J",
            "Karlsson EK",
            "et al."
          ],
          "year": 2022,
          "venue": "Science",
          "whyRelevant": "Community science cohort pairing large scale owner phenotyping with low pass WGS plus imputation. Matches DAP genetics modality and QC validation approach.",
          "methodOverlap": [
            "Low pass WGS with imputation using reference panel",
            "Validation against 30x WGS and genotyping arrays with QC thresholds",
            "Owner collected saliva kits with some veterinarian blood draws"
          ],
          "methodComparison": {
            "sample": "2,155 dogs with genetics and 18,385 survey respondents spanning purebred and mixed breeds.",
            "materials": "DNA saliva kits and subset blood; owner surveys; public data and code repository.",
            "equipment": "Low coverage sequencing and imputation pipeline; merged with array data; GWAS using mixed models.",
            "procedure": "Sequencing at about 0.6 to 1x coverage, imputation, stringent QC, ancestry panel assembly; survey genotype integration.",
            "outcomes": "Reported loci for behaviour and morphology; performance metrics for low pass sequencing and imputation."
          },
          "gaps": "Cross sectional collection; repeated longitudinal sampling absent. EMR and environment linkage not central.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.3389/fvets.2023.1168711",
          "title": "A masked, placebo controlled, randomised clinical trial of low dose rapamycin in 17 healthy client owned dogs",
          "authors": [
            "Barnett BG",
            "Wesselowski SR",
            "Gordon SG",
            "et al."
          ],
          "year": 2023,
          "venue": "Frontiers in Veterinary Science",
          "whyRelevant": "Prospective randomised double masked placebo controlled trial in healthy client owned dogs with cardiology endpoints. Closest procedural match to TRIAD for dosing, masking, and visit cadence.",
          "methodOverlap": [
            "Double masked block randomisation with pharmacy controlled allocation",
            "Echocardiography protocol with specified device and repeated measures",
            "Serial blood, urine, fecal sampling and frequent owner questionnaires"
          ],
          "methodComparison": {
            "sample": "Seventeen client owned dogs aged 6 to 10 years and 18 to 36 kg; baseline ECG and echocardiography screening.",
            "materials": "Rapamycin 0.025 mg per kg three times weekly for 6 months versus placebo; identical capsules; pill counts; clinicopathology panels.",
            "equipment": "Vivid E95 Vet echocardiography, Doppler blood pressure, Siemens analysers, heartworm antigen test, ECG.",
            "procedure": "Baseline, 3, 6, and 12 month visits; cardiology at 6 and 12 months; biweekly owner surveys; adverse event monitoring and safety labs.",
            "outcomes": "No significant echocardiography differences versus placebo; drug well tolerated; higher owner reported subjective positives in rapamycin group."
          },
          "gaps": "Underpowered due to early cessation and small sample size. Single centre and lower cumulative dose than TRIAD limit efficacy comparability.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        }
      ],
      "researchGroups": {
        "maxChars": 7485,
        "truncated": false,
        "text": "Paper: An open science study of ageing in companion dogs (Nature 2022)\nGroup: Dog Aging Project - Clinical Core (Texas A&M University, College of Veterinary Medicine)\nWebsite: https://vetmed.tamu.edu/news/press-releases/dog-aging-project-nature-article/\nSummary: Leads clinical operations and site coordination for DAP, including TRIAD trial execution and cardiology imaging workflows.\n| Name | Email | Role |\n| --- | --- | --- |\n| Kate E. Creevy | kcreevy@cvm.tamu.edu | PI; DAP Chief Veterinary Officer |\n| Small Animal Cardiology Service (TAMU) | Not provided | Imaging core for TRIAD echocardiography visits and cardiac endpoints |\n\nGroup: Promislow Lab (University of Washington, Biology)\nWebsite: https://promislowlab.org/people/\nSummary: Co-directs DAP science and analytics; runs longitudinal epidemiology and genomics linking survey, EMR and multi-omics.\n| Name | Email | Role |\n| --- | --- | --- |\n| Daniel E. L. Promislow | promislow@tufts.edu | PI (DAP Co-Director; corresponded email listed via current affiliate profile) |\n| Silvan R. Urfer | Not provided | Research Scientist (ageing, cardiology endpoints; co-author on DAP rapamycin RCTs) |\n\nGroup: Snyder-Mackler Lab (Arizona State University, Center for Evolution & Medicine)\nWebsite: https://smack-lab.com/\nSummary: Oversees DAP epigenomics and biomarker development; active outputs since 2020 on social-environment and ageing genomics including companion dogs.\n| Name | Email | Role |\n| --- | --- | --- |\n| Noah Snyder-Mackler | nsnyderm@asu.edu | PI |\n| Kelsi Watkins | klwatki5@asu.edu | PhD student (genomics) |\n\nGroup: Cornell Veterinary Biobank (Cornell University, College of Veterinary Medicine)\nWebsite: https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-veterinary-biobank\nSummary: Accredited biobank supporting DAP's open-science sample access, QC and withdrawals; DAP partner for biospecimen governance.\n| Name | Email | Role |\n| --- | --- | --- |\n| Marta G. Castelhano | mgc27@cornell.edu | Director (PI on GRLS biobank assessment) |\n| General enquiries | vetbiobank@cornell.edu | Access and withdrawals |\n\nPaper: Cohort profile: The Golden Retriever Lifetime Study (10.1371/journal.pone.0269425)\nGroup: Golden Retriever Lifetime Study Team (Morris Animal Foundation)\nWebsite: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0269425\nSummary: Prospective owner-surveyed, EMR-linked canine cohort with biospecimen banking; mirrors DAP's observational and QC infrastructure.\n| Name | Email | Role |\n| --- | --- | --- |\n| Julia Labadie | Not provided | Principal Investigator, GRLS |\n| Janet Patterson-Kane | Not provided | Chief Scientific Officer, MAF (GRLS senior leadership) |\n| General GRLS enquiries | Not provided | Study contact |\n\nGroup: Flint Animal Cancer Center (Colorado State University)\nWebsite: https://www.csuvetce.org/organizations/6804/pages/110918\nSummary: Oncology centre historically leading GRLS scientific direction and cancer endpoints; ongoing translational cancer epidemiology.\n| Name | Email | Role |\n| --- | --- | --- |\n| Rodney L. Page | rodney.page@colostate.edu | Director; GRLS founding PI |\n\nGroup: Cornell Veterinary Biobank (Cornell University, College of Veterinary Medicine)\nWebsite: https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-veterinary-biobank\nSummary: Supports GRLS sample archiving, QC and access requests; ISO-accredited processes and governance.\n| Name | Email | Role |\n| --- | --- | --- |\n| Marta G. Castelhano | mgc27@cornell.edu | Director; GRLS biobank assessment PI |\n| General enquiries | vetbiobank@cornell.edu | Access and withdrawals |\n\nPaper: Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a multicentre RCT (10.1007/s11357-024-01484-7)\nGroup: Dog Aging Project - TRIAD Clinical Network (Texas A&M University)\nWebsite: https://link.springer.com/article/10.1007/s11357-024-01484-7\nSummary: Runs randomised, double-masked, placebo-controlled rapamycin RCT across DAP sites; prespecified lifespan and healthspan endpoints with DSMB and imaging cores.\n| Name | Email | Role |\n| --- | --- | --- |\n| Kate E. Creevy | kcreevy@cvm.tamu.edu | Clinical PI; DAP CVO |\n| Small Animal Cardiology Service (TAMU) | Not provided | TRIAD echocardiography core visits |\n\nGroup: Promislow Lab (University of Washington, Biology)\nWebsite: https://promislowlab.org/people/\nSummary: Co-leads TRIAD design and DAP analytics; integrates survey, EMR and omics with trial endpoints.\n| Name | Email | Role |\n| --- | --- | --- |\n| Daniel E. L. Promislow | promislow@tufts.edu | PI; DAP Co-Director |\n| Silvan R. Urfer | Not provided | Research Scientist; co-author on rapamycin trials |\n\nGroup: Snyder-Mackler Lab (Arizona State University)\nWebsite: https://smack-lab.com/\nSummary: Provides epigenomic and biomarker expertise supporting TRIAD's healthspan measures and DAP multi-omics.\n| Name | Email | Role |\n| --- | --- | --- |\n| Noah Snyder-Mackler | nsnyderm@asu.edu | PI |\n| Kelsi Watkins | klwatki5@asu.edu | PhD student |\n\nPaper: A randomised controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs (10.1007/s11357-017-9972-z)\nGroup: University of Washington - Ageing Dog Studies (University of Washington)\nWebsite: https://europepmc.org/article/PMC/PMC5411365\nSummary: Ran the pilot masked RCT that informed TRIAD endpoints, safety labs and echocardiography measures.\n| Name | Email | Role |\n| --- | --- | --- |\n| Daniel E. L. Promislow | promislow@tufts.edu | PI (DAP Co-Director) |\n| Silvan R. Urfer | Not provided | Research Scientist; co-author and trial operator |\n\nGroup: VCA Clinical Studies/Oncology (VCA Animal Hospitals)\nWebsite: https://vcahospitals.com/oncology/leadership\nSummary: Veterinary oncology network collaborating on canine ageing and oncology trials; co-authored the rapamycin pilot RCT.\n| Name | Email | Role |\n| --- | --- | --- |\n| Philip J. Bergman | philip.bergman@vca.com | PI; Oncology R&D Leader |\n\nPaper: DNA methylation clocks for dogs and humans (10.1073/pnas.2120887119)\nGroup: Horvath Lab / Epigenetic Clock Development Foundation (UCLA and Clock Foundation)\nWebsite: https://dnamage.clockfoundation.org/\nSummary: Develops and validates cross-species methylation clocks (including canine) and provides research-grade tools for trials; prolific outputs since 2020 via the Mammalian Methylation Consortium.\n| Name | Email | Role |\n| --- | --- | --- |\n| Steve Horvath | shorvath@mednet.ucla.edu | PI (UCLA) |\n| Clock Foundation team | info@clockfoundation.org | Foundation contact for collaboration and tools |\n| Amin Haghani | Not provided | Postdoctoral researcher; first author on mammalian traits methylation network paper (Science 2023) |\n\nPaper: Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom (10.1038/s41598-022-10341-6)\nGroup: VetCompass Programme (Royal Veterinary College, University of London)\nWebsite: https://www.rvc.ac.uk/VetCompass\nSummary: Primary-care EMR extraction and verification pipelines underpin population-scale mortality metrics used to benchmark DAP survival models.\n| Name | Email | Role |\n| --- | --- | --- |\n| Dan O'Neill | doneill@rvc.ac.uk | PI; VetCompass epidemiology lead |\n| Dave C. Brodbelt | dbrodbelt@rvc.ac.uk | Professor of Evidence-based Veterinary Medicine; co-author |\n| Camilla Pegram | cpegram@rvc.ac.uk | Epidemiology researcher; co-author |\n| David B. Church | dchurch@rvc.ac.uk | Professor of Small Animal Studies; co-author |",
        "structured": {
          "papers": [
            {
              "title": "An open science study of ageing in companion dogs",
              "identifier": "Nature 2022",
              "groups": [
                {
                  "name": "Dog Aging Project - Clinical Core",
                  "institution": "Texas A&M University, College of Veterinary Medicine",
                  "website": "https://vetmed.tamu.edu/news/press-releases/dog-aging-project-nature-article/",
                  "notes": "Leads clinical operations and site coordination for DAP, including TRIAD trial execution and cardiology imaging workflows.",
                  "researchers": [
                    {
                      "name": "Kate E. Creevy",
                      "email": "kcreevy@cvm.tamu.edu",
                      "role": "PI; DAP Chief Veterinary Officer"
                    },
                    {
                      "name": "Small Animal Cardiology Service (TAMU)",
                      "email": null,
                      "role": "Imaging core for TRIAD echocardiography visits and cardiac endpoints"
                    }
                  ]
                },
                {
                  "name": "Promislow Lab",
                  "institution": "University of Washington, Biology",
                  "website": "https://promislowlab.org/people/",
                  "notes": "Co-directs DAP science and analytics; runs longitudinal epidemiology and genomics linking survey, EMR and multi-omics.",
                  "researchers": [
                    {
                      "name": "Daniel E. L. Promislow",
                      "email": "promislow@tufts.edu",
                      "role": "PI (DAP Co-Director; corresponded email listed via current affiliate profile)"
                    },
                    {
                      "name": "Silvan R. Urfer",
                      "email": null,
                      "role": "Research Scientist (ageing, cardiology endpoints; co-author on DAP rapamycin RCTs)"
                    }
                  ]
                },
                {
                  "name": "Snyder-Mackler Lab",
                  "institution": "Arizona State University, Center for Evolution & Medicine",
                  "website": "https://smack-lab.com/",
                  "notes": "Oversees DAP epigenomics and biomarker development; active outputs since 2020 on social-environment and ageing genomics including companion dogs.",
                  "researchers": [
                    {
                      "name": "Noah Snyder-Mackler",
                      "email": "nsnyderm@asu.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Kelsi Watkins",
                      "email": "klwatki5@asu.edu",
                      "role": "PhD student (genomics)"
                    }
                  ]
                },
                {
                  "name": "Cornell Veterinary Biobank",
                  "institution": "Cornell University, College of Veterinary Medicine",
                  "website": "https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-veterinary-biobank",
                  "notes": "Accredited biobank supporting DAP's open-science sample access, QC and withdrawals; DAP partner for biospecimen governance.",
                  "researchers": [
                    {
                      "name": "Marta G. Castelhano",
                      "email": "mgc27@cornell.edu",
                      "role": "Director (PI on GRLS biobank assessment)"
                    },
                    {
                      "name": "General enquiries",
                      "email": "vetbiobank@cornell.edu",
                      "role": "Access and withdrawals"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Cohort profile: The Golden Retriever Lifetime Study",
              "identifier": "10.1371/journal.pone.0269425",
              "groups": [
                {
                  "name": "Golden Retriever Lifetime Study Team",
                  "institution": "Morris Animal Foundation",
                  "website": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0269425",
                  "notes": "Prospective owner-surveyed, EMR-linked canine cohort with biospecimen banking; mirrors DAP's observational and QC infrastructure.",
                  "researchers": [
                    {
                      "name": "Julia Labadie",
                      "email": null,
                      "role": "Principal Investigator, GRLS"
                    },
                    {
                      "name": "Janet Patterson-Kane",
                      "email": null,
                      "role": "Chief Scientific Officer, MAF (GRLS senior leadership)"
                    },
                    {
                      "name": "General GRLS enquiries",
                      "email": null,
                      "role": "Study contact"
                    }
                  ]
                },
                {
                  "name": "Flint Animal Cancer Center",
                  "institution": "Colorado State University",
                  "website": "https://www.csuvetce.org/organizations/6804/pages/110918",
                  "notes": "Oncology centre historically leading GRLS scientific direction and cancer endpoints; ongoing translational cancer epidemiology.",
                  "researchers": [
                    {
                      "name": "Rodney L. Page",
                      "email": "rodney.page@colostate.edu",
                      "role": "Director; GRLS founding PI"
                    }
                  ]
                },
                {
                  "name": "Cornell Veterinary Biobank",
                  "institution": "Cornell University, College of Veterinary Medicine",
                  "website": "https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-veterinary-biobank",
                  "notes": "Supports GRLS sample archiving, QC and access requests; ISO-accredited processes and governance.",
                  "researchers": [
                    {
                      "name": "Marta G. Castelhano",
                      "email": "mgc27@cornell.edu",
                      "role": "Director; GRLS biobank assessment PI"
                    },
                    {
                      "name": "General enquiries",
                      "email": "vetbiobank@cornell.edu",
                      "role": "Access and withdrawals"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a multicentre RCT",
              "identifier": "10.1007/s11357-024-01484-7",
              "groups": [
                {
                  "name": "Dog Aging Project - TRIAD Clinical Network",
                  "institution": "Texas A&M University",
                  "website": "https://link.springer.com/article/10.1007/s11357-024-01484-7",
                  "notes": "Runs randomised, double-masked, placebo-controlled rapamycin RCT across DAP sites; prespecified lifespan and healthspan endpoints with DSMB and imaging cores.",
                  "researchers": [
                    {
                      "name": "Kate E. Creevy",
                      "email": "kcreevy@cvm.tamu.edu",
                      "role": "Clinical PI; DAP CVO"
                    },
                    {
                      "name": "Small Animal Cardiology Service (TAMU)",
                      "email": null,
                      "role": "TRIAD echocardiography core visits"
                    }
                  ]
                },
                {
                  "name": "Promislow Lab",
                  "institution": "University of Washington, Biology",
                  "website": "https://promislowlab.org/people/",
                  "notes": "Co-leads TRIAD design and DAP analytics; integrates survey, EMR and omics with trial endpoints.",
                  "researchers": [
                    {
                      "name": "Daniel E. L. Promislow",
                      "email": "promislow@tufts.edu",
                      "role": "PI; DAP Co-Director"
                    },
                    {
                      "name": "Silvan R. Urfer",
                      "email": null,
                      "role": "Research Scientist; co-author on rapamycin trials"
                    }
                  ]
                },
                {
                  "name": "Snyder-Mackler Lab",
                  "institution": "Arizona State University",
                  "website": "https://smack-lab.com/",
                  "notes": "Provides epigenomic and biomarker expertise supporting TRIAD's healthspan measures and DAP multi-omics.",
                  "researchers": [
                    {
                      "name": "Noah Snyder-Mackler",
                      "email": "nsnyderm@asu.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Kelsi Watkins",
                      "email": "klwatki5@asu.edu",
                      "role": "PhD student"
                    }
                  ]
                }
              ]
            },
            {
              "title": "A randomised controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs",
              "identifier": "10.1007/s11357-017-9972-z",
              "groups": [
                {
                  "name": "University of Washington - Ageing Dog Studies",
                  "institution": "University of Washington",
                  "website": "https://europepmc.org/article/PMC/PMC5411365",
                  "notes": "Ran the pilot masked RCT that informed TRIAD endpoints, safety labs and echocardiography measures.",
                  "researchers": [
                    {
                      "name": "Daniel E. L. Promislow",
                      "email": "promislow@tufts.edu",
                      "role": "PI (DAP Co-Director)"
                    },
                    {
                      "name": "Silvan R. Urfer",
                      "email": null,
                      "role": "Research Scientist; co-author and trial operator"
                    }
                  ]
                },
                {
                  "name": "VCA Clinical Studies/Oncology",
                  "institution": "VCA Animal Hospitals",
                  "website": "https://vcahospitals.com/oncology/leadership",
                  "notes": "Veterinary oncology network collaborating on canine ageing and oncology trials; co-authored the rapamycin pilot RCT.",
                  "researchers": [
                    {
                      "name": "Philip J. Bergman",
                      "email": "philip.bergman@vca.com",
                      "role": "PI; Oncology R&D Leader"
                    }
                  ]
                }
              ]
            },
            {
              "title": "DNA methylation clocks for dogs and humans",
              "identifier": "10.1073/pnas.2120887119",
              "groups": [
                {
                  "name": "Horvath Lab / Epigenetic Clock Development Foundation",
                  "institution": "UCLA and Clock Foundation",
                  "website": "https://dnamage.clockfoundation.org/",
                  "notes": "Develops and validates cross-species methylation clocks (including canine) and provides research-grade tools for trials; prolific outputs since 2020 via the Mammalian Methylation Consortium.",
                  "researchers": [
                    {
                      "name": "Steve Horvath",
                      "email": "shorvath@mednet.ucla.edu",
                      "role": "PI (UCLA)"
                    },
                    {
                      "name": "Clock Foundation team",
                      "email": "info@clockfoundation.org",
                      "role": "Foundation contact for collaboration and tools"
                    },
                    {
                      "name": "Amin Haghani",
                      "email": null,
                      "role": "Postdoctoral researcher; first author on mammalian traits methylation network paper (Science 2023)"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom",
              "identifier": "10.1038/s41598-022-10341-6",
              "groups": [
                {
                  "name": "VetCompass Programme",
                  "institution": "Royal Veterinary College, University of London",
                  "website": "https://www.rvc.ac.uk/VetCompass",
                  "notes": "Primary-care EMR extraction and verification pipelines underpin population-scale mortality metrics used to benchmark DAP survival models.",
                  "researchers": [
                    {
                      "name": "Dan O'Neill",
                      "email": "doneill@rvc.ac.uk",
                      "role": "PI; VetCompass epidemiology lead"
                    },
                    {
                      "name": "Dave C. Brodbelt",
                      "email": "dbrodbelt@rvc.ac.uk",
                      "role": "Professor of Evidence-based Veterinary Medicine; co-author"
                    },
                    {
                      "name": "Camilla Pegram",
                      "email": "cpegram@rvc.ac.uk",
                      "role": "Epidemiology researcher; co-author"
                    },
                    {
                      "name": "David B. Church",
                      "email": "dchurch@rvc.ac.uk",
                      "role": "Professor of Small Animal Studies; co-author"
                    }
                  ]
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      },
      "researcherTheses": {
        "maxChars": 4539,
        "truncated": false,
        "text": "Researcher: Kate E. Creevy\nEmail: kcreevy@cvm.tamu.edu\nData publicly available: yes\nLatest publication:\n  - Title: Dog size and patterns of disease history across the canine age spectrum: Results from the Dog Aging Project\n  - Year: 2024\n  - Venue: PLOS ONE\n  - URL: https://doi.org/10.1371/journal.pone.0295840\nPhD thesis: Not found\n\nResearcher: Daniel E. L. Promislow\nEmail: daniel.promislow@tufts.edu\nData publicly available: yes\nLatest publication:\n  - Title: Systems biology approaches identify metabolic signatures of dietary lifespan and healthspan across species\n  - Year: 2024\n  - Venue: Nature Communications\n  - URL: https://www.nature.com/articles/s41467-024-52909-y\nPhD thesis:\n  - Title: Mortality patterns in natural populations of mammals and their consequences\n  - Year: 1990\n  - Institution: University of Oxford\n  - URL: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.256377\n\nResearcher: Julia D. Labadie\nEmail: jdlabadie@gmail.com\nData publicly available: unknown\nLatest publication:\n  - Title: Lifetime age-related changes in clinical laboratory results, aging clocks and mortality predictors in 2412 Golden Retrievers\n  - Year: 2025\n  - Venue: Aging Cell\n  - URL: https://onlinelibrary.wiley.com/doi/10.1111/acel.14438\nPhD thesis:\n  - Title: Using the dog as a model to investigate environmental and genetic risk factors for mature, antigen-driven lymphoproliferative disorders\n  - Year: 2017\n  - Institution: Colorado State University\n  - URL: https://mountainscholar.org/bitstream/handle/10217/184031/Labadie_colostate_0053A_14407.pdf?sequence=1\n\nResearcher: Janet C. Patterson-Kane\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Cohort profile: The Golden Retriever Lifetime Study (GRLS)\n  - Year: 2022\n  - Venue: PLOS ONE\n  - URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0269425\nPhD thesis:\n  - Title: The effect of exercise on the collagen fibril morphology of the digital flexor tendons of the Thoroughbred\n  - Year: 1996\n  - Institution: Massey University\n  - URL: https://mro.massey.ac.nz/docserver/handle/10179/3280?sequence=1\n\nResearcher: Jane Katherine Murray\nEmail: jane.murray@dogstrust.org.uk\nData publicly available: unknown\nLatest publication:\n  - Title: Prevalence and risk factors for gingivitis in a cohort of UK companion cats aged up to 6 years\n  - Year: 2024\n  - Venue: Journal of Small Animal Practice\n  - URL: https://research-information.bris.ac.uk/en/publications/prevalence-and-risk-factors-for-gingivitis-in-a-cohort-of-uk-comp\nPhD thesis: Not found\n\nResearcher: Rachel Alison Casey\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Dogs are more pessimistic if their owners use two or more aversive training methods\n  - Year: 2021\n  - Venue: Scientific Reports\n  - URL: https://research-information.bris.ac.uk/en/publications/dogs-are-more-pessimistic-if-their-owners-use-two-or-more-aversiv\nPhD thesis: Not found\n\nResearcher: Kathleen Morrill\nEmail: kathleen.morrill@umassmed.edu\nData publicly available: unknown\nLatest publication:\n  - Title: Comparative neurogenetics of dog behavior complements efforts towards human neuropsychiatric genetics\n  - Year: 2023\n  - Venue: Human Genetics\n  - URL: https://repository.escholarship.umassmed.edu/handle/20.500.14038/52650\nPhD thesis:\n  - Title: The Genomics of Canine Behavior and its Comparative Relevance to Human Neuropsychiatric Conditions\n  - Year: 2023\n  - Institution: UMass Chan Medical School, Morningside Graduate School of Biomedical Sciences\n  - URL: https://repository.escholarship.umassmed.edu/entities/publication/f3de5270-26e1-4362-87d2-bf0c2e708910\n\nResearcher: Elinor K. Karlsson\nEmail: elinor.karlsson@umassmed.edu\nData publicly available: unknown\nLatest publication:\n  - Title: Evolutionary constraint and innovation across hundreds of placental mammals\n  - Year: 2023\n  - Venue: Science\n  - URL: Not found\nPhD thesis:\n  - Title: Mapping Trait Loci in the Genome of the Domesticated Dog\n  - Year: 2008\n  - Institution: Boston University, Bioinformatics Program (Graduate School of Arts & Sciences)\n  - URL: Not found\n\nResearcher: Brian G. Barnett\nEmail: bgray90@uga.edu\nData publicly available: yes\nLatest publication:\n  - Title: A masked, placebo-controlled, randomized clinical trial evaluating safety and the effect on cardiac function of low-dose rapamycin in 17 healthy client-owned dogs\n  - Year: 2023\n  - Venue: Frontiers in Veterinary Science\n  - URL: https://doi.org/10.3389/fvets.2023.1168711\nPhD thesis: Not found",
        "structured": {
          "researchers": [
            {
              "name": "Kate E. Creevy",
              "email": "kcreevy@cvm.tamu.edu",
              "latest_publication": {
                "title": "Dog size and patterns of disease history across the canine age spectrum: Results from the Dog Aging Project",
                "year": 2024,
                "venue": "PLOS ONE",
                "url": "https://doi.org/10.1371/journal.pone.0295840"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "Daniel E. L. Promislow",
              "email": "daniel.promislow@tufts.edu",
              "latest_publication": {
                "title": "Systems biology approaches identify metabolic signatures of dietary lifespan and healthspan across species",
                "year": 2024,
                "venue": "Nature Communications",
                "url": "https://www.nature.com/articles/s41467-024-52909-y"
              },
              "phd_thesis": {
                "title": "Mortality patterns in natural populations of mammals and their consequences",
                "year": 1990,
                "institution": "University of Oxford",
                "url": "https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.256377"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Julia D. Labadie",
              "email": "jdlabadie@gmail.com",
              "latest_publication": {
                "title": "Lifetime age-related changes in clinical laboratory results, aging clocks and mortality predictors in 2412 Golden Retrievers",
                "year": 2025,
                "venue": "Aging Cell",
                "url": "https://onlinelibrary.wiley.com/doi/10.1111/acel.14438"
              },
              "phd_thesis": {
                "title": "Using the dog as a model to investigate environmental and genetic risk factors for mature, antigen-driven lymphoproliferative disorders",
                "year": 2017,
                "institution": "Colorado State University",
                "url": "https://mountainscholar.org/bitstream/handle/10217/184031/Labadie_colostate_0053A_14407.pdf?sequence=1"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Janet C. Patterson-Kane",
              "email": null,
              "latest_publication": {
                "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
                "year": 2022,
                "venue": "PLOS ONE",
                "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0269425"
              },
              "phd_thesis": {
                "title": "The effect of exercise on the collagen fibril morphology of the digital flexor tendons of the Thoroughbred",
                "year": 1996,
                "institution": "Massey University",
                "url": "https://mro.massey.ac.nz/docserver/handle/10179/3280?sequence=1"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Jane Katherine Murray",
              "email": "jane.murray@dogstrust.org.uk",
              "latest_publication": {
                "title": "Prevalence and risk factors for gingivitis in a cohort of UK companion cats aged up to 6 years",
                "year": 2024,
                "venue": "Journal of Small Animal Practice",
                "url": "https://research-information.bris.ac.uk/en/publications/prevalence-and-risk-factors-for-gingivitis-in-a-cohort-of-uk-comp"
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Rachel Alison Casey",
              "email": null,
              "latest_publication": {
                "title": "Dogs are more pessimistic if their owners use two or more aversive training methods",
                "year": 2021,
                "venue": "Scientific Reports",
                "url": "https://research-information.bris.ac.uk/en/publications/dogs-are-more-pessimistic-if-their-owners-use-two-or-more-aversiv"
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Kathleen Morrill",
              "email": "kathleen.morrill@umassmed.edu",
              "latest_publication": {
                "title": "Comparative neurogenetics of dog behavior complements efforts towards human neuropsychiatric genetics",
                "year": 2023,
                "venue": "Human Genetics",
                "url": "https://repository.escholarship.umassmed.edu/handle/20.500.14038/52650"
              },
              "phd_thesis": {
                "title": "The Genomics of Canine Behavior and its Comparative Relevance to Human Neuropsychiatric Conditions",
                "year": 2023,
                "institution": "UMass Chan Medical School, Morningside Graduate School of Biomedical Sciences",
                "url": "https://repository.escholarship.umassmed.edu/entities/publication/f3de5270-26e1-4362-87d2-bf0c2e708910"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Elinor K. Karlsson",
              "email": "elinor.karlsson@umassmed.edu",
              "latest_publication": {
                "title": "Evolutionary constraint and innovation across hundreds of placental mammals",
                "year": 2023,
                "venue": "Science",
                "url": null
              },
              "phd_thesis": {
                "title": "Mapping Trait Loci in the Genome of the Domesticated Dog",
                "year": 2008,
                "institution": "Boston University, Bioinformatics Program (Graduate School of Arts & Sciences)",
                "url": null
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Brian G. Barnett",
              "email": "bgray90@uga.edu",
              "latest_publication": {
                "title": "A masked, placebo-controlled, randomized clinical trial evaluating safety and the effect on cardiac function of low-dose rapamycin in 17 healthy client-owned dogs",
                "year": 2023,
                "venue": "Frontiers in Veterinary Science",
                "url": "https://doi.org/10.3389/fvets.2023.1168711"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            }
          ],
          "promptNotes": "Compiled from all thesis discovery responses in this thread. Where no PhD thesis was verified, phd_thesis is null."
        }
      },
      "patents": {
        "text": "Patent: US11894143B2\nTitle: System and methods for integrating animal health records\nAssignee: Whiskers Worldwide LLC\nFiling Date: 2020-03-06\nGrant Date: 2024-02-06\nAbstract: Integrates veterinary EMRs, owner-reported data, wearables and other sources into a unified pet health record, with analytics at individual and population levels. Factors include breed, age, geography, living conditions, diet and exercise.\nOverlaps with paper claims: C1\nTechnical overlap: The claims cover ingestion and normalisation of heterogeneous pet data streams (veterinary EMRs, owner surveys, wearables) and linkage to demographic and geographic variables to produce cohort-level analytics. This maps directly to DAP's longitudinal data backbone that combines EMRs, annual surveys, environmental linkage and biospecimens to enable open-data cohort analyses. The patented architecture validates the feasibility and independent development of the data integration approach described in C1.\n\nPatent: US20220401421A1\nTitle: Veterinary formulations comprising rapamycin and methods of using the same for treating animal disease\nAssignee: TriviumVet DAC\nFiling Date: 2020-12-18\nGrant Date: Not provided\nAbstract: Rapamycin formulations and dosing regimens for companion animals, including dogs, to treat cardiac dysfunction and ageing-related decline, supported by pharmacokinetic modelling and repeated-dose simulations.\nOverlaps with paper claims: C3\nTechnical overlap: Independent claims recite administering low, non-immunosuppressive doses of rapamycin to dogs using oral formulations to improve cardiac function and mitigate ageing effects. This maps to the TRIAD protocol's weekly low-dose rapamycin intervention in middle-aged, large-breed dogs with cardiology endpoints. The dosing rationale and veterinary indications provide patent-level validation of the intervention strategy described in C3.\n\nPatent: US20240287605A1\nTitle: Epigenetic clocks\nAssignee: The Regents of the University of California (UC San Diego)\nFiling Date: 2022-06-24\nGrant Date: Not provided\nAbstract: Discloses methylation-based ageing biomarkers, including dual-species human-dog clocks using targeted CpG panels, to estimate chronological and biological age and evaluate interventions across mammals.\nOverlaps with paper claims: C1, C2\nTechnical overlap: Claims cover specific CpG panels and computational methods that generate canine and human-dog dual epigenetic clocks, enabling cross-species measurement of biological ageing. This operationalises the translational premise that companion dogs model human ageing and provides a concrete assay modality compatible with DAP's multi-omics plan. The patented clock methods validate C1's biomarker strategy and substantiate C2's translational rationale by providing tools to compare canine and human ageing trajectories.\n\nPatent: WO2023232812A1\nTitle: Method to improve health outcomes of a dog using biological age\nAssignee: Société des Produits Nestlé SA\nFiling Date: 2023-05-30\nGrant Date: Not provided\nAbstract: Determines a dog's biological age from DNA methylation and selects lifestyle, dietary or therapeutic interventions, then reassesses biological age post-intervention using computer-implemented systems and kits.\nOverlaps with paper claims: C1, C3\nTechnical overlap: Independent claims implement a longitudinal loop: measure canine methylation age, apply an intervention, and re-measure to quantify biological age change with system and data workflows. This mirrors DAP's plan to collect multi-omics over time and evaluate intervention impact, and it aligns with TRIAD's need for biomarker endpoints to track healthspan effects. The patented framework validates using methylation-based biological age as an outcome measure within the DAP infrastructure and rapamycin trial.",
        "structured": {
          "patents": [
            {
              "patentNumber": "US11894143B2",
              "title": "System and methods for integrating animal health records",
              "assignee": "Whiskers Worldwide LLC",
              "filingDate": "2020-03-06",
              "grantDate": "2024-02-06",
              "abstract": "Integrates veterinary EMRs, owner-reported data, wearables and other sources into a unified pet health record, with analytics at individual and population levels. Factors include breed, age, geography, living conditions, diet and exercise.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1"
                ],
                "summary": "The claims cover ingestion and normalisation of heterogeneous pet data streams (veterinary EMRs, owner surveys, wearables) and linkage to demographic and geographic variables to produce cohort-level analytics. This maps directly to DAP's longitudinal data backbone that combines EMRs, annual surveys, environmental linkage and biospecimens to enable open-data cohort analyses. The patented architecture validates the feasibility and independent development of the data integration approach described in C1."
              },
              "url": null
            },
            {
              "patentNumber": "US20220401421A1",
              "title": "Veterinary formulations comprising rapamycin and methods of using the same for treating animal disease",
              "assignee": "TriviumVet DAC",
              "filingDate": "2020-12-18",
              "grantDate": null,
              "abstract": "Rapamycin formulations and dosing regimens for companion animals, including dogs, to treat cardiac dysfunction and ageing-related decline, supported by pharmacokinetic modelling and repeated-dose simulations.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "Independent claims recite administering low, non-immunosuppressive doses of rapamycin to dogs using oral formulations to improve cardiac function and mitigate ageing effects. This maps to the TRIAD protocol's weekly low-dose rapamycin intervention in middle-aged, large-breed dogs with cardiology endpoints. The dosing rationale and veterinary indications provide patent-level validation of the intervention strategy described in C3."
              },
              "url": null
            },
            {
              "patentNumber": "US20240287605A1",
              "title": "Epigenetic clocks",
              "assignee": "The Regents of the University of California (UC San Diego)",
              "filingDate": "2022-06-24",
              "grantDate": null,
              "abstract": "Discloses methylation-based ageing biomarkers, including dual-species human-dog clocks using targeted CpG panels, to estimate chronological and biological age and evaluate interventions across mammals.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C2"
                ],
                "summary": "Claims cover specific CpG panels and computational methods that generate canine and human-dog dual epigenetic clocks, enabling cross-species measurement of biological ageing. This operationalises the translational premise that companion dogs model human ageing and provides a concrete assay modality compatible with DAP's multi-omics plan. The patented clock methods validate C1's biomarker strategy and substantiate C2's translational rationale by providing tools to compare canine and human ageing trajectories."
              },
              "url": null
            },
            {
              "patentNumber": "WO2023232812A1",
              "title": "Method to improve health outcomes of a dog using biological age",
              "assignee": "Société des Produits Nestlé SA",
              "filingDate": "2023-05-30",
              "grantDate": null,
              "abstract": "Determines a dog's biological age from DNA methylation and selects lifestyle, dietary or therapeutic interventions, then reassesses biological age post-intervention using computer-implemented systems and kits.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C3"
                ],
                "summary": "Independent claims implement a longitudinal loop: measure canine methylation age, apply an intervention, and re-measure to quantify biological age change with system and data workflows. This mirrors DAP's plan to collect multi-omics over time and evaluate intervention impact, and it aligns with TRIAD's need for biomarker endpoints to track healthspan effects. The patented framework validates using methylation-based biological age as an outcome measure within the DAP infrastructure and rapamycin trial."
              },
              "url": null
            }
          ],
          "promptNotes": "Parsed and normalised from analyst notes into Evidentia JSON with dates in ISO format and Google Patents URLs."
        }
      },
      "verifiedClaims": {
        "text": "=== OVERALL ASSESSMENT ===\nDAP's platform and embedded TRIAD trial are robustly described and operationally feasible, with independent cohorts, EMR-based life tables, biobanking partners, community-science genomics and related patents converging on methodological soundness. The strongest caveats are that open-data access is staged and governed, the dog model is context-dependent rather than universally ideal, and rapamycin efficacy in dogs remains unproven with some neutral results; overall the paper's platform claims are solid while translational and interventional outcomes require further independent replication.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: The DAP is a large, open-data, long-term longitudinal study capturing genetic, environmental, clinical and multi-omics data from companion dogs to identify determinants of healthy lifespan and enable community science.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Cohort profile: The Golden Retriever Lifetime Study (GRLS)\n    Independent, large, prospective owner-survey cohort with annual biospecimens and central biobanking demonstrating feasibility similar to DAP's platform.\n  - [Similar Paper] Generation Pup - protocol for a longitudinal study of dog behaviour and health\n    National all-breeds survey cohort with optional biological sampling, consented veterinary notes and biobanking that mirrors DAP's survey plus biospecimen workflows.\n  - [Similar Paper] Ancestry inclusive dog genomics challenges popular breed stereotypes\n    Community-science phenotyping paired with low-pass whole genome sequencing and imputation, matching DAP's genetics modality.\n  - [Research Group] Cornell Veterinary Biobank\n    ISO-accredited biobank partner supporting DAP's sample governance, quality control and withdrawals for open-science access.\n  - [Patent] US11894143B2 System and methods for integrating animal health records\n    Independently describes integrating EMRs, owner surveys and wearables with geo-demographics for cohort analytics, aligning with DAP's informatics backbone.\n\nContradicting Evidence:\n  - [Research Group] Dog Aging Project data-access page\n    Staged, governed releases mean not all raw genomic and multi-omics modalities are immediately open, tempering a blanket open-data characterisation.\n\nSummary: DAP's infrastructure for surveys, EMRs, environmental linkage, biobanking and genetics is well substantiated, and comparable large cohorts show the platform is feasible. Open-data is accurate in spirit but is phased and governed for sensitive modalities, so the claim is only partially met.\n\nClaim: C2\nOriginal: Companion dogs are an ideal, socially relevant model for studying biological ageing with translational potential to humans because they share human environments and healthcare, experience similar age-related diseases, and age much faster.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] The companion dog as a model for human ageing and mortality\n    Compares human and canine mortality and comorbidity patterns and argues translational relevance based on shared environments.\n  - [Similar Paper] The companion dog as a unique translational model for ageing\n    Reviews shared environments, naturally occurring age-related diseases and faster ageing that enable feasible longitudinal and interventional studies.\n  - [Similar Paper] Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom\n    EMR-derived survival metrics enable human-style survival modelling and benchmarking in dogs.\n  - [Patent] US20240287605A1 Epigenetic clocks\n    Provides cross-species epigenetic clock methods that allow comparative biological age measurement in dogs and humans, supporting translational assessment.\n\nSummary: Independent reviews and EMR-based epidemiology support dogs as socially embedded, fast-ageing models with human-relevant morbidities and measurable cross-species biomarkers. Differences in disease spectra, breed structure and care patterns limit universal translation, so the model is strong but not globally ideal.\n\nClaim: C3\nOriginal: The DAP will test whether a one-year course of weekly low-dose rapamycin increases lifespan and healthspan in middle-aged, large-breed dogs via the randomised, double-masked, placebo-controlled TRIAD trial.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] TRIAD: study design and rationale for a multicentre randomised, double-masked, placebo-controlled RCT\n    Details a DAP-embedded RCT across multiple hospitals with prespecified lifespan, cardiac and cognitive endpoints, safety labs and imaging.\n  - [Similar Paper] A randomized controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs\n    Pilot masked RCT informing TRIAD's cardiology and safety endpoints and demonstrating feasibility of low-dose rapamycin in client-owned dogs.\n  - [Similar Paper] A masked, placebo-controlled, randomized clinical trial evaluating safety and the effect on cardiac function of low-dose rapamycin in 17 healthy client-owned dogs\n    Independent RCT aligning with TRIAD dosing, masking and visit cadence, supporting operational feasibility.\n  - [Patent] US20220401421A1 Veterinary formulations comprising rapamycin and methods of using the same for treating animal disease\n    Claims non-immunosuppressive oral rapamycin for canine cardiac and ageing endpoints, supporting veterinary dosing rationale.\n\nContradicting Evidence:\n  - [Similar Paper] A masked, placebo-controlled, randomized clinical trial evaluating safety and the effect on cardiac function of low-dose rapamycin in 17 healthy client-owned dogs\n    Reported no significant change in primary echocardiographic endpoints versus placebo over 6 months, tempering efficacy expectations.\n\nSummary: The existence and design of a year-long, weekly low-dose rapamycin RCT within DAP are well documented, but definitive lifespan and healthspan results are not yet reported. Small trials show mixed or null cardiac effects, so only the testing claim is supported while efficacy remains unproven.\n",
        "structured": {
          "claims": [
            {
              "claimId": "C1",
              "originalClaim": "The DAP is a large, open-data, long-term longitudinal study capturing genetic, environmental, clinical and multi-omics data from companion dogs to identify determinants of healthy lifespan and enable community science.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
                  "relevance": "Independent, large, prospective owner-survey cohort with annual biospecimens and central biobanking demonstrating feasibility similar to DAP's platform."
                },
                {
                  "source": "Similar Paper",
                  "title": "Generation Pup - protocol for a longitudinal study of dog behaviour and health",
                  "relevance": "National all-breeds survey cohort with optional biological sampling, consented veterinary notes and biobanking that mirrors DAP's survey plus biospecimen workflows."
                },
                {
                  "source": "Similar Paper",
                  "title": "Ancestry inclusive dog genomics challenges popular breed stereotypes",
                  "relevance": "Community-science phenotyping paired with low-pass whole genome sequencing and imputation, matching DAP's genetics modality."
                },
                {
                  "source": "Research Group",
                  "title": "Cornell Veterinary Biobank",
                  "relevance": "ISO-accredited biobank partner supporting DAP's sample governance, quality control and withdrawals for open-science access."
                },
                {
                  "source": "Patent",
                  "title": "US11894143B2 System and methods for integrating animal health records",
                  "relevance": "Independently describes integrating EMRs, owner surveys and wearables with geo-demographics for cohort analytics, aligning with DAP's informatics backbone."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Research Group",
                  "title": "Dog Aging Project data-access page",
                  "relevance": "Staged, governed releases mean not all raw genomic and multi-omics modalities are immediately open, tempering a blanket open-data characterisation."
                }
              ],
              "verificationSummary": "DAP's infrastructure for surveys, EMRs, environmental linkage, biobanking and genetics is well substantiated, and comparable large cohorts show the platform is feasible. Open-data is accurate in spirit but is phased and governed for sensitive modalities, so the claim is only partially met.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C2",
              "originalClaim": "Companion dogs are an ideal, socially relevant model for studying biological ageing with translational potential to humans because they share human environments and healthcare, experience similar age-related diseases, and age much faster.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "The companion dog as a model for human ageing and mortality",
                  "relevance": "Compares human and canine mortality and comorbidity patterns and argues translational relevance based on shared environments."
                },
                {
                  "source": "Similar Paper",
                  "title": "The companion dog as a unique translational model for ageing",
                  "relevance": "Reviews shared environments, naturally occurring age-related diseases and faster ageing that enable feasible longitudinal and interventional studies."
                },
                {
                  "source": "Similar Paper",
                  "title": "Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom",
                  "relevance": "EMR-derived survival metrics enable human-style survival modelling and benchmarking in dogs."
                },
                {
                  "source": "Patent",
                  "title": "US20240287605A1 Epigenetic clocks",
                  "relevance": "Provides cross-species epigenetic clock methods that allow comparative biological age measurement in dogs and humans, supporting translational assessment."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "Independent reviews and EMR-based epidemiology support dogs as socially embedded, fast-ageing models with human-relevant morbidities and measurable cross-species biomarkers. Differences in disease spectra, breed structure and care patterns limit universal translation, so the model is strong but not globally ideal.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C3",
              "originalClaim": "The DAP will test whether a one-year course of weekly low-dose rapamycin increases lifespan and healthspan in middle-aged, large-breed dogs via the randomised, double-masked, placebo-controlled TRIAD trial.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "TRIAD: study design and rationale for a multicentre randomised, double-masked, placebo-controlled RCT",
                  "relevance": "Details a DAP-embedded RCT across multiple hospitals with prespecified lifespan, cardiac and cognitive endpoints, safety labs and imaging."
                },
                {
                  "source": "Similar Paper",
                  "title": "A randomized controlled trial to establish effects of short-term rapamycin in 24 middle-aged dogs",
                  "relevance": "Pilot masked RCT informing TRIAD's cardiology and safety endpoints and demonstrating feasibility of low-dose rapamycin in client-owned dogs."
                },
                {
                  "source": "Similar Paper",
                  "title": "A masked, placebo-controlled, randomized clinical trial evaluating safety and the effect on cardiac function of low-dose rapamycin in 17 healthy client-owned dogs",
                  "relevance": "Independent RCT aligning with TRIAD dosing, masking and visit cadence, supporting operational feasibility."
                },
                {
                  "source": "Patent",
                  "title": "US20220401421A1 Veterinary formulations comprising rapamycin and methods of using the same for treating animal disease",
                  "relevance": "Claims non-immunosuppressive oral rapamycin for canine cardiac and ageing endpoints, supporting veterinary dosing rationale."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "A masked, placebo-controlled, randomized clinical trial evaluating safety and the effect on cardiac function of low-dose rapamycin in 17 healthy client-owned dogs",
                  "relevance": "Reported no significant change in primary echocardiographic endpoints versus placebo over 6 months, tempering efficacy expectations."
                }
              ],
              "verificationSummary": "The existence and design of a year-long, weekly low-dose rapamycin RCT within DAP are well documented, but definitive lifespan and healthspan results are not yet reported. Small trials show mixed or null cardiac effects, so only the testing claim is supported while efficacy remains unproven.",
              "confidenceLevel": "Moderate"
            }
          ],
          "overallAssessment": "DAP's platform and embedded TRIAD trial are robustly described and operationally feasible, with independent cohorts, EMR-based life tables, biobanking partners, community-science genomics and related patents converging on methodological soundness. The strongest caveats are that open-data access is staged and governed, the dog model is context-dependent rather than universally ideal, and rapamycin efficacy in dogs remains unproven with some neutral results; overall the paper's platform claims are solid while translational and interventional outcomes require further independent replication.",
          "promptNotes": "Independence: multiple sources from different institutions were used, but some evidence originates from the same consortium.   Data availability: public releases and code exist, yet EMRs and some omics are under governed, phased access, limiting full reproducibility today.   Statistical rigour: existing RCTs in client-owned dogs are small and often underpowered for hard outcomes.   Replication: platform features are replicated across cohorts, but rapamycin efficacy lacks large, independent outcome replications."
        }
      },
      "authorContacts": {
        "maxChars": 2066,
        "truncated": false,
        "text": "Paper: An open science study of ageing in companion dogs\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Kate E. Creevy | kcreevy@cvm.tamu.edu | Professor, Small Animal Clinical Sciences, Texas A&M University | 0000-0003-4169-374X |\n| Daniel E. L. Promislow | daniel.promislow@tufts.edu | Senior Scientist and Scientific Advisor, HNRCA at Tufts University | 0000-0001-7088-4495 |\n\nPaper: Cohort profile: The Golden Retriever Lifetime Study\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Julia Labadie | jdlabadie@gmail.com | Director of Data Science, Copper Leaf Biotherapeutics | 0000-0002-9942-7797 |\n| Janet M. Patterson-Kane | Not found | Chief Scientific Officer, Morris Animal Foundation | 0000-0002-9094-1263 |\n\nPaper: 'Generation Pup' - protocol for a longitudinal study of dog behaviour and health\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Jane Katherine Murray | jane.murray@dogstrust.org.uk | Deputy Head of Research, Welfare Projects & Grants, Dogs Trust | 0000-0002-8525-2877 |\n| Rachel Alison Casey | Not found | Director of Strategy and Transformation, Dogs Trust | 0000-0002-8518-232X |\n\nPaper: Ancestry-inclusive dog genomics challenges popular breed stereotypes\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Kathleen Morrill | kathleen.morrill@umassmed.edu | Researcher, Colossal Biosciences | 0000-0002-9139-453X |\n| Elinor K. Karlsson | elinor.karlsson@umassmed.edu | Director, Vertebrate Genomics Group, Broad Institute; Professor, UMass Chan Medical School | 0000-0002-4343-3776 |\n\nPaper: A masked, placebo-controlled, randomised clinical trial of low-dose rapamycin in 17 healthy client-owned dogs\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Brian G. Barnett | bgray90@uga.edu | Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia | Not found |\n| Kate E. Creevy | kcreevy@cvm.tamu.edu | Professor, Small Animal Clinical Sciences, Texas A&M University; Chief Veterinary Officer, Dog Aging Project | 0000-0003-4169-374X |",
        "structured": {
          "papers": [
            {
              "title": "An open science study of ageing in companion dogs",
              "identifier": null,
              "authors": [
                {
                  "name": "Kate E. Creevy",
                  "email": "kcreevy@cvm.tamu.edu",
                  "role": "Professor, Small Animal Clinical Sciences, Texas A&M University",
                  "orcid": "0000-0003-4169-374X",
                  "profiles": []
                },
                {
                  "name": "Daniel E. L. Promislow",
                  "email": "daniel.promislow@tufts.edu",
                  "role": "Senior Scientist and Scientific Advisor, HNRCA at Tufts University",
                  "orcid": "0000-0001-7088-4495",
                  "profiles": []
                }
              ]
            },
            {
              "title": "Cohort profile: The Golden Retriever Lifetime Study",
              "identifier": null,
              "authors": [
                {
                  "name": "Julia Labadie",
                  "email": "jdlabadie@gmail.com",
                  "role": "Director of Data Science, Copper Leaf Biotherapeutics",
                  "orcid": "0000-0002-9942-7797",
                  "profiles": []
                },
                {
                  "name": "Janet M. Patterson-Kane",
                  "email": null,
                  "role": "Chief Scientific Officer, Morris Animal Foundation",
                  "orcid": "0000-0002-9094-1263",
                  "profiles": []
                }
              ]
            },
            {
              "title": "'Generation Pup' - protocol for a longitudinal study of dog behaviour and health",
              "identifier": null,
              "authors": [
                {
                  "name": "Jane Katherine Murray",
                  "email": "jane.murray@dogstrust.org.uk",
                  "role": "Deputy Head of Research, Welfare Projects & Grants, Dogs Trust",
                  "orcid": "0000-0002-8525-2877",
                  "profiles": []
                },
                {
                  "name": "Rachel Alison Casey",
                  "email": null,
                  "role": "Director of Strategy and Transformation, Dogs Trust",
                  "orcid": "0000-0002-8518-232X",
                  "profiles": []
                }
              ]
            },
            {
              "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes",
              "identifier": null,
              "authors": [
                {
                  "name": "Kathleen Morrill",
                  "email": "kathleen.morrill@umassmed.edu",
                  "role": "Researcher, Colossal Biosciences",
                  "orcid": "0000-0002-9139-453X",
                  "profiles": []
                },
                {
                  "name": "Elinor K. Karlsson",
                  "email": "elinor.karlsson@umassmed.edu",
                  "role": "Director, Vertebrate Genomics Group, Broad Institute; Professor, UMass Chan Medical School",
                  "orcid": "0000-0002-4343-3776",
                  "profiles": []
                }
              ]
            },
            {
              "title": "A masked, placebo-controlled, randomised clinical trial of low-dose rapamycin in 17 healthy client-owned dogs",
              "identifier": null,
              "authors": [
                {
                  "name": "Brian G. Barnett",
                  "email": "bgray90@uga.edu",
                  "role": "Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Kate E. Creevy",
                  "email": "kcreevy@cvm.tamu.edu",
                  "role": "Professor, Small Animal Clinical Sciences, Texas A&M University; Chief Veterinary Officer, Dog Aging Project",
                  "orcid": "0000-0003-4169-374X",
                  "profiles": []
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      }
    }
  ]
} as const;
